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Abstract 
 
Kristina Ile: Diverse roles of phosphatidylinositol transfer protein PITPβ in eukaryotic 
cells 
(Under the direction of Vytas A. Bankaitis) 
 
Phosphatidylinositol transfer proteins (PITPs) provide a dynamic interface 
between membrane dynamics and lipid signaling. PITPα and PITPβ encode for two 
soluble class I, metazoan specific PITPs.  However, despite the fact that PITPα and 
PITPβ share 77 and 95% primary sequence identity and similarity (respectively), PITPα 
and PITPβ are functionally distinct and play nonredundant functions in cells.  Whereas 
PITPα knockout mice have been created, and these mice display neuronal, intestinal, and 
liver pathologies, PITPβ functionality remains largely unknown.   
In this work, I addressed the distinguishing properties of PITPβ and its role in 
mammalian and zebrafish cells.  We identified regions of PITPβ that contributed to its 
unique properties: Golgi localization and sphingomyelin (SM) binding.  Two single point 
mutations are sufficient to ablate the SM binding properties of PITPβ, and the Golgi 
localization was attributed to the combination of two regions of the protein. Next, siRNA 
and morpholino analyses, in mammalian cells and zebrafish respectively, were developed 
to understand the physiological role of PITPβ in cells. In mammalian cells, PITPβ was 
essential for cell survival.  Particularly, PITPβ-depleted cells displayed disorganized 
Golgi networks and anterograde trafficking defects.  Surprisingly, PITPβ was not 
required for cell survival or early development in zebrafish.  Instead, PITPβ maintains the 
 ii
outer segment of the double cone cells of the eye – a cell type required for detection of 
red and green light.  The lack of a housekeeping role for PITPβ led us to examine the 
roles of other PITPs in zebrafish.  A novel third soluble PITP in zebrafish, PITPγ, was 
identified, though its function is not yet determined because we have no means of 
detecting the protein levels to ascertain knockdown.  PITPα, however, had an unexpected 
role in early development: reduction of PITPα led to an arrest at an early stage of 
development (about 12 hpf), ultimately leading to embryonic lethality.  Together, this 
dissertation presents novel roles for class I PITPs in zebrafish, and represents the first 
functional characterization of PITPβ. 
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Abstract 
Membrane lipids function as structural molecules, reservoirs for second messengers, 
membrane platforms that scaffold protein assembly and regulators of enzymes and ion 
channels. Such diverse lipid functions contribute substantially to cellular mechanisms for 
fine-tuning membrane-signaling events. Meaningful coordination of these events requires 
exquisite spatial and temporal control of lipid metabolism and organization, and reliable 
mechanisms for specifically coupling these parameters to dedicated physiological 
processes. Recent studies suggest such integration is linked to the action of 
phosphatidylinositol transfer proteins that operate at the interface of the metabolism, 
trafficking and organization of specific lipids. 
Intro 
An important feature of eukaryotic membranes is their lipid heterogeneity (van 
Meer, 2005). There are over 100 distinct lipid species in a mammalian cell based on the 
criteria of lipid headgroup and backbone composition alone. When one also considers 
acyl-chain heterogeneity (that is, heterogeneity in the chemical nature of the fatty-acyl 
groups that are incorporated into lipid molecules), the number of lipid molecular species 
rises to over 1,000. Why such diversity if the role of membranes is simply to act as 
barriers that define the boundary of the cell and physically segregate biochemically 
distinct internal compartments from one another? We now know that membrane surfaces 
are sites of robust interfacial chemical reactions that are necessary for proper 
maintenance of organellar and cellular homeostasis. Thus, membranes serve as platforms 
for intricate orchestration of the complex biochemistry of signal transduction. Because 
signaling systems are intrinsic properties of eukaryotic cells, the microanatomy of the 
membrane surface must also be sufficiently complex to satisfy the intricacies in the 
organization of such systems. 
Recent progress in many laboratories is leading to an increasing appreciation for 
the complexity of the interface between lipids and proteins, even when one considers 
only the cytoplasmic leaflet of cellular membranes. As one simple example, 
phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P2) constitutes only ~1 mole percent 
of total lipid in mammalian plasma membranes (van Meer, 2005). Yet PtdIns(4,5)P2 has 
many roles in production of second messengers(Berridge and Irvine, 1989; Majerus, 
1992; Nishizuka, 1995; Rhee, 2001). PtdIns(4,5)P2 also regulates membrane-protein 
interactions (Shaw, 1996; Hurley and Meyer, 2001; Lemmon, 2003), enzyme and ion-
channel activity (Suh and Hille, 2005), membrane trafficking to and from the plasma 
membrane (Martin, 2001; Simonsen et al., 2001; Wenk and De Camilli, 2004), activity of 
actin-binding proteins (York et al., 1999; Defacque et al., 2002; Janmey and Lindberg, 
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2004) and, indirectly, transcription and mRNA transport (Kronke, 1999; Odom et al., 
2000). The picture becomes even more complicated when other phosphorylated forms of 
phosphatidylinositol (PtdIns) are considered. There are seven distinct species of 
phosphoinositides (PIPs) in higher eukaryotic cell membranes, of which PtdIns(4,5)P2 is 
one. There is growing evidence that each of these individual PIP isomers also has unique 
biological activity. This chemical diversity offers impressive prospects for intricate and 
combinatorial fine-tuning of PIP-dependent regulation of complex cell functions. In this 
regard, PIPs are uniquely eukaryotic phospholipids. 
Other lipids, previously relegated to 'housekeeping' status, are also more 
functionally versatile than first believed. Enzyme activation by ceramide-based lipids is a 
highly active area of investigation (Pettus et al., 2002; Spiegel and Milstien, 2003; Pettus 
et al., 2004). Phosphatidylserine (PtdSer) activates specific protein kinase C isozymes 
(Stahelin et al., 2003), phosphatidylethanolamine (PtdEtN) organization imparts spatial 
organization to the actin cytoskeleton (Iwamoto et al., 2004) and phosphatidylcholine 
(PtdCho) is a substrate for various phospholipases that release hydrolytic products (for 
example, phosphatidic acid, lysophosphatidic acid and arachidonic acid) having diverse 
signaling capabilities (Exton, 1990; Moolenaar, 1995; Singer et al., 1997). The cellular 
lipid signaling circuitry that connects these regulatory pathways is very complex. For 
example, PtdCho metabolism intersects at several points with PIP metabolism, which 
indicates a cross-talk between these two signaling systems that permits their integration 
(Liscovitch and Cantley, 1995; Sciorra et al., 2002). It is now clear that lipids are not 
homogeneously distributed along the surface of any membrane system. Rather, they are 
dynamically organized into sets of domains that, in turn, impose spatial and temporal 
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regulation on interfacial protein binding and/or enzymatic reactions. Moreover, it is 
becoming increasingly apparent that populations of lipid molecules are functionally 
segregated from others of the same species with respect to their involvements in specific 
intracellular activities. Such functionally distinct populations of specific lipids are 
operationally referred to as 'pools' (Cleves et al., 1991a; Hinchliffe et al., 1998). A 
precise definition of what 'pools' means in a physical sense is often unclear because there 
are many physical explanations for how a functional lipid pool can be created and 
maintained. Some of these concepts are developed further below. 
How are lipid pools segregated in the face of powerful subversive forces, such as 
lateral lipid diffusion and membrane trafficking, that one might expect to erase higher 
order blueprints for lipid organization? Unrestrained lipids are mobile in the plane of a 
membrane bilayer (with diffusion coefficients in the range of 0.1–1.0 μm2 s-1) after all 
(Schwille et al., 1999). Given that yeast cells have a diameter of 5 μm, whereas 
mammalian cells are roughly 10–20 μm in each dimension, this is a considerable rate of 
movement. Vesicle trafficking is also a highly active process that would be expected to 
confound mechanisms for maintaining nonrandom distribution of lipids. The entire 
picture becomes even more confused when the robust contributions of 'household' lipid 
metabolism (both biosynthesis and turnover) are superimposed, particularly when one 
considers that lipids with signaling power are continuously generated and consumed by 
such constitutive metabolic pathways (Schwille et al., 1999). Obviously, the coupling of 
lipid pools to privileged biological functions demands the timely metabolism and/or 
organization of specific lipids. One mechanism for doing so is to interface lipid 
metabolism and signaling with spatial and temporal regulators that can control the 
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metabolic steps themselves, or the organization of the products of such metabolism. This 
concept implies the existence of very small machines, or nanoreactors, in which 
metabolic and signaling reactions take place and their products are subsequently 
organized. 
Herein, we explore the notion that the biological functions of an understudied 
class of eukaryotic proteins, the phosphatidylinositol transfer proteins (PITPs), adhere to 
some of the key principles implicit in a nanoreactor concept. We also discuss the 
emerging evidence that PITPs have key roles in defining the functional identities of 
individual lipid pools. These individual pools are, in turn, dedicated to the regulation of 
specific biological functions. For the purpose of this review, we define nanoreactor to 
mean a functional network connecting a phospholipid-bound PITP, at least one 
phospholipid metabolic enzyme, and a specific lipid-binding component in addition to the 
PITP (or PITP domain in the case of multidomain proteins; Fig. 1). This basic notion is 
inspired by work done some 15 years ago by Konrad Sandhoff and colleagues, who 
demonstrated the existence of activator proteins required for efficient turnover of 
sphingolipids in lysosomes. Although these sphingolipid activator proteins resemble 
PITPs in their behavior as lipid transfer proteins in vitro (see below), they actually 
function as substrate-presentation subunits that mark a bound phospholipid for 
degradation (Furst and Sandhoff, 1992). The metabolic channeling, by a subunit with 
lipid-transfer activity, of a privileged lipid molecule to a specific enzyme is an example 
of what we define as a lipid metabolic nanoreactor. 
PITPs: convergent evolution or something else? 
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To place this discussion in historical context, it has long been appreciated that 
cells express lipid transfer proteins; that is, provisionally cytosolic proteins that catalyze 
the desorption of lipid monomers from bilayers in vitro. In some (but not all) cases, these 
transfer proteins have lipid-binding specificity and are stable as lipid–protein complexes 
in solution. The sphingolipid activator proteins introduced above belong to this general 
class of lipid transfer proteins and have binding specificity for sphingolipids (Furst and 
Sandhoff, 1992). PITPs are uniquely eukaryotic proteins that also have both the property 
of lipid-binding specificity and the ability to form stable protein–phospholipid complexes 
in solution. PITPs catalyze exchange of either PtdIns or PtdCho between membranes in 
vitro (Wirtz, 1997; Hsuan and Cockcroft, 2001; Phillips et al., 2006b). A cycle for such a 
transfer reaction is illustrated in Figure 2. PITPs contain one phospholipid binding site 
per monomer, with a decided preference for PtdIns over PtdCho. PITPs exchange a 
bound phospholipid for a PtdIns or PtdCho monomer that resides in a bona fide 
membrane bilayer. This is done very efficiently and without ATP or other cofactors. 
PITPs abstract a phospholipid molecule from a monolayer, which indicates that bilayer 
organization is not an obligatory requirement for action. As a result, it has been taken 
somewhat as an article of faith that PITPs do not access, or otherwise disturb, the luminal 
leaflet of intracellular membranes. Whether this is actually true remains to be rigorously 
shown. How PITPs couple conformational changes to phospholipid recognition, and eject 
a bound phospholipid in favor of binding and desorbtion of another phospholipid 
molecule, remains unknown. 
PITPs fall into two families on the basis of primary sequence relationships and 
structural fold. We refer to these as the Sec14 family and the metazoan PITP family. 
 6
Sec14-like and metazoan PITPs have nearly identical in vitro activities but share no 
primary sequence similarity and, as shown in Figure 3, have unrelated three-dimensional 
folds. The Sec14 fold defined a novel fold when a crystal structure for the yeast Sec14p 
PITP was solved (Sha et al., 1998; Phillips et al., 1999). By contrast, the metazoan PITP 
fold belongs to the steroidogenic acute response protein–related START-domain family 
(Yoder et al., 2001; Schouten et al., 2002; Tilley et al., 2004). In that respect, it groups 
with other lipid transfer proteins (for example, ceramide transfer protein (Hanada et al., 
2003), PtdCho transfer protein (Roderick et al., 2002) and the putative Kes1p (also called 
Osh4p) sterol transfer protein (Li et al., 2002; Im et al., 2005)) that either share primary 
sequence similarity with START domains or are otherwise known to adopt similar 
structural shapes. 
If the extent of gene expansion is a fair measure of functional importance, then 
the Sec14 family is an important one indeed. Sec14-like proteins make up a protein 
superfamily for which >500 member proteins can be discerned in available databases, 
and the expansion of this superfamily is clear in even the simplest unicellular eukaryotes. 
The yeast Saccharomyces cerevisiae expresses six Sec14-like proteins, whereas higher 
eukaryotes (humans, mice, Drosophila melanogaster, Caenorhabditis elegans, 
Arabidopsis thaliana) each harbor in excess of 20. The founding member of this 
superfamily is the yeast Sec14p, and it is arguably the best studied of the group (see 
below). It is almost certain that not all Sec14p-like proteins are PITPs. Some Sec14-like 
proteins (or proteins with Sec14 domains) have specific PIP-binding activities, and these 
comprise an interesting class in their own right. Some examples include the GTPase-
activating RhoGAP proteins (Kostenko et al., 2005; Sirokmany et al., 2006), the Meg2 
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protein tyrosine phosphatase (Gu et al., 1992; Huynh et al., 2003), Rho nucleotide 
exchange factors such as Dbl and Ost/Dbs (Whitehead et al., 1997; Cheng et al., 2002; 
Rossman et al., 2002), the rasGAP neurofibromin (D'Angelo et al., 2006) and plant PIP-
binding proteins implicated in osmoregulation (Kearns et al., 1998; Monks et al., 2001). 
The sheer number of Sec14-like proteins in eukaryotic cells argues for extensive 
diversification of function, but it remains uncertain whether PtdIns and PIP binding is a 
common feature of all Sec14p-like proteins. Some bind other hydrophobic ligands (such 
as vitamin E and retinaldehyde) (Stocker et al., 2002; Min et al., 2003; Panagabko et al., 
2003). However, functional studies already suggest that this evolutionary expansion 
cannot be explained by diversification of substrate binding specificity alone. We 
anticipate that many mammalian Sec14-like proteins retain PITP activity, and that the 
PITP complement in metazoans is underestimated. 
By contrast, the metazoan PITP family is not highly expanded, and no members 
of this family have yet been recognized in the genomes of even the higher plants. An 
enigmatic case is presented by the slime mold Dictyostelium discoideum, which 
expresses four Sec14-like and four metazoan PITP–like proteins. It is notable that the two 
classes of PITPs are so similar with respect to in vitro activity yet so different in 
structural construction and evolutionary expansion. Is this a case for convergent 
evolution, or does it reflect some functional distinction that is invisible in in vitro 
systems? In our view, the evidence suggests the latter. The difficulties in interpreting the 
in vitro lipid-transfer assays are known (Rogers and Bankaitis, 2000). Even in cell-free 
assays that are more directed, metazoan PITPs and Sec14p are functionally 
interchangeable (Hay and Martin, 1993; Ohashi et al., 1995; Cunningham et al., 1996; 
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Jones et al., 1998; Simon et al., 1998). This equivalence is not recapitulated in in vivo 
studies, however. Those studies consistently report a high degree of functional distinction 
between individual PITPs. In this review, we will primarily discuss the lipid nanoreactor 
concept in the context of the Sec14-like PITP family. We will close with a discussion of 
how this concept may also apply to the metazoan PITPs. 
Yeast Sec14p and Sec14-like proteins 
We now appreciate that a primary function for PITPs in cells is to coordinate lipid 
metabolism and signaling with membrane trafficking. The first indications to this effect 
came from studies of the main yeast PITP (Sec14p), which is essential for protein 
transport from the yeast trans-Golgi network (TGN) and for yeast cell viability (Bankaitis 
et al., 1990; Cleves et al., 1991b). Sec14p uses both its PtdIns- and PtdCho-bound forms 
to regulate many aspects of lipid metabolism. The net purpose of this is to generate a 
membrane-lipid environment conducive to optimal activity of core components of the 
TGN vesicle-budding machinery (Fig. 4). Both PtdCho metabolism and conversion of 
PtdIns to PtdIns(4)phosphate are subject to regulation by Sec14p. That is, Sec14p 
regulates the metabolic fate of specific pools of PtdCho and PtdIns that are specifically 
interfaced with the activity of a yeast Golgi subcompartment (Bankaitis et al., 1990; 
Cleves et al., 1991b; Guo et al., 1999; Hama et al., 1999; Rivas et al., 1999). The 
localized interplay among Sec14p, lipid metabolism, and proteins of the Arf GTPase 
cycle define at least one, and perhaps two, TGN lipid nanoreactors (that is, Sec14p-
PtdCho-based and Sec14p-PtdIns-based nanoreactors; see below). 
Why argue the nanoreactor concept for Sec14p, when it seems equally plausible 
that Sec14p simply delivers lipids from the endoplasmic reticulum (ER) to the TGN (for 
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example, PtdIns) or vice versa (for example, PtdCho)? The reasons are several. First, 
unlike the case for mammalian cells, PtdCho and PtdIns are the most abundant 
phospholipids in yeast cell membranes. Elevating PtdIns levels to 40 mole percent of 
total bulk phospholipid in yeast membranes does not circumvent the Sec14p requirement 
for protein transport from the TGN (Jones et al., 1998). Second, loss of activity of one 
specific pathway for PtdCho biosynthesis is one of the mechanisms that permits cell 
viability and TGN functionality in the absence of Sec14p (ref. (Cleves et al., 1991b)). 
Third, a mutant Sec14p that retains PtdCho-transfer activity but is ablated for PtdIns-
transfer activity retains substantial function in vivo (Phillips et al., 1999). Presumably, 
this mutant Sec14p is incapable of driving vectorial movement of any phospholipid 
species—a seemingly necessary condition for meaningful lipid transfer between 
membranes in cells. It is difficult to conceive how these various data are consistent with 
lipid transfer mechanisms, but the data are readily consistent with precisely tuned 
metabolic control mechanisms for Sec14p function. 
Though the details of this Sec14p-dependent combinatorial regulation of TGN 
vesicle trafficking await resolution, the ability of a peripheral membrane protein to 
execute function at the TGN provides a clear example of a dedicated coupling of a PITP 
to a specific physiological function. In the case of PtdCho metabolism, Sec14p is 
proposed to act as a lipid sensor that modulates the antagonistic effects of household lipid 
metabolism on an essential TGN process regulated by multiple lipids (for example, 
PtdCho, diacylglycerol and PIPs). This set of reactions is proposed to couple to activity 
of the Arf GTPase cycle (Fig. 4) and defines a Sec14p-PtdCho nanoreactor in the TGN 
(see also Fig. 1b). In the case of PtdIns(4)phosphate synthesis, Sec14p channels PtdIns to 
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the Pik1p PtdIns-4-OH kinase of the yeast TGN (Pik1p and Stt4p are the two 
demonstrated PtdIns-4-OH kinases). Which proteins couple to this particular metabolic 
reaction remains unknown, but one candidate is the sterol-binding protein Kes1p/Osh4p 
(Fig. 4). This Sec14p-PtdIns/Pik1p circuit defines a Sec14p-PtdIns nanoreactor in the 
TGN (see also Fig. 1a). 
Other studies in yeast are also inconsistent with the notion that PITPs execute the 
types of 'one size fits all' activities that are reported by in vitro reconstitutions. Sec14p is 
only one of six yeast Sec14-like proteins, and several of the other Sec14 homologs 
(SFHs) are biochemically related to Sec14p on the basis of phenotypic rescue or 
determined phospholipid-transfer activities (Li et al., 2000; Schnabl et al., 2003; Routt et 
al., 2005). Testimony to the diversification of biological function of Sec14-domain 
proteins is apparent from analysis of these SFH proteins. First, SFH proteins are required 
for optimal activation of the yeast PtdCho-hydrolyzing enzyme phospholipase D (PLD). 
This is in contrast to the case for Sec14p, whose deficiency activates PLD (Sreenivas et 
al., 1998; Xie et al., 1998; Xie et al., 2001). Second, the Sec14-like Sfh4p is uniquely 
required for coordinating the localization and assembly of an enzymatic machinery 
dedicated to nonmitochondrial decarboxylation of PtdSer to PtdEtN (Wu et al., 2000; Wu 
and Voelker, 2004; Routt et al., 2005). This machinery is posited to involve formation of 
intermembrane contact sites between the ER and a TGN or endosomal compartment. 
Such contact sites serve as portals for nonvesicular trafficking of lipids between distinct 
compartments, and lipid trafficking via this mechanism is likely to represent a 
quantitatively significant and underappreciated pathway for intracellular lipid transport 
(Wu and Voelker, 2002). Present evidence suggests that assembly of this intermembrane 
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contact site requires an intricate organization of acidic phospholipids that help orchestrate 
the activity of proteins that chaperone formation of this class of intermembrane contact 
site. In other words, this particular intermembrane contact machine is coupled to an 
Sfh4p-dependent metabolic nanoreactor. Third, Sfh5p has the unique ability to promote 
expansion of what seems to be a plasma-membrane pool of PtdIns(4,5)P2 (ref. (Routt et 
al., 2005). This pool optimizes the activity of specific t-SNARES (components of the 
plasma-membrane machinery for vesicle docking and fusion). We propose that the 
Sfh5p-dependent nanoreactor consists of Sfh5p, the Stt4p PtdIns-4-OH kinase, the Mss4p 
PtdIns(4)phosphate-5-OH kinase and specific t-SNAREs (Routt et al., 2005). Finally, 
yeast PITPs control actin organization in yeast. But, whereas Sec14p has a constitutive 
role in this process, SFH isoforms are involved in evoked pathways for actin 
reorganization (Routt et al., 2005). 
The conclusions derived from study of the SFH proteins are instructive on several 
counts with regard to the nanoreactor concept. The budding yeast PITPs execute 
functions unique to individual members of this family, and one can imagine that the 
coupling of any single PITP to a particular PtdIns kinase may underly functional 
specification. Yet these proteins, including Sec14p, act at least in part through the same 
Stt4p PtdIns-4-OH kinase isoform (Routt et al., 2005). Thus, specific PIP pools are 
defined not only by the lipid kinases that generate them, but also by the individual PITP 
that couples to a particular lipid kinase. This interface demonstrates a considerable 
plasticity. Coupling of both the PtdIns kinase isoform and the PITP is subject to 
developmental regulation in that the activation of PLD is dependent on SFH proteins and 
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Stt4p in vegetative cells, but it is dependent on Sec14p and Pik1p in sporulating cells 
(Engebrecht, 2003; Rudge et al., 2004). 
Multidomain Sec14-like PITPs and nanoreactors 
Potentially the most notable example of a PITP-dependent nanoreactor comes 
from studies of two-domain Sec14-nodulin proteins of higher plants (Fig. 5a). Unlike 
Sec14p, these are membrane-associated proteins, at least on the basis of the one case that 
has been analyzed (Kapranov et al., 2001; Vincent et al., 2005). The Sec14 domains are 
PITP modules that stimulate PIP synthesis, whereas the C-terminal nodulin domains 
represent membrane targeting units. Root-hair PtdIns(4,5)P2 homeostasis and 
organization is dependent on AtSfh1p function, and there are strong similarities between 
the nonrandom distributions of the AtSfh1p Sec14-nodulin and PtdIns(4,5)P2 in A. 
thaliana root hairs (Vincent et al., 2005). This is a prime example in which the 
distribution of a PITP sets the distribution of a PIP, and Sec14-nodulin proteins may do 
so via PIP binding. There are examples of multidomain Sec14-like proteins that bind 
PIPs, such as the Sec14-GOLD proteins that are conserved across the higher Eukaryota 
(including mammals) (Anantharaman and Aravind, 2002; McLaughlin and Murray, 2005; 
Phillips et al., 2006b). Multidomain Sec14 proteins present interesting cases for the PITP 
nanoreactor concept. 
The chemical properties of nodulin domains suggest the way in which PIP 
synthesis and organization may be coordinated by a multidomain PITP. Nodulin domains 
have highly basic C-terminal tails with properties reminiscent of PIP-binding motifs (Fig. 
5b). Given the ability of unstructured and highly basic protein domains to sequester 
PtdIns(4,5)P2 on the basis of membrane surface electrostatics (McLaughlin and Murray, 
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2005), Sec14-nodulin proteins theoretically have the capability to regulate the spatial 
organization of the very PIP molecules whose synthesis they promote. Available 
evidence, though admittedly scant, does suggest that Sec14-nodulin proteins can 
functionally discriminate PIP pools in the context of polarized membrane-trafficking 
pathways. As PIPs are known regulators of membrane trafficking and of actin 
cytoskeleton dynamics, we posit that it is through the functional specification of PIP 
pools that Sec14-nodulin proteins evoke their specific biological effects. 
The concept of PIP pools in the context of Sec14-nodulin function suggests other 
interesting possibilities. One attractive conjecture is that nodulin domains sequester PIPs 
via high-affinity, but regulated, electrostatic interactions. This sequestration could 
potentially be controlled so that these PIPs are rendered accessible to the proper effectors 
(or enzymes) on cue. One hypothetical mechanism for such regulated 'release' involves 
calmodulin. Basic unstructured polypeptides are excellent binding substrates for Ca2+-
calmodulin (Yamniuk and Vogel, 2004; McLaughlin and Murray, 2005), which suggests 
the possibility that calmodulin activation could loosen the 'nodulin clamp' and release a 
spatially restricted PIP pool in response to a temporal program responsive to cytosolic 
Ca2+ flux. The fact that A. thaliana encodes 13 distinct Sec14-nodulin proteins (Vincent 
et al., 2005) provides an indication of the potential diversity such a strategy may hold for 
the coupling of distinct Sec14-nodulin–dependent PIP metabolic nanoreactors to 
developmental pathways for membrane morphogenesis. 
Metazoan PITPs: few but potent 
As indicated above, the metazoan PITP family is quantitatively much more sparse 
than the Sec14-like PITP family. Even mammalian cells express no more than five PITP 
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genes, two of which encode membrane-bound isoforms (Fig. 6). Yet some of the same 
functional principles discussed above for Sec14p-like PITPs are likely to apply to these 
proteins. For example, the ability of these PITPs to stimulate PIP synthesis is a common 
denominator in their involvements in numerous exocytic reactions (for which they act as 
reconstituted stimulators) and in plasma-membrane receptor and G protein–coupled 
hydrolysis of PIPs by phospholipase C (Ohashi et al., 1995; Cunningham et al., 1996; 
Jones et al., 1998; Simon et al., 1998). This is in contrast to the results of in vivo studies 
that highlight the importance and functional specificities of individual metazoan PITPs. 
Genetic insufficiencies for the soluble PITPα lead to a perinatal morbidity in mice 
characterized by chylomicron retention disease (CRD), hypoglycemia and 
spinocerebellar neurodegeneration (Weimar et al., 1982; Hamilton et al., 1997; Alb et al., 
2003). With regard to the neurological component of this disease, recent results indicate 
that efficient recognition of axonal guidance cues via the netrin receptor requires PITPα 
(Xie et al., 2005). Soluble-PITP defects in D. melanogaster lead to defective oogenesis 
that results from dysfunction of the actin cytoskeleton (Gatt and Glover, 2006; Giansanti 
et al., 2006). 
Membrane-associated isoforms of metazoan PITPs also exist (but why, if lipid 
transfer is the operative function?), and these isoforms may yet prove to be analogs of the 
higher plant Sec14-nodulin proteins discussed above. An inherited and light-enhanced 
retinal degeneration in flies results from loss of function of the membrane-associated 
RdgB protein. RdgB expression is highly tissue-specific, and the 280-residue PITP 
domain of this protein lies at the N terminus of a much larger polypeptide (Fig. 6) 
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(Milligan et al., 1997). One mammalian RdgB ortholog is Nir2, and mice lacking this 
protein die before embryonic day 7.5 (ref. (Chang et al., 1997)). 
Why do metazoans invest in development of a small PITP family that is unrelated 
to Sec14 PITPs when trivial expansion of the already large Sec14 protein superfamily 
would presumably generate sufficient numbers of functionally unique PITPs to satisfy the 
same requirements? This puzzle is deepened by indications that mammals apply the same 
sets of functional-specificity rules to the small cohort of PITPs that they apply to the 
Sec14-like proteins. The PITPα and PITPβ isoforms are very similar, but they are 
functionally nonredundant (Alb et al., 2003). In part, this is likely the result of differential 
distribution of these isoforms within cells. PITPβ is a TGN-associated protein (Phillips et 
al., 2006a), whereas PITPα is localized to the cytosol and the nuclear matrix (De Vries et 
al., 1996; Phillips et al., 2006a). However, the cases of PITPβ and the membrane-
associated Nir2 cannot be so easily dismissed. Both Nir2 and PITPβ localize to TGN 
membranes (Litvak et al., 2005; Phillips et al., 2006a), yet these two proteins define a 
functionally nonredundant pair of PITPs. 
The building evidence suggests that a lipid metabolic nanoreactor concept applies 
to metazoan PITPs as well as the Sec14-like PITPs. What is perhaps more notable, given 
the structural dissimilarity between these classes of proteins, is that the lipid metabolic 
nanoreactors under metazoan PITP control resemble those described for Sec14-like 
PITPs. For example, the Nir2 PITP regulates a TGN lipid metabolic nanoreactor that 
coordinates diacylglycerol and PtdCho metabolism with protein trafficking in a fashion 
very similar to that seen in yeast for Sec14p (Litvak et al., 2005). In this instance, the 
effectors of this lipid regulation include diacylglycerol-binding proteins of the protein 
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kinase D family (Liljedahl et al., 2001; Baron and Malhotra, 2002; Litvak et al., 2005). 
The function of PITPβ in the TGN is unknown, but speculations have been made about a 
PITP-PLD interface on mammalian Golgi membranes (Liscovitch and Cantley, 1995). 
Such a PITP-PLD interface offers the prospect of a lipid metabolic nanoreactor that 
couples with the Arf small GTPase cycle in regulating vesicle trafficking. A role for 
PITPβ in regulating the Arf GTPase cycle and Golgi vesicle trafficking would also be 
directly analogous to models for Sec14p function in yeast (Phillips et al., 2006b). 
Returning to comparisons of the functional scenarios for Nir2 and PITPβ, the data further 
emphasize that the functional specification of PITPs can be achieved via differential 
coupling of distinct lipid metabolic nanoreactors to sets of distinct effectors. 
Along those same lines, mouse PITPα nullizygosity evokes some phenotypes that 
resemble human CRD (Alb et al., 2003), a disorder caused by ER-localized Sar1 GTPase 
insuffiency (Jones et al., 2003). Sar1 is a distant member of the Arf GTPase family. Thus, 
physiological coupling of the soluble metazoan PITPs to the action of small GTPase 
catalytic cycles may prove a common theme. Why a specialized trafficking cargo 
transport pathway from the ER (the primary site of lipid synthesis in the cell) requires 
PITPα for efficient operation is an intriguing question—one that again suggests that lipid 
delivery is not the final word in terms of metazoan PITP function. 
Future directions and future challenges 
The idea that PITPs functionally define specific lipid metabolic pools, and do so 
via the action of dedicated lipid metabolic nanoreactors, is supported by a growing body 
of data. Much remains to be discovered, however. As a first step, we need to decipher the 
in vivo wiring diagram that connects individual PITPs to the regulation of lipid 
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metabolism and ultimately to biological readout. The physical nature of PITP-dependent 
nanoreactors also begs analysis. Certainly intermembrane contact sites provide one 
appealing (but not well-supported) notion (Holthuis and Levine, 2005). Functional 
analyses are obviously required for assessing the nature of PITP-dependent lipid 
metabolic nanoreactors, but these will likely prove tricky. For instance, the physiological 
fidelity of PITP activity is sensitive to protein dosage (Skinner et al., 1993; Li et al., 
2000). New ideas for how to approach these questions are needed. 
From a more general perspective, lipid metabolism cannot be viewed as an 
averaged activity in any single membrane system—much less in the cell. Unfortunately, 
we are ill equipped to analyze the mosaic nature of lipid metabolism in vivo. 
Development of new technologies that report, with spatial and temporal resolution, the 
activities of specific lipid metabolic nanoreactors in living cells would represent a 
tremendous advance. New and powerful vital-imaging approaches are required, and 
possibilities for exploration include methods based on fluorescence resonance energy 
transfer (FRET) that score activated conformations of protein components of specific 
nanoreactors. Such status-sensitive reporters are available for Cdc42 GTPases (Nalbant et 
al., 2004). PITPs provide at least a conceptual starting point for thinking about how one 
would design such vital 'activity' sensors. 
Finally, the concepts discussed herein will extend beyond the PITPs. There are 
other lipid transfer proteins (for example, ceramide transfer protein; (Hanada et al., 
2003), the putative sterol transporter Kes1p/Osh4p and other members of the large 
oxysterol-binding protein family (Li et al., 2002; Im et al., 2005; Raychaudhuri et al., 
2006)) that may define additional lipid metabolic nanoreactors whose activities are 
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interfaced with signaling events. Finally, a highly diverse system of metabolic 
nanoreactors clearly demands multiple levels of higher order integration of these 
machines. The physical basis for regulation of cellular lipid metabolism and signaling in 
such microenvironments, and how the action of lipid metabolic nanoreactors is integrated 
at higher levels, are two important questions for the next decade. 
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Figures
 
 
Figure 1.1 A lipid metabolic nanoreactor. 
Two scenarios for Sec14p-dependent nanoreactors relevant to this discussion are shown. 
(a) Sec14p binds substrate PtdIns and channels the bound PtdIns to a metabolic enzyme 
(for example, PtdIns kinases), and the ultimate metabolic product (in this illustration, 
PtdIns(4,5)P2) then binds another protein (or protein domain), thereby leading to a 
nonrandom organization of the product. (b) Sec14p binds PtdCho and is thereby 
programmed to regulate a specific phospholipid metabolic pathway (in this case the 
cytidine diphosphocholine pathway for PtdCho biosynthesis that involves the sequential 
activity of a choline kinase (CKIase), a choline-phosphate cytidylyltransferase (CCTase) 
and a cholinephosphotransferase (CPTase)). The lipid compositional consequences of the 
Sec14p-dependent regulation in that nanoreactor are transmitted to the action of lipid-
responsive proteins. DAG, diacylglycerol. 
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Figure 1.2: Phospholipid transfer reaction. 
A cycle for PITP-mediated phospholipid exchange is shown. This reaction proceeds 
down a concentration gradient in vitro. 
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Figure 1.3: PITP crystal structures. 
(a,b) Three-dimensional structures of apo forms of yeast Sec14p (a) and mammalian 
PITPα (b). The apo-Sec14p fold consists of twelve α-helices, six β-strands and eight 310-
helices (bound detergent not shown). PITPα is a START-domain protein, and the fold 
consists of seven α-helices and eight β-sheets. 
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Figure 1.4: The proposed Sec14p nanoreactor. 
Sec14p bound to PtdCho downregulates PtdCho biosynthesis to generate a DAG-rich, 
PtdCho-poor membrane domain that is conducive to the recruitment and activation of 
specific ArfGAPs. Genetic and biochemical data indicate that the relevant ArfGAPs are 
activated by DAG and inhibited by PtdCho (Yanagisawa et al., 2002). These ArfGAPs 
potentiate later steps in secretory cargo packaging and vesicle biogenesis on TGN 
membranes (Lewis et al., 2004; Lee et al., 2005; Robinson et al., 2006). The PtdIns-
bound form of Sec14p independently potentiates a distinct step in the vesicle biogenesis 
pathway by promoting synthesis of a PtdIns(4)phosphate (PI4P) pool that regulates 
downstream effector proteins (perhaps the PIP and sterol-binding protein Kes1p/Osh4p, 
whose action is antagonistic to TGN vesicle biogenesis). PC, phosphatidylcholine. 
 23
 
 
Figure 1.5: The Sec14-nodulin PITP family in A. thaliana. 
(a) Schematic of the two general domain arrangements of the 13 A. thaliana Sec14-
nodulin proteins. The Sec14p (blue), nodulin (green) and hydrophobic (red) domains are 
shown. Members of the family that conform to each arrangement are identified at left. (b) 
Shown is an alignment of the C-terminal half of each of 13 A. thaliana nodulin domains 
of Sec14-nodulin proteins. These nodulin domains are grouped into three classes on the 
basis of sequence similarity. Conserved residues are highlighted in red and basic residues 
in the extreme C termini of these proteins are highlighted in blue. The bar at the top 
highlights sequences predicted to reside in coiled coils. For purposes of comparison, 
known high-affinity PtdIns(4,5)P2 binding sites for myristoylated alanine-rich C-kinase 
substrate (MARCKS) protein and the NMDA (N-methyl-D-aspartate) receptor are shown 
at bottom (from ref. McLaughlin and Murray, 2005). 
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Figure 1.6: The metazoan PITP family in humans. 
Schematic alignment of the five human PITPs of the metazoan PITP family. The PITP 
domain (blue), FFAT (green; sequence that binds an ER-localized receptor of the 
VAP/Scs2 family; (Loewen et al., 2003) and DDHD (brown; a putative metal-binding 
domain) are shown. The primary sequence identities shared by each PITP domain to 
PITPα is given at right. 
 
 25
 References 
Alb, J.G., Jr., Cortese, J.D., Phillips, S.E., Albin, R.L., Nagy, T.R., Hamilton, B.A., and 
Bankaitis, V.A. (2003). Mice lacking phosphatidylinositol transfer protein-alpha exhibit 
spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. J Biol 
Chem 278, 33501-33518. 
 
Anantharaman, V., and Aravind, L. (2002). The GOLD domain, a novel protein module 
involved in Golgi function and secretion. Genome Biol 3, research0023. 
 
Bankaitis, V.A., Aitken, J.R., Cleves, A.E., and Dowhan, W. (1990). An essential role for 
a phospholipid transfer protein in yeast Golgi function. Nature 347, 561-562. 
 
Baron, C.L., and Malhotra, V. (2002). Role of diacylglycerol in PKD recruitment to the 
TGN and protein transport to the plasma membrane. Science 295, 325-328. 
 
Berridge, M.J., and Irvine, R.F. (1989). Inositol phosphates and cell signalling. Nature 
341, 197-205. 
 
Chang, J.T., Milligan, S., Li, Y., Chew, C.E., Wiggs, J., Copeland, N.G., Jenkins, N.A., 
Campochiaro, P.A., Hyde, D.R., and Zack, D.J. (1997). Mammalian homolog of 
Drosophila retinal degeneration B rescues the mutant fly phenotype. J Neurosci 17, 5881-
5890. 
 
Cheng, L., Rossman, K.L., Mahon, G.M., Worthylake, D.K., Korus, M., Sondek, J., and 
Whitehead, I.P. (2002). RhoGEF specificity mutants implicate RhoA as a target for Dbs 
transforming activity. Mol Cell Biol 22, 6895-6905. 
 
Cleves, A., McGee, T., and Bankaitis, V. (1991a). Phospholipid transfer proteins: a 
biological debut. Trends Cell Biol 1, 30-34. 
 
Cleves, A.E., McGee, T.P., Whitters, E.A., Champion, K.M., Aitken, J.R., Dowhan, W., 
Goebl, M., and Bankaitis, V.A. (1991b). Mutations in the CDP-choline pathway for 
phospholipid biosynthesis bypass the requirement for an essential phospholipid transfer 
protein. Cell 64, 789-800. 
 
Cunningham, E., Tan, S.K., Swigart, P., Hsuan, J., Bankaitis, V., and Cockcroft, S. 
(1996). The yeast and mammalian isoforms of phosphatidylinositol transfer protein can 
all restore phospholipase C-mediated inositol lipid signaling in cytosol-depleted RBL-
2H3 and HL-60 cells. Proc Natl Acad Sci U S A 93, 6589-6593. 
 
D'Angelo, I., Welti, S., Bonneau, F., and Scheffzek, K. (2006). A novel bipartite 
phospholipid-binding module in the neurofibromatosis type 1 protein. EMBO Rep 7, 
174-179. 
 
 26
De Vries, K.J., Westerman, J., Bastiaens, P.I., Jovin, T.M., Wirtz, K.W., and Snoek, G.T. 
(1996). Fluorescently labeled phosphatidylinositol transfer protein isoforms (alpha and 
beta), microinjected into fetal bovine heart endothelial cells, are targeted to distinct 
intracellular sites. Exp Cell Res 227, 33-39. 
 
Defacque, H., Bos, E., Garvalov, B., Barret, C., Roy, C., Mangeat, P., Shin, H.W., Rybin, 
V., and Griffiths, G. (2002). Phosphoinositides regulate membrane-dependent actin 
assembly by latex bead phagosomes. Mol Biol Cell 13, 1190-1202. 
 
Engebrecht, J. (2003). Cell signaling in yeast sporulation. Biochem Biophys Res 
Commun 306, 325-328. 
 
Exton, J.H. (1990). Signaling through phosphatidylcholine breakdown. J Biol Chem 265, 
1-4. 
 
Furst, W., and Sandhoff, K. (1992). Activator proteins and topology of lysosomal 
sphingolipid catabolism. Biochim Biophys Acta 1126, 1-16. 
 
Gatt, M.K., and Glover, D.M. (2006). The Drosophila phosphatidylinositol transfer 
protein encoded by vibrator is essential to maintain cleavage-furrow ingression in 
cytokinesis. J Cell Sci 119, 2225-2235. 
 
Giansanti, M.G., Bonaccorsi, S., Kurek, R., Farkas, R.M., Dimitri, P., Fuller, M.T., and 
Gatti, M. (2006). The class I PITP giotto is required for Drosophila cytokinesis. Curr Biol 
16, 195-201. 
 
Gu, M., Warshawsky, I., and Majerus, P.W. (1992). Cloning and expression of a 
cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to 
retinaldehyde-binding protein and yeast SEC14p. Proc Natl Acad Sci U S A 89, 2980-
2984. 
 
Guo, S., Stolz, L.E., Lemrow, S.M., and York, J.D. (1999). SAC1-like domains of yeast 
SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide 
phosphatases. J Biol Chem 274, 12990-12995. 
 
Hama, H., Schnieders, E.A., Thorner, J., Takemoto, J.Y., and DeWald, D.B. (1999). 
Direct involvement of phosphatidylinositol 4-phosphate in secretion in the yeast 
Saccharomyces cerevisiae. J Biol Chem 274, 34294-34300. 
 
Hamilton, B.A., Smith, D.J., Mueller, K.L., Kerrebrock, A.W., Bronson, R.T., van 
Berkel, V., Daly, M.J., Kruglyak, L., Reeve, M.P., Nemhauser, J.L., Hawkins, T.L., 
Rubin, E.M., and Lander, E.S. (1997). The vibrator mutation causes neurodegeneration 
via reduced expression of PITP alpha: positional complementation cloning and extragenic 
suppression. Neuron 18, 711-722. 
 
 27
Hanada, K., Kumagai, K., Yasuda, S., Miura, Y., Kawano, M., Fukasawa, M., and 
Nishijima, M. (2003). Molecular machinery for non-vesicular trafficking of ceramide. 
Nature 426, 803-809. 
 
Hay, J.C., and Martin, T.F. (1993). Phosphatidylinositol transfer protein required for 
ATP-dependent priming of Ca(2+)-activated secretion. Nature 366, 572-575. 
 
Hinchliffe, K.A., Ciruela, A., and Irvine, R.F. (1998). PIPkins1, their substrates and their 
products: new functions for old enzymes. Biochim Biophys Acta 1436, 87-104. 
 
Holthuis, J.C., and Levine, T.P. (2005). Lipid traffic: floppy drives and a superhighway. 
Nat Rev Mol Cell Biol 6, 209-220. 
 
Hsuan, J., and Cockcroft, S. (2001). The PITP family of phosphatidylinositol transfer 
proteins. Genome Biol 2, REVIEWS3011. 
 
Hurley, J.H., and Meyer, T. (2001). Subcellular targeting by membrane lipids. Curr Opin 
Cell Biol 13, 146-152. 
 
Huynh, H., Wang, X., Li, W., Bottini, N., Williams, S., Nika, K., Ishihara, H., Godzik, 
A., and Mustelin, T. (2003). Homotypic secretory vesicle fusion induced by the protein 
tyrosine phosphatase MEG2 depends on polyphosphoinositides in T cells. J Immunol 
171, 6661-6671. 
 
Im, Y.J., Raychaudhuri, S., Prinz, W.A., and Hurley, J.H. (2005). Structural mechanism 
for sterol sensing and transport by OSBP-related proteins. Nature 437, 154-158. 
Iwamoto, K., Kobayashi, S., Fukuda, R., Umeda, M., Kobayashi, T., and Ohta, A. (2004). 
Local exposure of phosphatidylethanolamine on the yeast plasma membrane is implicated 
in cell polarity. Genes Cells 9, 891-903. 
 
Janmey, P.A., and Lindberg, U. (2004). Cytoskeletal regulation: rich in lipids. Nat Rev 
Mol Cell Biol 5, 658-666. 
 
Jones, B., Jones, E.L., Bonney, S.A., Patel, H.N., Mensenkamp, A.R., Eichenbaum-
Voline, S., Rudling, M., Myrdal, U., Annesi, G., Naik, S., Meadows, N., Quattrone, A., 
Islam, S.A., Naoumova, R.P., Angelin, B., Infante, R., Levy, E., Roy, C.C., Freemont, 
P.S., Scott, J., and Shoulders, C.C. (2003). Mutations in a Sar1 GTPase of COPII vesicles 
are associated with lipid absorption disorders. Nat Genet 34, 29-31. 
 
Jones, S.M., Alb, J.G., Jr., Phillips, S.E., Bankaitis, V.A., and Howell, K.E. (1998). A 
phosphatidylinositol 3-kinase and phosphatidylinositol transfer protein act synergistically 
in formation of constitutive transport vesicles from the trans-Golgi network. J Biol Chem 
273, 10349-10354. 
 
 28
Kapranov, P., Routt, S.M., Bankaitis, V.A., de Bruijn, F.J., and Szczyglowski, K. (2001). 
Nodule-specific regulation of phosphatidylinositol transfer protein expression in Lotus 
japonicus. Plant Cell 13, 1369-1382. 
 
Kearns, M.A., Monks, D.E., Fang, M., Rivas, M.P., Courtney, P.D., Chen, J., Prestwich, 
G.D., Theibert, A.B., Dewey, R.E., and Bankaitis, V.A. (1998). Novel developmentally 
regulated phosphoinositide binding proteins from soybean whose expression bypasses the 
requirement for an essential phosphatidylinositol transfer protein in yeast. Embo J 17, 
4004-4017. 
 
Kostenko, E.V., Mahon, G.M., Cheng, L., and Whitehead, I.P. (2005). The Sec14 
homology domain regulates the cellular distribution and transforming activity of the Rho-
specific guanine nucleotide exchange factor Dbs. J Biol Chem 280, 2807-2817. 
 
Kronke, M. (1999). Biophysics of ceramide signaling: interaction with proteins and phase 
transition of membranes. Chem Phys Lipids 101, 109-121. 
 
Lee, S.Y., Yang, J.S., Hong, W., Premont, R.T., and Hsu, V.W. (2005). ARFGAP1 plays 
a central role in coupling COPI cargo sorting with vesicle formation. J Cell Biol 168, 
281-290. 
 
Lemmon, M.A. (2003). Phosphoinositide recognition domains. Traffic 4, 201-213. 
Lewis, S.M., Poon, P.P., Singer, R.A., Johnston, G.C., and Spang, A. (2004). The 
ArfGAP Glo3 is required for the generation of COPI vesicles. Mol Biol Cell 15, 4064-
4072. 
 
Li, X., Rivas, M.P., Fang, M., Marchena, J., Mehrotra, B., Chaudhary, A., Feng, L., 
Prestwich, G.D., and Bankaitis, V.A. (2002). Analysis of oxysterol binding protein 
homologue Kes1p function in regulation of Sec14p-dependent protein transport from the 
yeast Golgi complex. J Cell Biol 157, 63-77. 
 
Li, X., Routt, S.M., Xie, Z., Cui, X., Fang, M., Kearns, M.A., Bard, M., Kirsch, D.R., and 
Bankaitis, V.A. (2000). Identification of a novel family of nonclassic yeast 
phosphatidylinositol transfer proteins whose function modulates phospholipase D activity 
and Sec14p-independent cell growth. Mol Biol Cell 11, 1989-2005. 
 
Liljedahl, M., Maeda, Y., Colanzi, A., Ayala, I., Van Lint, J., and Malhotra, V. (2001). 
Protein kinase D regulates the fission of cell surface destined transport carriers from the 
trans-Golgi network. Cell 104, 409-420. 
 
Liscovitch, M., and Cantley, L.C. (1995). Signal transduction and membrane traffic: the 
PITP/phosphoinositide connection. Cell 81, 659-662. 
 
Litvak, V., Dahan, N., Ramachandran, S., Sabanay, H., and Lev, S. (2005). Maintenance 
of the diacylglycerol level in the Golgi apparatus by the Nir2 protein is critical for Golgi 
secretory function. Nat Cell Biol 7, 225-234. 
 29
 
Loewen, C.J., Roy, A., and Levine, T.P. (2003). A conserved ER targeting motif in three 
families of lipid binding proteins and in Opi1p binds VAP. Embo J 22, 2025-2035. 
 
Majerus, P.W. (1992). Inositol phosphate biochemistry. Annu Rev Biochem 61, 225-250. 
Martin, T.F. (2001). PI(4,5)P(2) regulation of surface membrane traffic. Curr Opin Cell 
Biol 13, 493-499. 
 
McLaughlin, S., and Murray, D. (2005). Plasma membrane phosphoinositide 
organization by protein electrostatics. Nature 438, 605-611. 
 
Milligan, S.C., Alb, J.G., Jr., Elagina, R.B., Bankaitis, V.A., and Hyde, D.R. (1997). The 
phosphatidylinositol transfer protein domain of Drosophila retinal degeneration B protein 
is essential for photoreceptor cell survival and recovery from light stimulation. J Cell Biol 
139, 351-363. 
 
Min, K.C., Kovall, R.A., and Hendrickson, W.A. (2003). Crystal structure of human 
alpha-tocopherol transfer protein bound to its ligand: implications for ataxia with vitamin 
E deficiency. Proc Natl Acad Sci U S A 100, 14713-14718. 
 
Monks, D.E., Aghoram, K., Courtney, P.D., DeWald, D.B., and Dewey, R.E. (2001). 
Hyperosmotic stress induces the rapid phosphorylation of a soybean phosphatidylinositol 
transfer protein homolog through activation of the protein kinases SPK1 and SPK2. Plant 
Cell 13, 1205-1219. 
 
Moolenaar, W.H. (1995). Lysophosphatidic acid signalling. Curr Opin Cell Biol 7, 203-
210. 
 
Nalbant, P., Hodgson, L., Kraynov, V., Toutchkine, A., and Hahn, K.M. (2004). 
Activation of endogenous Cdc42 visualized in living cells. Science 305, 1615-1619. 
Nishizuka, Y. (1995). Protein kinase C and lipid signaling for sustained cellular 
responses. Faseb J 9, 484-496. 
 
Odom, A.R., Stahlberg, A., Wente, S.R., and York, J.D. (2000). A role for nuclear 
inositol 1,4,5-trisphosphate kinase in transcriptional control. Science 287, 2026-2029. 
 
Ohashi, M., Jan de Vries, K., Frank, R., Snoek, G., Bankaitis, V., Wirtz, K., and Huttner, 
W.B. (1995). A role for phosphatidylinositol transfer protein in secretory vesicle 
formation. Nature 377, 544-547. 
 
Panagabko, C., Morley, S., Hernandez, M., Cassolato, P., Gordon, H., Parsons, R., 
Manor, D., and Atkinson, J. (2003). Ligand specificity in the CRAL-TRIO protein 
family. Biochemistry 42, 6467-6474. 
 
Pettus, B.J., Chalfant, C.E., and Hannun, Y.A. (2002). Ceramide in apoptosis: an 
overview and current perspectives. Biochim Biophys Acta 1585, 114-125. 
 30
 
Pettus, B.J., Chalfant, C.E., and Hannun, Y.A. (2004). Sphingolipids in inflammation: 
roles and implications. Curr Mol Med 4, 405-418. 
 
Phillips, S.E., Ile, K.E., Boukhelifa, M., Huijbregts, R.P., and Bankaitis, V.A. (2006a). 
Specific and nonspecific membrane-binding determinants cooperate in targeting 
phosphatidylinositol transfer protein beta-isoform to the mammalian trans-Golgi network. 
Mol Biol Cell 17, 2498-2512. 
 
Phillips, S.E., Sha, B., Topalof, L., Xie, Z., Alb, J.G., Klenchin, V.A., Swigart, P., 
Cockcroft, S., Martin, T.F., Luo, M., and Bankaitis, V.A. (1999). Yeast Sec14p deficient 
in phosphatidylinositol transfer activity is functional in vivo. Mol Cell 4, 187-197. 
 
Phillips, S.E., Vincent, P., Rizzieri, K.E., Schaaf, G., Bankaitis, V.A., and Gaucher, E.A. 
(2006b). The diverse biological functions of phosphatidylinositol transfer proteins in 
eukaryotes. Crit Rev Biochem Mol Biol 41, 21-49. 
 
Raychaudhuri, S., Im, Y.J., Hurley, J.H., and Prinz, W.A. (2006). Nonvesicular sterol 
movement from plasma membrane to ER requires oxysterol-binding protein-related 
proteins and phosphoinositides. J Cell Biol 173, 107-119. 
 
Rhee, S.G. (2001). Regulation of phosphoinositide-specific phospholipase C. Annu Rev 
Biochem 70, 281-312. 
 
Rivas, M.P., Kearns, B.G., Xie, Z., Guo, S., Sekar, M.C., Hosaka, K., Kagiwada, S., 
York, J.D., and Bankaitis, V.A. (1999). Pleiotropic alterations in lipid metabolism in 
yeast sac1 mutants: relationship to "bypass Sec14p" and inositol auxotrophy. Mol Biol 
Cell 10, 2235-2250. 
 
Robinson, M., Poon, P.P., Schindler, C., Murray, L.E., Kama, R., Gabriely, G., Singer, 
R.A., Spang, A., Johnston, G.C., and Gerst, J.E. (2006). The Gcs1 Arf-GAP mediates 
Snc1,2 v-SNARE retrieval to the Golgi in yeast. Mol Biol Cell 17, 1845-1858. 
 
Roderick, S.L., Chan, W.W., Agate, D.S., Olsen, L.R., Vetting, M.W., Rajashankar, 
K.R., and Cohen, D.E. (2002). Structure of human phosphatidylcholine transfer protein in 
complex with its ligand. Nat Struct Biol 9, 507-511. 
 
Rogers, D.P., and Bankaitis, V.A. (2000). Phospholipid transfer proteins and 
physiological functions. Int Rev Cytol 197, 35-81. 
 
Rossman, K.L., Worthylake, D.K., Snyder, J.T., Siderovski, D.P., Campbell, S.L., and 
Sondek, J. (2002). A crystallographic view of interactions between Dbs and Cdc42: PH 
domain-assisted guanine nucleotide exchange. Embo J 21, 1315-1326. 
 
Routt, S.M., Ryan, M.M., Tyeryar, K., Rizzieri, K.E., Mousley, C., Roumanie, O., 
Brennwald, P.J., and Bankaitis, V.A. (2005). Nonclassical PITPs activate PLD via the 
 31
Stt4p PtdIns-4-kinase and modulate function of late stages of exocytosis in vegetative 
yeast. Traffic 6, 1157-1172. 
 
Rudge, S.A., Sciorra, V.A., Iwamoto, M., Zhou, C., Strahl, T., Morris, A.J., Thorner, J., 
and Engebrecht, J. (2004). Roles of phosphoinositides and of Spo14p (phospholipase D)-
generated phosphatidic acid during yeast sporulation. Mol Biol Cell 15, 207-218. 
 
Schnabl, M., Oskolkova, O.V., Holic, R., Brezna, B., Pichler, H., Zagorsek, M., 
Kohlwein, S.D., Paltauf, F., Daum, G., and Griac, P. (2003). Subcellular localization of 
yeast Sec14 homologues and their involvement in regulation of phospholipid turnover. 
Eur J Biochem 270, 3133-3145. 
 
Schouten, A., Agianian, B., Westerman, J., Kroon, J., Wirtz, K.W., and Gros, P. (2002). 
Structure of apo-phosphatidylinositol transfer protein alpha provides insight into 
membrane association. Embo J 21, 2117-2121. 
 
Schwille, P., Haupts, U., Maiti, S., and Webb, W.W. (1999). Molecular dynamics in 
living cells observed by fluorescence correlation spectroscopy with one- and two-photon 
excitation. Biophys J 77, 2251-2265. 
 
Sciorra, V.A., Rudge, S.A., Wang, J., McLaughlin, S., Engebrecht, J., and Morris, A.J. 
(2002). Dual role for phosphoinositides in regulation of yeast and mammalian 
phospholipase D enzymes. J Cell Biol 159, 1039-1049. 
 
Sha, B., Phillips, S.E., Bankaitis, V.A., and Luo, M. (1998). Crystal structure of the 
Saccharomyces cerevisiae phosphatidylinositol-transfer protein. Nature 391, 506-510. 
 
Shaw, G. (1996). The pleckstrin homology domain: an intriguing multifunctional protein 
module. Bioessays 18, 35-46. 
 
Simon, J.P., Morimoto, T., Bankaitis, V.A., Gottlieb, T.A., Ivanov, I.E., Adesnik, M., and 
Sabatini, D.D. (1998). An essential role for the phosphatidylinositol transfer protein in 
the scission of coatomer-coated vesicles from the trans-Golgi network. Proc Natl Acad 
Sci U S A 95, 11181-11186. 
 
Simonsen, A., Wurmser, A.E., Emr, S.D., and Stenmark, H. (2001). The role of 
phosphoinositides in membrane transport. Curr Opin Cell Biol 13, 485-492. 
 
Singer, W.D., Brown, H.A., and Sternweis, P.C. (1997). Regulation of eukaryotic 
phosphatidylinositol-specific phospholipase C and phospholipase D. Annu Rev Biochem 
66, 475-509. 
 
Sirokmany, G., Szidonya, L., Kaldi, K., Gaborik, Z., Ligeti, E., and Geiszt, M. (2006). 
Sec14 homology domain targets p50RhoGAP to endosomes and provides a link between 
Rab and Rho GTPases. J Biol Chem 281, 6096-6105. 
 
 32
Skinner, H.B., Alb, J.G., Jr., Whitters, E.A., Helmkamp, G.M., Jr., and Bankaitis, V.A. 
(1993). Phospholipid transfer activity is relevant to but not sufficient for the essential 
function of the yeast SEC14 gene product. Embo J 12, 4775-4784. 
 
Spiegel, S., and Milstien, S. (2003). Sphingosine-1-phosphate: an enigmatic signalling 
lipid. Nat Rev Mol Cell Biol 4, 397-407. 
 
Sreenivas, A., Patton-Vogt, J.L., Bruno, V., Griac, P., and Henry, S.A. (1998). A role for 
phospholipase D (Pld1p) in growth, secretion, and regulation of membrane lipid synthesis 
in yeast. J Biol Chem 273, 16635-16638. 
 
Stahelin, R.V., Rafter, J.D., Das, S., and Cho, W. (2003). The molecular basis of 
differential subcellular localization of C2 domains of protein kinase C-alpha and group 
IVa cytosolic phospholipase A2. J Biol Chem 278, 12452-12460. 
 
Stocker, A., Tomizaki, T., Schulze-Briese, C., and Baumann, U. (2002). Crystal structure 
of the human supernatant protein factor. Structure 10, 1533-1540. 
 
Suh, B.C., and Hille, B. (2005). Regulation of ion channels by phosphatidylinositol 4,5-
bisphosphate. Curr Opin Neurobiol 15, 370-378. 
 
Tilley, S.J., Skippen, A., Murray-Rust, J., Swigart, P.M., Stewart, A., Morgan, C.P., 
Cockcroft, S., and McDonald, N.Q. (2004). Structure-function analysis of human 
[corrected] phosphatidylinositol transfer protein alpha bound to phosphatidylinositol. 
Structure 12, 317-326. 
 
van Meer, G. (2005). Cellular lipidomics. Embo J 24, 3159-3165. 
 
Vincent, P., Chua, M., Nogue, F., Fairbrother, A., Mekeel, H., Xu, Y., Allen, N., 
Bibikova, T.N., Gilroy, S., and Bankaitis, V.A. (2005). A Sec14p-nodulin domain 
phosphatidylinositol transfer protein polarizes membrane growth of Arabidopsis thaliana 
root hairs. J Cell Biol 168, 801-812. 
 
Weimar, W.R., Lane, P.W., and Sidman, R.L. (1982). Vibrator (vb): a spinocerebellar 
system degeneration with autosomal recessive inheritance in mice. Brain Res 251, 357-
364. 
 
Wenk, M.R., and De Camilli, P. (2004). Protein-lipid interactions and phosphoinositide 
metabolism in membrane traffic: insights from vesicle recycling in nerve terminals. Proc 
Natl Acad Sci U S A 101, 8262-8269. 
 
Whitehead, I.P., Campbell, S., Rossman, K.L., and Der, C.J. (1997). Dbl family proteins. 
Biochim Biophys Acta 1332, F1-23. 
 
Wirtz, K.W. (1997). Phospholipid transfer proteins revisited. Biochem J 324 ( Pt 2), 353-
360. 
 33
 
Wu, W.I., Routt, S., Bankaitis, V.A., and Voelker, D.R. (2000). A new gene involved in 
the transport-dependent metabolism of phosphatidylserine, PSTB2/PDR17, shares 
sequence similarity with the gene encoding the phosphatidylinositol/phosphatidylcholine 
transfer protein, SEC14. J Biol Chem 275, 14446-14456. 
 
Wu, W.I., and Voelker, D.R. (2002). Biochemistry and genetics of interorganelle 
aminoglycerophospholipid transport. Semin Cell Dev Biol 13, 185-195. 
 
Wu, W.I., and Voelker, D.R. (2004). Reconstitution of phosphatidylserine transport from 
chemically defined donor membranes to phosphatidylserine decarboxylase 2 implicates 
specific lipid domains in the process. J Biol Chem 279, 6635-6642. 
 
Xie, Y., Ding, Y.Q., Hong, Y., Feng, Z., Navarre, S., Xi, C.X., Zhu, X.J., Wang, C.L., 
Ackerman, S.L., Kozlowski, D., Mei, L., and Xiong, W.C. (2005). Phosphatidylinositol 
transfer protein-alpha in netrin-1-induced PLC signalling and neurite outgrowth. Nat Cell 
Biol 7, 1124-1132. 
 
Xie, Z., Fang, M., and Bankaitis, V.A. (2001). Evidence for an intrinsic toxicity of 
phosphatidylcholine to Sec14p-dependent protein transport from the yeast Golgi 
complex. Mol Biol Cell 12, 1117-1129. 
 
Xie, Z., Fang, M., Rivas, M.P., Faulkner, A.J., Sternweis, P.C., Engebrecht, J.A., and 
Bankaitis, V.A. (1998). Phospholipase D activity is required for suppression of yeast 
phosphatidylinositol transfer protein defects. Proc Natl Acad Sci U S A 95, 12346-12351. 
 
Yamniuk, A.P., and Vogel, H.J. (2004). Calmodulin's flexibility allows for promiscuity in 
its interactions with target proteins and peptides. Mol Biotechnol 27, 33-57. 
 
Yanagisawa, L.L., Marchena, J., Xie, Z., Li, X., Poon, P.P., Singer, R.A., Johnston, G.C., 
Randazzo, P.A., and Bankaitis, V.A. (2002). Activity of specific lipid-regulated ADP 
ribosylation factor-GTPase-activating proteins is required for Sec14p-dependent Golgi 
secretory function in yeast. Mol Biol Cell 13, 2193-2206. 
 
Yoder, M.D., Thomas, L.M., Tremblay, J.M., Oliver, R.L., Yarbrough, L.R., and 
Helmkamp, G.M., Jr. (2001). Structure of a multifunctional protein. Mammalian 
phosphatidylinositol transfer protein complexed with phosphatidylcholine. J Biol Chem 
276, 9246-9252. 
 
York, J.D., Odom, A.R., Murphy, R., Ives, E.B., and Wente, S.R. (1999). A 
phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient 
messenger RNA export. Science 285, 96-100. 
 
 
 34
Chapter 1b 
 
The PITP proteins 
 The PITP superfamily of proteins is defined by the ability of the proteins to 
transfer lipids between membranes in vitro.  Within the superfamily, there are two 
subfamilies that share the same biochemical activity, but do not have any sequence or 
structural similarity.  These families are called the Sec14 PITP family, named for the 
founding yeast PITP, and the Class I or Metazoan PITPs.  In many cases, there are more 
Sec14 family proteins in a given organism than PITP members.  The most striking case is 
Drosophila, where there are 15 Sec14 family members and just three metazoan PITPs 
(Phillips et al, 2006).  The reason for the many family members in the Sec14 family may 
be related to the ability of these proteins to bind to different lipids (such as the α-
tocopherol transfer proteins), and the fact that Sec14 domains are often found in 
association with other domains such as the GOLD or nodulin domains.  The PITP family, 
which is the focus of my thesis, and thus this review, is a smaller family with members 
that are often essential for survival. 
Sec14 
 While Sec14 is not related to the PITPs in structure or sequence, the functional 
interchangability of these molecules suggests that Sec14 is still a relevant model for PITP 
function. 
 The first clues to Sec14 function came from finding mutations in yeast genes that 
allowed yeast to grow despite a non-functional Sec14 molecule (known as bypass 
mutations).  Seven molecules were found that fell into three groups.  The first group of 
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bypass mutations inactivated the phosphatidylcholine biosynthesis pathway, suggesting a 
role for Sec14 in downregulating PtdCho levels, while keeping DAG levels high (Cleves 
et al., 1991; McGee et al., 1994a; McGee et al., 1994b; Skinner et al., 1995; Xie et al., 
2001).  The second bypass mutation allowing growth in the absence of Sec14 is Sac1, a 
PtdIns (4)P phosphatase (Cleves et al., 1989).  The inactivation of Sac1 is believed to 
increase PtdIns (4)P levels, and compensate for the wild type Sec14 function of 
maintaining PtdIns (4)P levels.  The final and least well understood bypass mutation is in 
Kes1 (Fang et al., 1996), a member of the oxysterol binding protein (OSBP) family.  
Deletion of Kes1 can restore viability to a strain with a temperature sensitive mutation in 
the yeast kinase pik1, suggesting that the deletion of Kes1 “frees up” PtdIns-4P 
molecules (Li et al., 2002). 
Together, the bypass mutant data demonstrate a role for Sec14 in regulation of 
two lipid pathways: PtdIns to PtdIns-4P and PtdCho/DAG.  In the PtdCho/DAG pathway, 
Sec14 maintains high levels of the pro-secretory lipid DAG through preventing its 
consumption in synthesis of PtdCho, which is itself inhibitory towards secretion.  Sec14p 
increases the levels of PtdIns-4P in the TGN, though the mechanism is not clear from the 
genetic data. 
 Recent work provided clues to a molecular mechanism by which Sec14 could 
work.  Crystal structures of the closely related Sfh1 protein revealed overlapping, but 
distinct binding sites for PtdIns and PtdCho.  Subsequent mutagenesis of Sec14p revealed 
that the binding sites were conserved.  Surprisingly, Sec14 required both PtdIns and 
PtdCho binding sites in the same molecule in order to function.  Thus, the regulation of 
PtdCho/DAG and PtdIns are not distinct functions, but rather are related, leading to the 
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current model that as a heterotypic exchange reaction occurs, lipids are presented to 
modifying enzymes (Schaaf et al., 2008). 
 The Sec14 model demonstrates a mechanism of action that could be universal for 
PITP molecules.  However, it is also important to emphasize that there are distinctions 
between the Sec14 and PITP classes of proteins.  PITPs bind lipid with the headgroup 
buried within the molecule, unlike Sec14p (discussed in more detail below).  In addition, 
it is known that the PtdIns and PtdCho lipid headgroups bind in the same pocket of 
PITPs, rather than in distinct sites, as seen in Sec14/Sfh1.  To better understand the 
unique features of PITPs, I’ll discuss what is known about the structure and function of 
these molecules. 
Structural Insights into PITP function 
 The solved crystal structures for PITPα in the apo-, PI- and PC-bound forms, 
along with a PC-bound form of PITPβ, have given a clear picture of how mammalian 
PITPs bind lipids (Oliver et al., 1999; Yoder et al., 2001; Schouten et al., 2002; Tilley et 
al., 2004; Vordtriede et al., 2005).  The PITP molecules are constructed of a lipid-binding 
core consisting of an 8-stranded β sheet, and 6 alpha-helices.  In contrast to Sec14p, the 
lipid headgroup is buried within the pocket with the acyl chains facing the membrane 
binding site (Oliver et al., 1999; Yoder et al., 2001).  Genetic studies showed a role for 
the T59 residue in PI transfer, and the crystal structure made clear why this residue was 
important (Alb et al., 1995; Yoder et al., 2001).  The T59 residue is located within the 
binding pocket and forms a hydrogen bond with PtdIns.  In addition to the T59 residue, 
residues K61 and N90 were also identified from the crystal structure and confirmed by 
binding and transfer assays to be essential for PtdIns binding/transfer (Tilley et al., 2004). 
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The crystal structure of the PITPs indicated surprisingly few differences between 
PITP species or lipid bound forms.  The closed form of the protein is the same when it is 
bound to PI or PC, dispelling previous predictions that PITPα would have different 
binding partners depending on which lipid is bound.  As predicted by their high sequence 
similarity, PITPβ bound to PC is almost identical to lipid-bound PITPα (Tilley et al., 
2004).   
The C-terminal tail of the PITPs is shown in this work (Chapter 2) and others to 
be of key importance.  The C-terminal tail displays increased movement and increased 
trypsin sensitivity in the presences of vesicles.  When the C-terminal tail is deleted, the 
protein displays conformational changes, increased membrane binding, and decreased 
transfer ability.  (Tremblay et al., 1996; Voziyan et al., 1996; Tremblay et al., 2005).  
Together, these data indicate that the C-terminal is both sensitive to and responsible for 
the membrane bound status of the protein, and the C-terminal tail is critical for function. 
PITP biochemistry 
 Early clues to the function of PITPs came from in vitro experiments using 
permeabilized cells.  These experiments showed a role for PITPs in a wide variety of 
signaling and secretion pathways.  In particular, PITPs were shown to restore activity of 
PLC-β and PLC-γ isoforms in response to various stimuli(Thomas et al., 1993; 
Cunningham et al., 1995; Kauffmann-Zeh et al., 1995; Cunningham et al., 1996; Currie 
et al., 1997).  Additionally, PITPs supported both constitutive secretion in 
neuroendocrine and HL60 cells and regulated secretion in PC12 cells and mast cells (Hay 
and Martin, 1993; Ohashi et al., 1995; Fensome et al., 1996; Jones et al., 1998; Simon et 
al., 1998).  The requirement for PITPs in these experiments is not specific; when tested, 
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the yeast PITP (Sec14p) could restore activity at levels comparable to either of the 
mammalian isoforms (Hay and Martin, 1993; Ohashi et al., 1995; Cunningham et al., 
1996). 
 That the common role of PITP in the in vitro studies was PI transfer/presentation,  
was indicated by several lines of evidence: i) the non-specific PITP requirement in in 
vitro assays suggests that the necessary activity is a biochemical one, not a protein-
protein interaction.  ii) Some studies show an increase in cellular PtdIns-4P or PtdInsP2 
when PITPs are present and several secretion assays require a PI-kinase as an additional 
factor, suggesting that PITP presents PI to the kinase (Cunningham et al., 1995; Hay et 
al., 1995; Kauffmann-Zeh et al., 1995; Fensome et al., 1996; Jones et al., 1998).  iii) 
Kinetics suggest that in some cases, PITP is not required for initial phases of PLC 
activation, but rather for extended signaling, which is consistent with a role in providing 
PI once PI on the membrane has been used up (Currie et al., 1997) . 
 The notion of PITPs as PtdIns presenting molecules, suggested by permeabilized 
cell studies, is consistent with what is known about Sec14.  For a true understanding of 
how these molecules work, however, they must be considered in the context of intact 
cells and animals.  Studies of several PITP family members in animals displayed a range 
of functions for these molecules. 
In vivo Function of Metazoan PITPs 
 Metazoan PITPs have been found in Dictyostelium, C. elegans, Drosophila, and 
mammals, however in vivo studies have focused mainly on Drosophila and mammalian 
isoforms.  These PITPs can be divided into two groups based on homology: the RdgB 
subfamily and the soluble PITP subfamily. 
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 Some of the soluble PITPs have well characterized roles.  The Drosophila RdgB 
isoform RdgBα (or RdgB) is involved in phototransduction light response in flies; in the 
absence of RdgB, flies have an initial response to light, but this response cannot be 
terminated and the photoreceptor cells degenerate.  The PITP domain of RdgB is 
essential in this process: the PITP domain alone can rescue the loss of RdgB (Milligan et 
al., 1997). 
 Another well characterized RdgB isoform is the mammalian protein RdgB1 
(Nir2).  Nir2 is a multidomain protein is required for embryogenesis with roles in lipid 
homeostasis of the Golgi and in cytokinesis (Lu et al., 2001; Litvak et al., 2004). The role 
of Nir2 in cytokinesis is related to its Rho inhibitory domain (Rid), and there is no 
evidence for a role of the PITP domain in regulation of cytokinesis.  A clear role for the 
Nir2 PITP domain, however, was demonstrated in Golgi lipid dynamics.  Like Sec14p 
yeast mutants, knockdown of Nir2 causes Golgi dysmorphology and a decrease in 
diacylglycerol (DAG) due to upregulation of the CDP-choline pathway (Litvak et al., 
2005).  These defects cannot be rescued by Nir2 with a PI binding site mutant. 
Soluble PITP family 
 Within the soluble PITP family, a Drosophila and a mouse protein provide two 
different examples of how soluble PITPs can function.  Drosophila have one soluble 
PITP family member, which shares 59% and 61% identity with mammalian PITPα and 
PITPβ respectively, and this protein (called vibrator or giotto) is critical for cytokinesis 
during spermatid meiosis and neuroblast mitosis (Gatt and Glover, 2006; Giansanti et al., 
2006).  In vib-null cells, spindle and contractile ring form normally, but do not fully 
constrict, which is proposed to be because Golgi-like vesicles don’t reach the cell poles.  
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Consistent with a role in cytokinesis, P-element insertions in the vib gene are lethal as 
early as larvae second instar(Gatt and Glover, 2006; Giansanti et al., 2006).   
 There are two mammalian soluble PITPs: PITPα and PITPβ.  As discussed above, 
in vitro studies indicated an interchangable role for these proteins in presenting PI for 
modification and in promoting signaling or vesicle budding reactions.  Cell culture and in 
vivo studies, however, indicate distinct cellular roles for these proteins.  PITPα-null ES 
cells have no defects in cell survival, nor is there a difference in lipid levels, secretion, 
endocytosis, or growth (Alb et al., 2002).   
Reduction of PITPα levels does result in profound effects on the organism.  In the 
vibrator mouse, where PITPα levels are decreased 5-fold, mice are viable but exhibit 
whole body tremors and die 30 days after birth (Hamilton et al., 1997; Alb et al., 2003).  
The complete ablation of PITPα leads to hypoglycemia, intestine and liver steatosis, and 
neurodegeneration.  While all of the phenotypes seen in PITPα knockout mice can be 
rescued by a construct expressing wild type PITPα, expression of a T59D construct (the 
PtdIns binding mutant) rescues none of the phenotypes (Alb et al., 2007).  This indicates 
a clear importance for PtdIns binding in PITPα activity, though the molecular mechanism 
of action is not yet known. 
One role of PITPα in the brain seems to be in neurite outgrowth.  PITPα is 
reported to interact via its C-terminal tail with the netrin receptors DCC and neogenin, 
and this netrin-1 induced interaction stimulates PITPα PtdIns transfer ability and PIP2 
hydrolysis.  In vibrator mouse neurons, the PIP2 hydrolysis response is completely 
abolished and neurite outgrowth from cortical explants is diminished (Xie et al., 2005).  
While studies in our lab have not been able to replicate the PITPα interaction with DCC, 
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axonal guidance is strongly defective in PITPα knockout mice (Malika Boukhelifa, 
unpublished data).   
 In vivo studies of PITPβ are hampered by the fact that PITPβ-null cells cannot be 
obtained, which suggests that PITPβ is an essential housekeeping protein.  Despite the 
clear importance of PITPβ, little is known about its function. 
 My dissertation focuses on the in vivo role of PITPβ in mammals and zebrafish.  
We demonstrate that PITPβ localizes to the TGN, and identify regions of the protein that 
contribute to the localization.  PITPβ is not localized to the Golgi by a single region of 
the protein; several regions are necessary for correct localization.  I then examined the 
effects of loss of PITPβ expression in human cell lines and zebrafish.  In mammalian 
cells, PITPβ is required for survival, and its loss leads to abnormal Golgi formation and 
decreased secretion kinetics.  PITPs in zebrafish demonstrate completely different roles 
than their mammalian counterparts.  PITPβ is not an essential gene for embryonic 
development in zebrafish.  Instead, it proves to be essential for the normal formation of 
the outer cone cells of the retina.  A novel zebrafish PITP, termed PITPγ, is identified and 
its function is so far unclear.  PITPα, however, is essential for early development, unlike 
its mammalian counterpart.  Together, this thesis demonstrates the range of functions 
performed by PITPs in eukaryotes. 
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Abstract 
Phosphatidylinositol transfer proteins (PITPs) regulate the interface between lipid 
metabolism and specific steps in membrane trafficking through the secretory pathway in 
eukaryotes. Herein, we describe the cis-acting information that controls PITPβ 
localization in mammalian cells. We demonstrate PITPβ localizes predominantly to the 
trans-Golgi network (TGN) and that this localization is independent of the phospholipid-
bound state of PITPβ. Domain mapping analyses show the targeting information within 
PITPβ consists of three short C-terminal specificity elements and a nonspecific 
membrane-binding element defined by a small motif consisting of adjacent tryptophan 
residues (the W202W203 motif). Combination of the specificity elements with the 
W202W203 motif is necessary and sufficient to generate an efficient TGN-targeting 
module. Finally, we demonstrate that PITPβ association with the TGN is tolerant to a 
range of missense mutations at residue serine 262, we describe the TGN localization of a 
novel PITPβ isoform with a naturally occurring S262Q polymorphism, and we find no 
other genetic or pharmacological evidence to support the concept that PITPβ localization 
to the TGN is obligately regulated by conventional protein kinase C (PKC) or the Golgi-
localized PKC isoforms δ or ε. These latter findings are at odds with a previous report 
that conventional PKC-mediated phosphorylation of residue Ser262 is required for PITPβ 
targeting to Golgi membranes.  
Introduction 
Because the discovery that a phosphatidylinositol transfer protein (PITP) plays an 
essential role in regulating the interface between lipid metabolism and membrane 
trafficking from the yeast trans-Golgi network (TGN; Bankaitis et al., 1990; Cleves et al., 
1991a; Cleves et al., 1991b), it has become increasingly clear that lipid metabolism 
regulates many individual trafficking steps throughout the secretory pathway (Cleves et 
al., 1991a; De Camilli et al., 1996; Simonsen et al., 2001). In vivo studies demonstrate 
PITPs either control the efficiency at which trafficking reactions occur (Bankaitis et al., 
1989; Bankaitis et al., 1990; Cleves et al., 1991b; Kearns et al., 1997) or impart spatial 
organization to these reactions (Lopez et al., 1994; Nakase et al., 2001; Vincent et al., 
2005). PITPs do so by coupling their ability to bind and/or transfer specific lipids to the 
coordination of lipid metabolic pathways with specific membrane trafficking steps (see 
(Phillips et al., 2006). In vitro reconstitution of various membrane trafficking or receptor-
coupled signaling reactions also identify involvements for PITPs in these events ((Hay 
and Martin, 1993; Ohashi et al., 1995; Cunningham et al., 1996; Jones et al., 1998).  
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The available evidence indicates confident assignment of function for any 
individual PITP requires in vivo studies with model genetic systems. The reconstituted 
systems that show PITP dependence are remarkably promiscuous from the perspective of 
source of PITP. This is amply demonstrated by the stoichiometric interchangeability of 
yeast and mammalian PITPs in such reconstitutions (Ohashi et al., 1995; Cunningham et 
al., 1996; Jones et al., 1998), even though these PITPs exhibit unrelated structural folds 
(Sha et al., 1998; Yoder et al., 2001; Tilley et al., 2004). By contrast, in vivo studies 
show even very closely related PITPs play nonredundant functions in cells (Li et al., 
2000; Alb et al., 2002; Alb et al., 2003; Routt and Bankaitis, 2004; Vincent et al., 2005).  
Mammalian cells express three soluble PITPs. PITPα and PITPβ share 77 and 
95% primary sequence identity and similarity, respectively, and are encoded by distinct 
genes. The third, rdgBβ, is considerably more diverged and remains largely unstudied 
(Fullwood et al., 1999). The shared homologies notwithstanding, PITPα and PITPβ are 
functionally distinct (Alb et al., 2002; Alb et al., 2003). In this regard, PITPα binds 
PtdIns and PtdCho, whereas PITPβ binds both those phospholipids and, in addition, 
sphingomyelin (SM; de Vries et al., 1995). Moreover, recombinant PITPα and PITPβ 
localize to distinct compartments, the former to the cytosol and nucleus and the latter to 
the cytosol and a perinuclear compartment that is likely the Golgi complex (de Vries et 
al., 1995; De Vries et al., 1996; van Tiel et al., 2002). The relationship between the 
distinct biochemical properties of these two PITP isoforms and localization and function 
(if any) remain to be determined.  
Herein, we report that endogenous PITPβ (and a novel spliceoform thereof) 
localizes predominantly to TGN membranes and that localization is specified by a 
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functionally redundant set of three short C-terminal motifs. These motifs are collectively 
insufficient to target a naive reporter to Golgi membranes, but cooperate with a W202W203 
motif to generate an efficient TGN-targeting module. We also show that the 
phospholipid-bound status of PITPβ does not contribute to its association with the TGN. 
Finally, in contrast to a previous claim (van Tiel et al., 2002), our data indicate that 
neither localization of PITPβ nor its novel spliceoform to Golgi membranes is obligately 
regulated by conventional protein kinase C (PKC)-mediated phosphorylation of residue 
serine 262. 
 
Materials and Methods 
Mammalian Cell Culture and Transfections 
Murine embryonic fibroblasts (MEFs) were derived from E16.5 wild-type and 
PITPα–/– embryos as previously described (Alb et al., 2003). The mammalian cell lines 
used in this study were cultured in DMEM containing 10% fetal bovine serum, 1 U/ml 
penicillin G, 100 µg/ml streptomycin, and 4.2 µl β-mercaptoethanol (for 500 ml of 
complete medium). Cultures were incubated at 37°C and in 5% CO2.  
COS-7 cells were transfected using Lipofectamine Plus reagent (Invitrogen, 
Carlsbad, CA). Briefly, 24 h before transfection the cells were plated at 50–60% 
confluency in six-well plates containing glass coverslips. DNA (1.5–2 µg) was 
reconstituted in 100 µl of OptiMEM (Invitrogen), mixed with 2 µl of Plus reagent, and 
incubated at room temperature for 15 min. In a separate microcentrifuge tube, 3 µl of 
Lipofectamine was diluted in 100 µl of OptiMEM for each transfection. After 15 min, the 
solutions were mixed and then incubated for 15 min at 25°C. Cells were washed twice 
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with OptiMEM and incubated at 37°C with DNA mixture in 1 ml OptiMEM for 3 h. 
Subsequently, 4 ml of complete medium was added, and cells were cultured for 18–24 h 
before processing for immunocytochemistry. MEFs were transfected using the Amaxa 
(Cologne, Germany) nucleofector following the manufacturer's directions.  
Antibody Reagents 
PITP antibodies used in this study included: a PITPβ isoform–specific rabbit 
polyclonal antibody directed against the C-terminal 25 amino acid of PITPβ (generous 
gift from Bruce Hamilton), a PITPα isoform–specific chicken polyclonal antibody 
directed against the last 15 amino acids of PITPα (Alb et al., 2002), and the NT-PITP-
antibody rabbit polyclonal immunoglobulin (Ig) raised against the N-terminus of PITP  
and that recognizes both PITPα and PITPβ (generous gift of Prof. George Helmkamp, 
Jr.).  
The following primary antibodies were used: a monoclonal antibody directed 
against actin (Chemicon, Temecula, CA), sheep polyclonal anti-TGN38 Ig (Serotec), 
monoclonal anti-GM130 antibodies (BD Bioscience, San Diego, CA), and murine 
monoclonal anti-giantin Ig (generous gift from Dr. Hans Peter Hauri, Switzerland). 
Secondary antibodies used included: Alexa fluorescein isothiocyanate 488 (Molecular 
Probes, Eugene, OR), Cy5-conjugated anti-mouse and fluorescein isothiocyanate–
conjugated anti-mouse (Jackson ImmunoResearch, West Grove, PA), and goat anti-
rabbit, goat anti-mouse, or goat anti-chicken horseradish peroxidase (HRP)-conjugated 
antibodies (Jackson ImmunoResearch). 
Immunocytochemistry 
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Cells were cultured on glass coverslips. Cells were fixed for 15 min with 3.7% 
formaldehyde in phosphate-buffered saline (PBS), permeabilized in 0.2% Triton X-100 in 
PBS for 4 min, rinsed once in PBS, and then preincubated for 30 min in blocking buffer 
(2% BSA in PBS). Permeabilized cells were subsequently incubated with suitable 
primary antibody appropriately diluted in blocking buffer for 1 h at room temperature, 
rinsed four times 5 min with PBS, and then incubated with the secondary antibodies 
appropriately diluted in blocking buffer for 1 h. Cells were rinsed four times in PBS, and 
coverslips were mounted onto glass slides and examined in a Leica SP2 Laser Scanning 
Confocal Microscope (Leica, Deerfield, IL). Images were processed with the use of 
Adobe Photoshop 6.0 (Adobe Systems, Mountain View, CA).  
In classifying PITP localization profiles as “Golgi”, two major criteria were 
applied. First, for to score a profile as Golgi the appropriate query profile (GFP or PITP) 
must exhibit obvious and predominant colocalization with a Golgi marker (TGN38 or 
GM130). Second, the Golgi component of the query profile must be the strongest signal 
recorded in the cell being scored. Failure to satisfy both these criteria resulted in a non-
Golgi score. Fixed and stained samples were blinded before scoring to control for 
investigator bias.  
Pharmacological Challenge 
PITPα–/– MEFs were grown on glass coverslips to subconfluency and intoxicated 
with chelerethryne chloride (0.66 µM; Sigma, St. Louis, MO) or G109203X (10 nM; 
Sigma) for appropriate times. PKC activity in MEFs was also stimulated by exposure of 
cells grown on coverslips to PMA (100 nM, Sigma) for 15 min in serum-free medium. 
Cells were subsequently fixed for PITPβ immunostaining as described above. Cell-free 
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extracts were prepared for parallel-treated cultures and processed for immunoblot 
analysis as described below.  
SDS-PAGE and Immunoblotting 
Cultures were rinsed with ice-cold PBS and scraped into lysis buffer (20 mM 
Tris-HCL, pH 7.4, 150 mM NaCl, 2 mM EDTA, 10 mM NaF, 1% Triton 1 mM 
orthovanadate supplemented with a cocktail of protease inhibitors (Complete; Roche, 
Indianapolis, IN). For preparation of cell-free extracts, cells (grown to confluency in a 
100-mm dish) were incubated with 700 µl of lysis buffer at 4°C for 10 min and then 
scraped with a rubber policeman into microcentrifuge tubes. After centrifugation at 
14,000 x g for 10 min, the supernatant was mixed in Laemmli sample buffer and heated 
for 5 min at 95°C. Samples were resolved by SDS-PAGE (10%) and transferred to 
nitrocellulose (Millipore, Billerica, MA). Membranes were blocked overnight at 4°C in 
TBST (5% dry nonfat milk in 0.05% Tween 20 in Tris-buffered saline) and then 
incubated for 3 h at room temperature with the appropriate primary antibodies diluted in 
TBST. Membranes were rinsed four times for 5 min each with TBST and then incubated 
with the appropriate HRP-conjugated secondary antibody for 1 h, and washed four times 
for 5 min each with TBST. Blots were developed on x-ray film (Eastman Kodak, 
Rochester, NY) using the enhanced chemiluminescence (ECL) Western blotting detection 
reagent (Amersham, Arlington Heights, IL).  
Generation of PITPα-GFP and PITPβ-GFP cDNAs 
PCR primers for rat-PITPα and rat-PITPβ cDNA sequences were flanked on the 5' end 
with the restriction enzyme site HindIII and on the 3' end with the restriction enzyme site 
BamHI. The HindIII-BamHI PCR fragments were cloned into the pEGFP-C1 plasmid 
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(Clontech, Palo Alto, CA). Yeast plasmids harboring PITPα and PITPβ cDNAs (Skinner 
et al., 1993) were used as templates in the PCR reactions used for generating the 
appropriate DNA fragments for cloning. The resulting plasmids were designated pRE772 
(PITPβ-GFP) and pRE774 (PITPα-GFP). Primer sequences used are available from the 
authors by request.  
Yeast Complementation Assay 
Wild-type and mutant PITPβ or PITPβ-GFP cDNAs, as appropriate, were cloned into the 
multicopy yeast URA3 vector YEplac195 such that the cDNA was expressed either under 
control of the powerful constitutive PGK promoter or the constitutively expressed but 
weaker SEC14 promoter. This expression vector was transformed into the sec14-1ts yeast 
strain (CTY 1-1A, MATa ura3-52 his3Δ200, lys2-810 sec14-1ts; (Cleves et al., 1991b) 
using the lithium acetate method of Ito et al. (1983). As matched controls, isogenic 
vectors with either no insert or with SEC14 or PITPβ cDNA inserts were also 
transformed into the sec14-1ts yeast host strain. Transformants were selected and cultured 
in uracil-free glucose minimal medium (Sherman, 1983). Five OD600 equivalents of each 
strain were resuspended in 200 µl Tris-EDTA buffer and serially diluted 10-fold in Tris-
EDTA buffer. An aliquot (5 µl) of each dilution was spotted on duplicate YPD agar 
plates. One plate was incubated at the 30°C (a permissive temperature for sec14-1ts 
mutants) to report unrestrained growth and viability. The companion plate was incubated 
at 37°C (normally a restrictive temperature for sec14-1ts mutants) to assess phenotypic 
rescue of sec14-1ts.  
Phospholipid-Transfer Assays 
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Assays were performed using cytosol prepared from the sec14 Δcki1 host strain CTY303 
expressing the desired PITP as described previously (Kearns et al., 1998; Phillips et al., 
1999; Li et al., 2000; Vincent et al., 2005). Cytosol fractions generated from CTY303 
variants expressing Sec14p (positive control) or no PITP (negative control) were 
generated and assayed in parallel with those fractions containing PITPα, PITPβ, or PITPβ 
variants.  
Site-directed Mutagenesis 
The QuickChange kit (Stratagene, La Jolla, CA) was used. Sequences of the various 
mutagenic primers used are available from the authors by request. All mutant versions 
generated were verified by nucleotide sequence analysis. 
Results 
Endogenous PITPβ Localizes to the Mammalian Golgi Complex 
Previous experiments suggesting a Golgi localization of PITPβ in mammalian 
cells relied on microinjection of purified fluorophore-modified protein into cells (De 
Vries et al., 1996) or creation of stable cell lines that overexpress PITPβ (van Tiel et al., 
2002). As a result, several key questions regarding PITPβ localization remain. First, it 
remains to be demonstrated whether endogenous PITPβ is genuinely a Golgi membrane–
associated protein. Second, the precise distribution of PITPβ within the Golgi stack also 
remains to be determined.  
Specific localization of endogenous PITPβ was complicated by our observation 
that antibodies generated against the extreme C-terminal 15- and 25-residue peptides of 
these proteins, although facile for distinguishing PITPα from PITPβ by immunoblotting, 
are not satisfactory for immunofluorescence experiments (unpublished data). To 
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circumvent this issue, we used polyclonal antibodies raised against amino-terminal 
sequences conserved between PITPα and PITPβ. These antibodies (NT-PITP-antibody) 
are suitable for immunofluorescence but are not specific reagents in that these recognize 
both PITPα and PITPβ isoforms in immunoblotting experiments. The specificity issue 
notwithstanding, we inspected the endogenous PITP immunofluorescence staining 
profiles obtained with NT-PITP-antibody in an array of cell lines. Swiss 3T3 fibroblasts 
exhibited a strong perinuclear staining of what appears to be the Golgi apparatus and a 
diffuse signal in the cytoplasm and the nuclear matrix (Figure 1A). The PITP profiles 
obtained with Swiss 3T3 cells and NT-PITP-antibody as reporter were typical. Very 
similar results were also obtained with a variety of other cell lines including astrocytes, 
primary neurons, and COS-7, HeLa, and HEK293 cells. That the perinuclear PITP 
staining identifies the Golgi complex is indicated by the coincidence of this profile with 
that obtained for the cis-Golgi marker GM130 (Figure 1A). As the NT-PITP-antibody 
immunofluorescence profiles collected with immortalized cell lines represent the sum of 
endogenous PITPβ and PITPα distribution, and previous studies indicate PITPα localizes 
to the cytoplasm and nuclear matrix (De Vries et al., 1996), these various localization 
profiles suggest that endogenous PITPβ targets to Golgi membranes in a variety of cell 
types. 
To visualize endogenous PITPβ in isolation from PITPα, we used NT-PITP-
antibody as PITP detector and took advantage of PITPα nullizygous primary cell lines 
that we had previously generated. The nullizygous MEFs are well suited for these 
experiments as these cells are phenotypically indistinguishable from wild-type MEFs and 
retain unadulterated levels of endogenous PITPβ (Alb et al., 2002; Alb et al., 2003). As 
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shown in Figure 1B, NT-PITP-antibody decorates an elaborate ribbonlike perinuclear 
structure in these PITPα–/– MEFs, and this structure is also stained by the cis-Golgi 
marker GM130. The GM130 and presumptive PITPβ staining profiles are very similar in 
form, but are not coincident. These data indicate that PITPβ does not localize to cis-Golgi 
membranes but, rather, localizes to a distinct subcompartment of the Golgi complex (see 
below). Very little staining of the cytoplasm or nucleus is observed, and staining of the 
lacelike ER is also evident. These staining profiles were absent when naive preimmune 
serum was substituted for NT-PITP-antibody in these experiments.  
To confirm localization of the known PITPβ, we constructed a PITPβ-GFP 
chimera, where GFP was fused to the C-terminus of PITPβ. The activity of the PITPβ-
GFP chimera was established with a yeast phenotypic rescue assay. This assay capitalizes 
on previous demonstrations that high-level expression of mammalian PITPs in yeast 
rescues the growth and secretory defects associated with inactivation of the essential 
yeast PITP Sec14p (Skinner et al., 1993; Tanaka and Hosaka, 1994). This rescue is 
dependent on robust PtdIns-binding/transfer by the heterologous mammalian PITP (Alb 
et al., 1995). As shown in Figure 1C, a sec14-1ts yeast strain carrying an ectopic copy of 
the wild-type SEC14 gene grows robustly at 37°C. By contrast, the isogenic sec14-1ts 
strain fails to grow at all at 37°C, i.e., the restrictive temperature at which the 
thermolabile sec14-1ts gene product is inactive. Expression of PITPβ-GFP restored 
robust growth to the sec14-1ts yeast mutant at the restrictive 37°C temperature.  
The functional PITPβ-GFP was expressed in MEFs and the distribution of the 
chimera was monitored. These localization experiments confirm an unambiguous affinity 
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of PITPβ-GFP for Golgi membranes in MEFs (Figure 1D) and also in COS-7 cells (see 
below).  
PITPβ Selectively Associates with the TGN 
Although both Golgi and ER membranes harbor pools of PITPβ, Golgi 
localization predominates and how PITPβ targets to the Golgi membrane system is the 
focus of this study. To more precisely assign the Golgi subcompartment of residence for 
endogenous PITPβ, we performed a series of double-label immunofluorescence 
experiments. In these experiments, NT-PITP-antibody was used in combination with 
compatible antibodies raised against markers for specific Golgi compartments. These 
markers included GM130 for cis-Golgi, giantin for cis- and medial-Golgi, and TGN38 for 
the TGN. PITPα nullizygous MEFs were used to ensure specific detection of endogenous 
forms of PITPβ.  
As shown in Figures 2, A and B, endogenous PITPβ exhibits little coincidence of 
staining with the cis-Golgi marker GM130, or the medial-Golgi marker giantin, even 
though the general profiles for PITPβ and these markers are very similar. Endogenous 
PITPβ species exhibit a higher degree of colocalization with the trans-Golgi membrane 
marker TGN38, however (Figure 2C). The predominant localization of PITPβ to TGN 
membranes is emphasized in a stereo reconstruction of the MEF Golgi apparatus 
generated from triple-label experiments monitoring PITP, giantin, and TGN38 
(Supplemental Video, Figure S1). The rotating image distinguishes giantin staining from 
the yellow staining that reports colocalization of TGN38 and PITPβ. We infer from these 
experiments that PITPβ targets predominantly to the trans-aspect of the Golgi stack in 
MEFs.  
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During the course of these studies, we noted the existence in the NCBI Protein 
Database of an uncharacterized PITPβ spliceoform (referred to as PITPβQGQR, as opposed 
to canonical spliceoform that we refer to as PITPβ) that is invisible to our PITPβ-specific 
antibodies in immunoblot experiments (murine form, accession number AAH34676; rat 
form, AAH61538; human form, AAH31427). This spliceoform is detected by the NT-
PITP-antibody, however, and the PITPβ localization profiles described in Figure 2 
represent the sum of the PITPβ and PITPβQGQR profiles (these two spliceoforms are both 
expressed in MEFs; unpublished data). Defined GFP-chimeras permit localization of 
each spliceoform in isolation, however. As further described below, we show that both 
PITPβ-GFP and PITPβQGQR-GFP reporters target efficiently to similar (albeit not 
identical) Golgi subcompartments.  
PITPβ C-terminal Motifs Necessary for TGN Targeting 
The distinctive localization profiles for PITPβ and PITPα are remarkable in light 
of the high degree of primary sequence identity shared by these PITPs. To map the 
determinants specifying targeting of PITPβ to the mammalian TGN in an unbiased 
manner, we constructed a reciprocal series of PITPβ/PITPα hybrid proteins in the context 
of a functional PITP-GFP chimera. The functional status of key chimeras was confirmed 
in the heterologous yeast sec14-1ts phenotypic rescue assay (Skinner et al., 1993); 
described above and in Figure 1C). All chimeras generated were active in the yeast 
phenotypic rescue assay and were expressed both in PITPα–/– MEFs and in COS-7 cells. 
The respective intracellular distributions were imaged and quantified for both cell types. 
In describing the results of the mapping experiments, we present data obtained with 
MEFs and report the COS-7 data in Supplemental Materials.  
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The C-terminal 28 PITPβ residues are both necessary for PITPβ targeting to 
Golgi membranes and are sufficient to efficiently redirect PITPα to that location (Figure 
3A). The results were robust because the incidence of Golgi targeting in cells was >90% 
for PITPβ and the PITPα/β chimera and <5% for PITPα and the PITPβ/α chimera. 
Representative images for each chimera are shown in Figure 3B. In the imaging 
experiments reported herein, we typically identify the Golgi region by surveying the cis-
Golgi marker GM130 but confirmed that assignment by costaining with the pan-Golgi 
marker wheat germ agglutinin and, for key reporter/mutant constructs, by costaining for 
TGN38 (see below). 
Alignment of the PITPβ and PITPα C-terminal primary sequences identifies three 
motifs of greatest divergence between these isoforms. We refer to these motifs as BOX1, 
BOX2, and BOX3 (Figure 3C). Mutagenesis experiments, where each individual BOX 
region from PITPα was substituted for the corresponding BOX region of PITPβ, 
demonstrated that PITPβKQE, PITPβQDPK, and PITPβMTD all exhibited efficiencies of 
Golgi localization similar to those recorded for the PITPβ control (Figure 3, C and D). 
Thus, no single BOX motif is essential for PITPβ targeting to Golgi membranes. We also 
observed that swap of any two of the BOX domains from PITPα into the PITPβ context 
did not compromise association of PITPβ with TGN membranes (Figure 3, C and D). 
These data indicate that the presence of any single PITPβ motif is sufficient for 
maintenance of PITPβ localization to the Golgi complex. Parallel analyses of the 
localization properties of each chimera were also conducted in COS-7 cells with 
essentially identical results (Supplemental Materials, Figure S2).  
PITPβ C-terminal Motifs Sufficient for Targeting PITPα to Golgi Membranes 
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To address the dual criteria of necessity and sufficiency, we tested whether any 
BOX residues sufficient for PITPβ localization to the TGN were capable of redirecting 
PITPα to the same. To this end, PITPβ BOX1 or BOX3 residues were incorporated into 
the context of an otherwise wild-type PITPα. The localization profiles of both constructs 
(PITPαQET and PITPαTSA) fully recapitulated the nuclear and cytoplasmic distribution of 
the PITPα control (Figure 4A). Thus, neither BOX1 nor BOX3 has an assignable 
targeting function on its own in the context of PITPα. However, BOX2 residues, although 
dispensable for PITPβ targeting to the Golgi complex, increased the efficiency with 
which an otherwise wild-type PITPα reporter associates with Golgi membranes. That 
construct (PITPαKGSR) was scored as targeting to Golgi membranes in 51% of the 
transfected cells analyzed. Although this level of targeting is not as robust as that 
observed with the PITPβ positive control (>90%), it is substantial when compared with 
the basal association of the PITPα control with the Golgi complex (ca. 5%; Figure 4A).  
When multiple PITPβ BOX motifs were swapped into the PITPα context, an 
essentially complete redirection of a PITPα reporter to the TGN was observed. 
Combinatorial incorporation of PITPβ BOX1 and BOX2 residues, BOX1 and BOX3 
residues, or BOX2 and BOX3 residues into the PITPα context yielded chimeras that 
efficiently targeted to Golgi membranes (Figures 4, A and B). For reasons detailed below, 
we were particularly interested in any role BOX2 or its individual residues may play in 
the localization of PITPβ to the TGN. In that regard, the dispensability of BOX2 residues 
for PITPβ Golgi targeting was further emphasized in a swap of BOX2 from PITPα for the 
PITPβ BOX2 in the context of a PITPα chimera that harbors the C-terminal 28 PITPβ 
residues. This PITPαQET-TSA chimera is composed entirely of PITPα primary sequence, 
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save 24 of 28 C-terminal residues where the PITPα BOX2 motif is substituted for that of 
PITPβ. Yet, PITPαQET-TSA retains its capacity to target to Golgi membranes (Figures 4, A 
and B). Again, these conclusions were confirmed when these same chimeras were 
expressed in COS-7 cells and the corresponding localization profiles were scored 
(Supplemental Materials, Figure S3). The data indicate that the combination of any two 
of the PITPβ BOX motifs is sufficient to generate a robust Golgi localization signal in the 
context of PITPα.  
PITPβ Ser262 Is Nonessential for Golgi Localization 
The dispensability of BOX2 for PITPβ localization to TGN membranes was 
counter to the findings of (van Tiel et al., 2002), who reported that phosphorylation of a 
BOX2 residue (S262) is essential for PITPβ targeting to Golgi membranes. Yet, our 
demonstration that swap of PITPβ BOX2 residues significantly improved PITPα 
targeting to Golgi membranes (i.e., the PITPαKGSR construct; Figure 4A) is consistent 
with a more substantial role for BOX2 in Golgi targeting. To investigate these 
paradoxical findings in more detail, we analyzed the involvement of S262 itself in PITPβ 
localization. Consistent with the results of the BOX2 chimera experiments, PITPβS262A, 
PITPβS262D, PITPβS262E, and PITPβS262P all targeted to Golgi membranes as efficiently as 
the PITPβ control (Figure 4C). These results were recapitulated in the context of COS-7 
cells (Supplemental Figures and Supplemental Table S1).  
To determine whether an analogous phosphorylation may be sufficient to redirect 
PITPα to Golgi membranes, we incorporated phosphomimetic amino acids at the 
corresponding P263 residue of PITPα to generate the PITPαP263D and PITPαP263E mutants. 
The ability of each to associate with MEF TGN membranes was then assessed. Neither 
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PITPαP263D nor PITPαP263E targeted to Golgi membranes any more efficiently than the 
PITPα control (Figure 4D). We repeated these analyses in COS-7 cells. Again, neither 
incorporation of the P263S missense substitution, nor P263E, into the context of PITPα-
GFP had any major effect on the intracellular distribution of the chimera (Supplemental 
Materials, Supplemental Table S1).  
A Novel PITPβ Isoform with Altered BOX2 Residues Targets to the TGN 
All of the experiments described above rely on mutagenesis of canonical PITPβ. 
The novel murine PITPβ spliceoform described above (PITPβQGQR) differs from 
canonical PITP β predominantly in BOX2 (Figure 4E). Interestingly, S262 of canonical 
PITPβ is Q262 in PITPβQGQR. PCR assays indicate both PITPβ and PITPβQGQR are 
expressed in PITPα–/– MEFs at approximately equal levels.  
Localization experiments using GFP-tagged forms show PITPβQGQR, like PITPβ, 
associates with MEF Golgi membranes (Figure 4E). These results are consistent with 
data indicating S262 is nonessential for efficient targeting of PITPβ species to that 
compartment. PITPβQGQR displays a single nonconserved serine residue (S259) in the 
region of divergence, but the S259A mutation has no effect on targeting of a PITPβQGQR-
GFP chimera to TGN membranes (Figure 4E). These data lead us to form two 
conclusions in addition to S262 dispensability for PITPβ targeting to Golgi. First, S259 
does not offer an alternative phosphorylation site required for PITPβQGQR association 
with Golgi membranes. Second, mammalian cells can express more than one PITPβ 
species in cells but, in this case, both PITPβ and PITPβQGQR isoforms home to Golgi 
membranes. Comparison of the localization profiles of PITPβ-GFP and PITPβQGQR-GFP 
chimeras indicates both target to the TGN, although PITPβQGQR-GFP also exhibits partial 
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colocalization with the medial-Golgi marker mannosidase II (Supplemental Materials, 
Figure S4, A and B). PITPβQGQR-GFP also appears to target more efficiently to cis-Golgi 
membranes than does PITPβ-GFP (Supplemental Materials, Figure S4C). Thus, 
PITPβQGQR may represent more of a pan-Golgi PITPβ than the canonical PITPβ.  
PITPβ Targeting to Golgi Membranes Is Independent of PtdIns- or SM-Transfer 
Activity 
As described in detail below, the C-terminal 28 PITPβ residues are sufficient to 
redirect PITPα to Golgi membranes but are insufficient to target a naive protein to this 
intracellular location. These data suggest that multiple localization signals may be 
involved in localizing PITPβ to the TGN and that a subset of these determinants likely 
resides in the PITP domain itself. As PITP domains represent specific lipid-binding 
modules, PITPβ lipid-binding properties themselves could potentially define components 
of a combinatorial targeting signal.  
To test this possibility, we took advantage of mutant PITPβ derivatives with 
selective defects in the loading/transfer of defined phospholipid substrates. Given that 
PITPβ is distinguished from PITPα in its ability to bind SM in addition to PtdIns and 
PtdCho, one attractive possibility is that SM loading contributes to the affinity of PITPβ 
for Golgi membranes. Data obtained from three independent lines of experimentation 
demonstrate that SM-loading and Golgi targeting are not strictly coupled. First, wholesale 
swap of the PITPα C-terminal 28 residues into the context of PITPβ leads to a PITP 
chimera that fails to associate with the Golgi complex (see Figure 3, A and B above). 
Yet, this PITPβ/α chimera exhibits robust SM transfer in vitro (Figure 5A). Second, 
reciprocal swap of the PITPβ C-terminal 28 residues into the context of PITPα results in 
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a hybrid PITPα/β that efficiently targets to the Golgi complex (see Figure 3, A and B 
above). This PITPα/β chimera, while elaborating both PtdIns- and PtdCho- transfer 
activity, exhibits no detectable SM-loading/transfer activity in vitro (Figure 5A). Third, 
substitution of only two amino acids in PITPα to the cognate PITPβ residues is sufficient 
to confer robust SM-transfer activity to PITPα (PITPαLF221,225IL; Figure 5A). 
Reciprocally, conversion of those cognate PITPβ residues to the corresponding PITPα 
residues strongly and specifically compromises the SM-transfer activity of PITPβ 
(PITPβIL220,224LF; Figure 5A). In neither case does modulation of SM-loading/transfer 
affect PtdIns- or PtdCho-transfer activity or PITP localization. PITPβIL220,224LF fully 
retains the ability to target efficiently to Golgi membranes, whereas PITPαLF221,225IL does 
not (Figure 5B). 
 To probe the involvement of PtdIns loading in targeting of PITPβ to the TGN, we 
took advantage of mutants specifically defective in PtdIns-binding/transfer activity. 
PITPα residue T59 is essential for PtdIns-binding/transfer, but plays no role in PtdCho-
binding/transfer (Alb et al., 1995). The selective effects of the mutant translated to the 
PITPβ context as biochemical analyses confirmed that the corresponding PITPβ mutant 
(PITPβT58D) retains high levels of both PtdCho- and SM-transfer activity in the absence 
of measurable PtdIns-transfer activity (unpublished data). We constructed the PITPβT58D-
GFP chimera and assessed its subcellular distribution in PITPα–/– MEFs. Imaging 
experiments show ca. 90% of the cells expressing PITPβT58D-GFP exhibited robust Golgi 
staining profiles, a score recapitulating that of the PITPβ control (Figure 5C). When the 
experiment was performed in COS-7 cells, PITPβT58D-GFP assumed an obvious Golgi 
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localization in 91% of the 99 expressing cells imaged (90 Golgi/9 non-Golgi profiles). 
Thus, PtdIns-loading/transfer does not contribute to PITPβ targeting to Golgi membranes.  
Uncoupling of Phospholipid-Transfer Activity from PITPβ Targeting to Golgi 
Membranes 
Although neither PtdIns- or SM-loading/transfer activity are required for PITPβ 
association with the TGN, a combination of phospholipid-loading/transfer activities could 
contribute to such targeting. We therefore tested whether residue Ser165 is required for 
targeting of PITPβ to the Golgi complex. This residue lies in the PITP regulatory loop 
(Yoder et al., 2001). The side-chain status of this residue is functionally important 
because incorporation of either alanine or glutamate at this position abolishes all PITPα 
phospholipid-transfer activities (van Tiel et al., 2000).  
The PITPβS165A mutant was generated and its biochemical properties were 
assayed in vitro. As reported by (van Tiel et al., 2000) for PITPαS166A, we too find 
PITPβS165A exhibited no measurable PtdIns-, PtdCho-, or SM-transfer activity, even 
though full-length PITPβ was readily detected in the cytosolic fractions by immunoblot 
(unpublished data). The S165A missense substitution had no effect on PITPβ localization 
when assayed in PITPα–/– MEFs. PITPβS165A-GFP was targeted as efficiently to Golgi 
membranes as the PITPβ-GFP control (Figure 5D). Because PITPβS165A exhibits no 
detectable phospholipid-transfer activity, PITPβS165A-GFP association with Golgi 
membranes is independent of phospholipid-transfer activity.  
We also expressed PITPβS165,262A-GFP in PITPα–/– MEFs and assessed the ability 
of this double mutant to target to TGN membranes. This experiment was motivated by 
the demonstration that PITPα residue S166 and PITPβ residue S165 are minor PKC 
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phosphorylation sites (van Tiel et al., 2000; van Tiel et al., 2002). PITPβS165,262A is 
therefore devoid of the PKC phosphorylation sites for which there is any evidence of use. 
Yet, PITPβS165,262A-GFP homes to TGN membranes in PITPα –/– MEFs (Figure 5D). 
These data provide further support for our conclusion that PKC-mediated 
phosphorylation of PITPβ (at least on the presently known S165 and S262 sites) does not 
play an essential role in localization of this protein to mammalian TGN membranes.  
A WW Motif Common to PITPα and PITPβ Contributes to Association of PITPβ 
with TGN Membranes 
PITPα occupied with either PtdCho or PtdIns crystallizes as a dimer, and the 
dimerization interface is defined by two small hydrophobic motifs displayed on exposed 
loops of the PITP fold (Figure 6A; Yoder et al., 2001; Tilley et al., 2004). These two 
motifs are represented by 72FVRML76 and W203W204 of PITPα and 71FVRMI75 and 
W202W203 of PITPβ, respectively, and both are suggested to play critical roles in 
mediating membrane binding by PITPα (Schouten et al., 2002; Tilley et al., 2004). To 
test whether 71FVRMI75 or W202W203 contribute to localization of PITPβ to the murine 
TGN, we mutagenized these motifs in the context of a PITPβ-GFP reporter and analyzed 
localization of the corresponding reporters in PITPα–/– MEFs. The comprehensive data 
are quantified in Figure 6B, and representative imaging profiles for the corresponding 
mutant PITPβ forms are given in Figure 6C. 
Consistent with the view that the WW motif contributes to membrane binding, the 
PITPβWW202,203AA-GFP chimera failed to associate stably with PITPα–/– MEF TGN 
membranes. By contrast, PITPβMI74,75AA-GFP retained near wild-type efficiencies for 
TGN targeting (Figure 6, B and C). Although there is a consistent diminution in TGN 
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association for the PITPβMI74,75AA-GFP chimera, the defect is minor. Essentially the same 
results were obtained with PITPβF71A-GFP and PITPβVR72,73AA-GFP chimeras. By 
contrast, the individual W202 and W203 residues each play important roles in localization 
of PITPβ, as evidenced by the obvious defects in PITPβW202A-GFP and PITPβW203A-GFP 
association with MEF TGN membranes (Figure 6B).  
Previous data obtained from PtdIns loading assays performed with permeabilized 
cells indicated PITPαWW202,203AA is strongly defective in PtdIns loading and is 
incompetent for the membrane interaction step of a phospholipid-transfer reaction (Tilley 
et al., 2004). We obtained two lines of evidence that are not congruent with this 
conclusion, at least in the PITPβ context. First, biochemical assays for phospholipid-
transfer activity demonstrate PITPβMI74,75AA and PITPβWW202,203AA exhibit significant 
levels of PtdIns-, PtdCho-, and SM-transfer activity in vitro (Figure 7A). Second, we 
again took advantage of the yeast phenotypic rescue assay described above to 
independently assess whether the phospholipid-binding/transfer activities of the double 
mutant PITPs were strongly compromised. The results from that rescue assay also 
support the conclusion that both PITPβMI74,75AA and PITPβWW202,203AA are substantially 
functional proteins. As shown in Figure 7B, a wild-type yeast strain grows robustly at 30 
and 37°C. By contrast, an isogenic sec14-1ts strain grows only at the permissive 
temperature of 30°C and not at all at the restrictive temperature of 37°C, i.e., the 
temperature at which the thermolabile sec14-1ts gene product is inactive. PITPβ 
expression from either a strong constitutive promoter (pPGK) or a weaker constitutive 
promoter (pSEC14) restored essentially wild-type growth properties to the sec14-1ts 
yeast mutant. Similarly, expression of either PITPβMI74,75AA or PITPβWW202,203AA from the 
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pPGK driver also supported efficient rescue of sec14-1ts-associated growth defects at 
37°C (Figure 7B). Rescue mediated by both mutant PITPβ forms was also recorded when 
the mutant proteins were expressed from the weaker pSEC14 promoter, although quality 
of rescue was diminished slightly under those conditions for PITPβWW202,203AA (Figure 
7B).  
Taken together, the data indicate neither PITPβMI74,75AA nor PITPβWW202,203AA 
exhibit dramatic defects in phospholipid-transfer activity and phospholipid loading. 
Because these various double mutant PITPs retain phospholipid-transfer activity, the 
PITP fold must remain unperturbed in the double mutants. We conclude that the TGN 
localization defects associated with mutation of W202W203 cannot be simply ascribed to a 
wholesale inability of PITPβ to interact with membranes. 
PITPβ Motifs Sufficient for Redirection of GFP to the TGN 
The collective data suggest it is the combination of weak membrane 
targeting/association signals defined by the C-terminal BOX residues and the W202W203 
motif that specifies PITPβ association with TGN membranes. To test this prediction we 
fused the C-terminal 35 and 71 residues of PITPβ to the GFP C-terminus. The former 
chimera (GFP-PITPβ237–271) elaborates all three of the C-terminal BOX motifs, is 
predicted to preserve the C-terminal PITPβ helix, but lacks both the W202W203 motif and 
obviously lacks an intact PITP fold. The latter chimera (GFP-PITPβ201–271) elaborates 
both W202W203 and the three BOX motifs, is predicted to maintain the ultimate two PITPβ 
helices, but lacks an intact PITP fold. The chimeras were expressed in PITPα−/− MEFs 
and their respective intracellular distributions were determined. 
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As expected, the GFP control distributes to the cytoplasm and nuclear matrix and 
fails to associate with Golgi membranes as evidenced by its lack of colocalization with 
the TGN marker TGN38 (Figure 8). This profile was recapitulated for the GFP-PITPβ237–
271 chimera that harbors all three of the C-terminal BOX motifs but no W202W203 motif. 
By contrast, GFP-PITPβ201–271 targeted efficiently to PITPα−/− MEF TGN as 
demonstrated by its colocalization with TGN38-positive structures (Figure 8). Some 85% 
of the cells showed coincident localization of GFP-PITPβ201–271 with the TGN. Thus, 
linking the PITPβ W202W203 motif with the three BOX motifs generated a targeting 
module that satisfies the dual criteria of necessity and sufficiency for specific association 
with TGN membranes. 
PITPβ Association with TGN Membranes and Action of PKCs 
The evidence reported herein is incongruent with the claim that PITPβ association with 
the Golgi complex depends on conventional PKC-mediated phosphorylation of S262 (van 
Tiel et al., 2002). We therefore investigated what effect inactivation of conventional 
PKCs has on localization of PITPβ to the TGN. As a first approach, we applied a blunt 
pharmacological strategy. PITPα−/− MEFs were intoxicated with two different inhibitors 
of conventional PKCs, and PITPβ distribution of was monitored at various times 
postchallenge. Neither GF109203X nor chelerythrine chloride intoxication had any 
effect, at any time, on the association of PITPβ with the MEF TGN (Figures 9, A and B). 
The efficacy of pharmacological challenge in inhibiting PKC activity was confirmed by 
monitoring phospho-MARCKS upon inhibitor challenge (Figure 9C). 
In the pharmacological challenge experiments we used the NT-PITP-antibody as 
reporter. Thus, we were unable to distinguish between PITPβ and PITPβQGQR in those 
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experiments. We therefore repeated these experiments using a PITP-GFP reporter and 
arrived at the same conclusions. PITPβ-GFP localization to the MEF TGN was resistant 
to challenge with GF109203X or chelerythrine chloride under the same conditions 
described in Figure 9C. Some 72% of mock-challenged MEFs exhibited a TGN profile 
for PITPβ-GFP (136/188 cells), and similar results were obtained upon MEF intoxication 
with GF109203X (78%; 192/247 cells) or chelerythrine chloride (85%; 109/129 cells). 
In a second approach, we derived MEFs from embryos individually nullizygous 
for either the nonconventional PKCδ or PKCε isoforms. Both of these isoforms localize 
to the mammalian Golgi complex (Lehel et al., 1995; Storz et al., 2004) and therefore 
represent reasonable candidate PKCs for which PITPβ is a physiological substrate. 
Again, localization to the murine Golgi of endogenous PITPβ species was unimpressed 
by genetic ablation of the PKCε or the PKCδ isoform (see Supplemental Materials, 
Figure S5A). Although we concur with (van Tiel et al., 2002) that PITPβ can be 
phosphorylated by PKCs in vivo (i.e., PMA stimulates phosphorylation of endogenous 
PITPβ), we believe this effect is likely mediated through PKCδ because PMA challenge 
has no obvious effect on PITPβ phosphorylation status in PKCδ−/− MEFs (see 
Supplemental Materials, Figure S5B). Given that the Golgi-associated PKCδ plays no 
obligate role in targeting PITPβ to the TGN, we suggest PMA-stimulated 
phosphorylation of PITPβ reflects elevated PKCδ activity evoking an adventitious 
phosphorylation of vicinal proteins on Golgi membranes. 
Discussion 
Herein, we identify endogenous PITPβ as a peripheral protein of mammalian 
TGN (and ER) membranes and describe a mechanism for PITPβ localization to those 
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membranes. This mechanism involves four elements that define two distinct categories of 
targeting information. The first consists of three functionally redundant motifs that reside 
in the PITPβ C-terminal 28 residues. The second is represented by a W202W203 motif 
required for PITPβ association with TGN membranes. We posit these two sets of 
elements cooperate to localize PITPβ to the mammalian TGN. The cooperative 
contribution of both sets of elements generates a modular targeting code both necessary 
and sufficient for specific homing of proteins to the TGN. 
How is specificity of targeting determined? The three motifs embedded in the C-
terminal 28 PITPβ residues represent the most logical candidates for specificity elements. 
The rationale is threefold. First, each motif defines a region of primary sequence 
divergence between PITPβ and PITPα. Second, the presence of at least one element is 
necessary to preserve PITPβ localization to the TGN. Third, transplantation of any two 
motifs into PITPα efficiently redirects this protein to the TGN. Thus, the three C-terminal 
elements satisfy the dual criteria of necessity and sufficiency for specifying localization 
of a PITP reporter to TGN membranes. Whether the C-terminal specificity elements 
engage a proteinaceous receptor or recognize some lipid platform unique to the TGN 
remains an open question. However, we find PITPβ association with Golgi membranes is 
sensitive to brefeldin A, indicating a dependence on a functional ARF (or ARL) GTPase 
cycle. 
We suggest the W202W203 motif contributes to PITPβ association with TGN 
membranes by providing a nonspecific and low-affinity membrane-binding site. Our 
demonstration that PITPβ association with TGN membranes is compromised by 
mutations of the W202W203 motif supports this view. The concept is also consistent with 
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structural data indicating W202W203 lies on a loop oriented on the same face of the PITPβ 
as the mouth of the phospholipid-binding pocket (Yoder et al., 2001; Tilley et al., 2004). 
The W202W203 motif does not confer specificity of membrane binding because this 
element is common to both PITPα and PITPβ, and these PITPs exhibit distinct 
localization profiles. 
Although the idea that W202W203 functions in a nonspecific and low-affinity 
membrane-binding reaction has its justification, other data do not readily conform to such 
a model. Alanine scanning mutagenesis indicates this motif has no major role in PITPβ 
phospholipid-transfer activity or loading with a phospholipid substrate. It could be argued 
this result is inconsistent with a nonspecific membrane-binding function for W202W203. 
We do not favor this interpretation because the phospholipid-transfer assays and yeast 
phenotypic rescue assay that we employ as functional tests are biased in favor of transient 
membrane associations. Such assays likely minimize the importance of a stabilization of 
membrane-binding function for W202W203. 
The various phospholipid loading properties of PITPβ do not contribute in any 
obvious way to its association with the TGN. Of particular interest is the case of SM-
binding/transfer because this property suggested an attractive mechanism for the specific 
homing of PITPβ to Golgi membranes. This mechanism was based on the dual arguments 
that PITPβ is distinguished from PITPα by its ability to load with SM and that the major 
site of SM synthesis in mammalian cells is the Golgi complex (Futerman et al., 1990; 
Bankaitis, 2002). The fact that the TGN-targeting mechanism does not survey the 
phospholipid-bound state of PITPβ also has implications for models invoking a delivery 
function for PITPβ in supply of TGN membranes with PtdIns (e.g., to support TGN 
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phosphoinositide pools). Other PITPs likely help execute such functions (Litvak et al., 
2005). 
Our data indicate a concerted action of specific and general membrane-binding 
elements in the targeting of PITPβ to the TGN. We find the targeting process is not 
obligately coupled to PITPβ phosphorylation of residue S262 by conventional PKCs or at 
least two nonconventional PKC isoforms. That conclusion is supported by both PKCδ−/− 
and PKCε−/− MEF data, and the general resistance of PITPβ TGN association to 
challenge of cells with inhibitors of conventional PKCs. Moreover, PITPβ TGN 
localization signals accommodate an array of side chains at residue S262—indicating 
neither S262 itself, nor its phosphorylation, is an essential component of PITPβ TGN-
targeting information. The fact that combined mutagenesis to alanine of PITPβ residues 
S262 and S165 (a minor PKC phosphorylation site in vitro) has no effect on PITPβ 
localization further emphasizes this point. We expect these general findings will hold 
equally true for the novel PITPβQGQR spliceoform. 
Our collective results are comprehensively at odds with the report of (van Tiel et 
al., 2002), who claim that phosphorylation of residue S262 is required for Golgi membrane 
localization of PITPβ. Can these conflicting conclusions be reconciled? (van Tiel et al., 
2002) utilized stable NIH3T3 cell lines that overproduce PITPβ for their studies. One 
formal possibility is that the visible pool of PITPβ in those stable cell lines behaves 
differently from the endogenous pool. We do not favor this interpretation because the 
PITPβ-GFP chimera we used consistently localized to TGN membranes with the same 
fidelity as endogenous PITPβ. Also, because van Tiel et al. were clearly monitoring 
PITPβ, and not PITPβQGQR, the discrepancies cannot be ascribed to spliceoform issues. 
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The possibility that NIH3T3 cells used by van Tiel et al. behave differently than MEFs or 
COS-7 cells cannot be formally excluded, although the absolute efficiencies of PITP-GFP 
targeting to the TGN in MEFs and COS-7 cells were consistently similar. 
The (van Tiel et al., 2002) report suggests several areas of experimentation that 
leave room for ambiguity of interpretation. First, the parameters of what constitutes a 
Golgi profile in their studies were not defined by the use of known Golgi markers, and no 
quantification of the imaging data was presented. Second, there was no description of 
controls for monitoring what effect pharmacological inhibition of conventional PKCs has 
on Golgi organization in their cell lines. Perturbation of Golgi organization may 
complicate interpretation of PITPβ localization data. Third, the scope of the mutagenesis 
from which van Tiel et al. reached their conclusions was limited to a single mutant 
(PITPβS262A). The issue of sufficiency of S262 phosphorylation for PITP targeting to Golgi 
membranes was not addressed. Finally, the arguments that PITPβ residue S262 represents 
a major in vivo phosphorylation site are based on in vitro schemes using recombinant 
proteins (van Tiel et al., 2002). Direct identification of phosphorylation sites in 
endogenous PITPβ is required to resolve this important issue. 
A remarkable facet of the biological activities of PITPs is the dedication with 
which these proteins couple to specific physiological functions (Routt and Bankaitis, 
2004; Phillips et al., 2006). The example of PITPα and PITPβ is clear testimony to this 
effect as these closely related PITP isoforms assume radically different localization 
profiles and are functionally nonredundant. Our finding that murine cells can express 
what are likely two biochemically indistinguishable PITPβ spliceoforms, and yet localize 
both to similar regions of the Golgi stack, suggests that even finer functional distinctions 
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may yet exist. Our analyses of how PITPβ targets to specific Golgi subcompartments 
gives us the ability to interchange, in a rational and directed way, either the localization, 
or the phospholipid-binding properties, or both, of PITPα and of defined PITPβ 
spliceoforms. This facility permits direct experimental address, in the mouse, of whether 
the distinct biological activities of these proteins are strictly a function of protein 
localization or whether differential phospholipid-binding properties also contribute to 
function. 
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Figures 
 
Figure 2.1: Endogenous PITP localization profiles. (A) Fixed and permeabilized cells 
of the indicated cell type were stained with a PITP antibody that detects PITPα and 
PITPβ and antibodies directed against the Golgi marker GM130. The PITP (top panels) 
and GM130 profiles (bottom panels) are shown. Arrows indicate one example of the clear 
colocalization of an endogenous PITP with Golgi membranes for each cell type and 
orient the remaining Golgi profiles in the matched panels. (B) PITPα−/− MEFs were fixed 
and decorated with primary antibodies directed against PITP antigen or the cis-Golgi 
marker GM130. Representative individual profiles for endogenous PITPβ and GM130 
are shown in the left panels, as indicated, and the merged profile is depicted in the right 
panel. (C) PITPβ-GFP chimera is a functional protein. Serial 10-fold dilutions of isogenic 
sets of a sec14-1ts strain, derivatives of that strain carrying a high-copy plasmid (YEp) 
driving expression of either PITPβ, PITPβ-GFP, or a wild-type SEC14 gene (as 
indicated) were spotted onto YPD agar and incubated at 37°C for 48 h. The 37°C 
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condition, although permissive for growth of wild-type yeast, is restrictive for growth of 
sec14-1ts yeast mutants. This sec14-1ts growth defect is rescued by expression of either 
PITPβ or the PITPβ-GFP chimera, indicative of preservation of PITPβ activity in the 
PITPβ-GFP chimera. Strains used: CTY1-1A (sec14-1ts), and CTY1-1A transformed with 
YEp(SEC14), YEp(PITPβ), and YEp(PITPβ-GFP), respectively. The respective PITPβ 
genes were driven by the strong and constitutively expressed yeast PGK promoter. (D) 
PITPβ-GFP faithfully targets to the Golgi complex. PITPα nullizygous MEFs were 
transfected with a PITPβ-GFP expression plasmid, fixed, and decorated with primary 
antibodies directed against GFP antigen and antibodies directed against GM130, as 
indicated. Representative individual profiles for PITPβ-GFP and GM130 are shown in 
the left panels, and the merged profile is depicted in the right panel. 
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 Figure 2.2: PITPβ localizes specifically to TGN membranes. PITPα nullizygous MEFs 
were fixed and decorated with primary antibodies directed against PITP antigen (rabbit 
polyclonal NT-PITP-antibody) and antibodies directed against either the cis-Golgi 
marker GM130 (A), the medial-Golgi marker giantin (B), or the trans-Golgi marker 
TGN38 (C). The individual and merged profiles are identified at the top. The respective 
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insets represent a higher magnification of the boxed region of the corresponding merged 
profile for purposes of enhanced detail. 
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Figure 2.3: C-terminal PITPβ localization elements necessary for TGN association. 
(A) Alignment of the C-terminal 28 residues of PITPβ with the corresponding region of 
PITPα is given. Schematic illustrations of PITPα, PITPβ, and each of the reciprocal C-
terminal swaps are depicted at bottom. At right, for each corresponding PITP version is 
given the number of imaged cells that exhibited a Golgi (G) or non-Golgi (N) 
immunofluorescence profile when that construct was expressed in MEFs as a PITP-GFP 
chimera and visualized along with the GM130 marker. The percentage of imaged cells 
with Golgi profiles is also given. (B) Imaging of PITPs with exchanged C-terminal 
regions. Representative localization profiles for PITPα/β-GFP and PITPβ/α-GFP when 
expressed in PITPα−/− MEFs are shown. Individual PITP-GFP and GM130 profiles are 
presented in the bottom panels underneath the corresponding merged profile. (C) Swap of 
divergent BOX motifs from PITPα into the context of PITPβ. The BOX motifs are 
defined at top, and the most divergent residues within each are highlighted (●). The series 
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of hybrid PITPs analyzed is illustrated and each swap is further defined at left by 
identification of which PITPα residues were introduced to generate the swap. 
Quantification of PITPα−/− MEFs expressing each individual hybrid with respect to 
number of cells displaying Golgi (G) or non-Golgi (N) localization profile, along with 
percentages of cells displaying Golgi localization, is also given. (D) Representative 
images of PITPα−/− MEFs individually expressing each of the three PITPβ-GFP chimeras 
where two of the three BOX motifs were mutagenized to PITPα versions. The identities 
of the swaps are indicated at top. Individual PITP-GFP and GM130 profiles are presented 
in the bottom panels underneath the corresponding merged profile. 
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Figure 2.4: (preceding page) C-terminal PITPβ localization elements sufficient for 
redirecting PITPα to TGN membranes. (A) Swap of divergent BOX motifs from 
PITPβ into the context of PITPα. The BOX motifs are defined at the top, and the most 
divergent residues within each are highlighted (●). The series of hybrid PITPs is 
illustrated and each swap is further defined at left by identification of which PITPβ 
residues were introduced to generate the swap. Quantification of PITPα−/− MEFs 
expressing each individual hybrid with respect to number of cells displaying Golgi (G) or 
non-Golgi (N) localization profile, along with percentages of cells displaying Golgi 
localization, is also given. Representative images of PITPα−/− MEFs individually 
expressing: (B) each of the three PITPα-GFP chimeras where two of the three BOX 
motifs were mutagenized to PITPβ versions. The identities of the swaps are indicated at 
top. Individual PITP-GFP and GM130 profiles are presented in the bottom panels 
underneath the corresponding merged profile. (C) Each of the three PITPβ-GFP chimeras 
where residue S262 is mutagenized to A, D, E, or P as indicated. Individual PITPβS262-
GFP and GM130 profiles are presented in the bottom panels underneath the 
corresponding merged profile. (D) Each of the three PITPα-GFP chimeras where residue 
P263 is mutagenized to S (the corresponding PITPβ residue) or the phosphomimetic 
residues D or E as indicated at top. Individual PITPαP263-GFP and GM130 profiles are 
presented in the bottom panels underneath the corresponding merged profile. (E) The C-
terminal 28 residues of PITPβ and the novel PITPβQGQR spliceoform are aligned at top, 
and the BOX motifs are identified. Differences in primary sequence are highlighted in 
red. The position of the S259A mutation in PITPβQGQR is also indicated. Representative 
profiles for the corresponding GFP chimeras and GM130 are shown, as are the merged 
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profiles. In B–E quantification of number of cells displaying Golgi (G) or non-Golgi (N) 
localization profile, along with percentages of cells displaying Golgi localization, is 
given. 
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 Figure 2.5: PITPβ localization to TGN membranes is independent of phospholipid 
loading. (A) Phospholipid-transfer properties of select PITP chimeras. Abilities of each 
individual PITP or PITP chimera to transfer [14C]-SM, [3H]PtdIns, or [14C]PtdCho (as 
indicated) was determined in cytosol fractions prepared from yeast strain CTY303 
(sec14Δ cki1Δ) expressing recombinant versions of the respective PITPs (Phillips et al., 
1999; Li et al., 2000). CTY303/YEp(URA3) cytosol was prepared and used as negative 
control. Activity is represented as the percentage of total input radiolabeled phospholipid 
transferred from donor membranes to unlabeled acceptor membranes during the course of 
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the experiment. Assay blanks represented addition of buffer alone to the transfer assay 
reactions, and these background values were subtracted from the other measurements. 
Values represent the averages of triplicate determinations from a representative 
experiment, and at least three independent experiments were performed. In the 
experiment shown, input phospholipid-transfer substrate was 19,850 cpm [14C]SM; 
21,050 cpm [3H]PtdIns; 21,250 cpm [14C]PtdCho. Background values for these respective 
transfer assays were 700, 315, and 820 cpm. A representative image of PITPα−/− MEFs 
expressing a (B) PITPβIL220,224LF-GFP or a PITPαLF221,225IL-GFP chimera. Cells were 
imaged for GFP and the pan-Golgi marker wheat germ agglutinin (WGA), as indicated. 
Corresponding merged profiles are shown. (C) PITPβT58D-GFP chimera. PITPβT58D-GFP 
and GM130 profiles are presented in the bottom panels underneath the corresponding 
merged profile. (D) PITPβS165A-GFP or a PITPβS165,262A-GFP chimera. Cells were imaged 
for GFP and GM130, as indicated. Corresponding merged profiles are shown. For C and 
D, quantification of number of cells displaying Golgi (G) or non-Golgi (N) localization 
profiles, along with the percentages of cells displaying Golgi localization, are given for 
each construct at the bottom of the corresponding panel set. 
 87
 Figure 2.6: General PITP elements required for PITPβ localization to TGN 
membranes. (A) Ribbon diagram of the PtdIns-bound PITPα crystal structure with 
space-fill renditions of the M74I75 and W202W203 side-chains, as indicated. (B) 
Quantification of percentage of transfected PITPα−/− MEFs displaying Golgi localization 
profiles for each PITPβ-GFP construct (identified at bottom). The ratio of number of cells 
imaged with clear Golgi profiles (G) for the indicated PITPβ-GFP chimera to the number 
of cells imaged for that chimera that show a non-Golgi profile (N) is given above each 
corresponding bar. (C) Representative images of PITPα−/− MEFs expressing the indicated 
PITPβ-GFP chimeras. The localization profiles for the indicated PITPβ-GFP (bottom left 
panels), corresponding TGN38 (bottom right panels), and merged profiles (top panels) 
are presented. 
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 Figure 2.7: Properties of PITPβW202W203 interaction with membranes. (A) 
Phospholipid-transfer assays. Abilities of each individual PITP to transfer [3H]PtdIns, 
[14C]PtdCho, or [14C]-SM, (indicated at top) was determined in cytosol fractions prepared 
from yeast strain CTY303 (sec14Δ cki1Δ) expressing the negative control gene URA3 
(black bars), or recombinant versions of the respective PITPs (PITPβ, white bars; 
PITPβMI74,75AA, hatched bars; PITPβWW202,203AA, stippled bars). Activity is represented as 
the percentage of total input radiolabeled phospholipid transferred from donor 
membranes to unlabeled acceptor membranes during the course of the experiment. 
Values represent the averages of triplicate determinations from a representative 
experiment, and at least three independent experiments were performed. Assay blanks 
represented addition of buffer alone to the transfer assay reactions, and corresponding 
background values were subtracted from the other measurements. In this set of assays, 
input substrate was 14,792 cpm [3H]PtdIns; 27,940 cpm [14C]PtdCho; 22,216 cpm 
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[14C]SM, respectively. Background values were 295, 485, and 236 cpm for each 
respective assay. (B) PITPβ WW202,203AA mutants preserve function as assayed in yeast. 
Serial 10-fold dilutions of isogenic sets of a sec14-1ts strain, derivatives of that strain 
carrying a high-copy plasmid (YEp) driving expression of either PITPβ, PITPβ-
WW202,203AA, PITPβ-MI74,75AA, or a wild-type SEC14 gene (as indicated) were spotted onto 
YPD agar and incubated at 37°C for 48 h. Strains used were CTY1-1A (sec14-1ts), and 
CTY1-1A transformed with YEp(SEC14), YEp(PITPβ), YEp(PITPβ-MI74,75AA), and 
YEp(PITPβWW202,203AA), respectively. The PITPβ genes were driven by the strong and 
constitutively expressed yeast PGK promoter (PPGK) or the weaker constitutively 
expressed SEC14 promoter (PSEC14), as indicated. 
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 Figure 2.8: W202W203 and C-terminal BOX motifs in TGN targeting. Representative 
profiles for a GFP control, the GFP-PITPβ237–271 chimera, and the GFP-PITPβ201–271 
chimera are shown. Quantification of transfected PITPα−/− MEFs displaying Golgi 
localization profiles for each GFP-PITPβ construct is given at bottom as the ratio of 
number of cells imaged with clear Golgi profiles for the indicated GFP-PITPβ chimera to 
the total number of cells imaged for that chimera. 
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Figure 2.9: (preceding page) PITPβ localization and protein kinases C. (A) Profiles 
(individual and merged) for endogenous PITPβ and TGN38 in PITPα−/− MEFs 
challenged with no inhibitor (MOCK), GF109203X (10 nM), or chelerythrine chloride 
(CHEL., 660 nM). The profiles shown at 6 h after challenge but are representative for 
what was observed at 3 and 16 h postchallenge as well. (B) Quantification of the imaging 
data presented in A. Number of cells imaged with clear Golgi profiles as a function of 
total number of cells imaged for each condition are indicated above each corresponding 
bar. (C) PITPα−/− MEFs were challenged with no inhibitor (MOCK) or GF109203X (10 
nM) or chelerythrine chloride (CHEL., 660 nM) for the indicated times. Cell-free lysates 
were prepared, resolved by SDS-PAGE and blotted to nitrocellulose, and blots were 
decorated with antibodies specific for phospho-MARCKs (a PKC substrate) and actin 
(loading control). Antibodies used detect MARCKS phosphorylated at Ser159Ser163 (Santa 
Cruz). 
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Figure 2.10 (Supplemental Figure 2) -C-terminal PITPβ localization elements 
necessary for TGN association. Alignment of the C-terminal 28 residues of PITPβ with 
the corresponding region of PITPα is given. The BOX motifs are shown at top. The most 
divergent residues within each are highlighted (•). Schematic illustrations of PITPα, 
PITPβ and each of the reciprocal C-terminal swaps are depicted at bottom. At right, for 
each corresponding PITP version, is given the number of imaged cells that exhibited a 
Golgi (G) or non-Golgi (N) immunofluorescence profile when that construct was 
expressed in COS-7 cells as a PITP-GFP chimera and visualized along with the GM130 
marker. The percentage of imaged cells with Golgi profiles is also given. 
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Figure 2.11 (Supplemental Figure 3) - C-terminal PITPβ localization elements 
sufficient for redirecting PITPα to TGN membranes. Swap series of divergent BOX 
motifs from PITPβ into the context of PITPα is shown. The most divergent residues 
within each are highlighted (•). The series of hybrid PITPs is illustrated and each swap is 
further defined at left by identification of which PITPβ residues were introduced to 
generate the swap. Quantification of COS-7 cells expressing each individual hybrid with 
respect to number of cells displaying Golgi (G) or non-Golgi (N) localization profile, 
along with percentages of cells displaying Golgi localization, is also given. 
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Figure 2.12 (Supplemental Figure 4; preceding page) - Comparison of PITPβ and 
PITPβQGQR localization in MEFs. PITPα nullizygous MEFs expressing PITPβ-GFP 
or PITPβ QGQR-GFP were fixed and decorated with primary antibodies directed against 
either the trans-Golgi marker TGN38 (A), the medial-Golgi marker mannosidase II (B) , 
or the cis-Golgi marker GM130 (C) . GFP-chimera localization was followed by intrinsic 
GFP fluorescence. The individual and merged profiles are identified. 
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Figure 2.13 (Supplemental Figure 5) - PITPβ localization in PKCδ-/- MEFs. (A) 
Endogenous PITPβ profile of E16.5 PITPα-/- PKCε-/-, and PKCδ-/- MEFs, as indicated. 
The NT-PITP serum was employed in these experiments, and the PITPα-/- MEFs 
represent the positive control. In all cases essentially all cells exhibited a robust Golgi 
profile for endogenous PITPβ species. (B) PMA-induced phosphorylation of PITPβ is 
ablated in PKCδ-/- MEFs. Cell-free extracts from MEFs of indicated PKCδ genotype 
were generated, resolved by SDS-PAGE, transferred to nitrocellulose and developed with 
PITPβ-specific antibodies (PITPβ QGQR is not detected) and an ECL scheme. Instances 
where cells were treated with PMA (100nM; 15 min), or extracts were incubated with 
calf-intestine phosphatase (CIP), are identified at bottom. MEF PKCδ genotypes for each 
condition are also identified. PITPβ is a phosphoprotein as indicated by the collapse of 
the PITPβ doublet to the lower apparent molecular mass form upon treatment of lysates 
 98
with CIP, and by the complete conversion of the PITPβ doublet to the higher apparent 
molecular mass form by treatment of cells with PMA. This PMA effect is not observed in 
PKCδ-/- MEFs, although the PITPβ doublet is maintained. 
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Table 2.1 (Supplemental Table 1) - Summary of effect of missense substitutions on PITP 
localization in COS-7 cells. Quantification of COS-7 cells expressing each indicated 
mutant form of PITPβ-GFP and PITPα-GFP with respect to number of cells displaying 
Golgi (G) or non-Golgi (N) localization profile. Corresponding percentages of cells 
displaying Golgi localization is also given. 
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Chapter 3  
siRNA mediated knockdown of PITPβ 
Abstract 
Phosphatidylinositol transfer proteins (PITPs) are a family of proteins that act at the 
interface of lipid metabolism and membrane trafficking.  Some members of the family act 
in specialized cell types, while others are required for general cell maintenance.  In 
mammals, the closely related PITPs PITPα and PITPβ are known to have distinct 
functions, and knockout mouse studies have revealed roles for PITPα in brain, intestine, 
and liver function.  The cellular role for PITPβ, however, is not known.  Attempts to 
make PITPβ knockout mice have been unsuccessful, suggesting that PITPβ is an 
essential protein.  In this chapter, I used siRNA-mediated gene silencing to address the 
role of PITPβ in human cell lines.  Treatment of HeLa or HEK293 cells resulted in a 40-
70% reduction in PITPβ RNA levels, and the reduction in PITPβ RNA levels was 
accompanied by a disorganization of the Golgi network.  Though PITPβ localizes 
specifically to the trans-Golgi network, the Golgi disorganization manifested itself at all 
levels of the Golgi.  Changes in Golgi morphology are often associated with trafficking 
defects, so we assessed the anterograde and retrograde trafficking in PITPβ siRNA-
treated cells.  Anterograde trafficking, as measured by a glycosaminoglycan labeling 
assay, was delayed, but retrograde trafficking was unaffected in PITPβ siRNA-treated 
cells.  The siRNA-mediated knockdown of PITPβ reveals a cellular function for PITPβ, 
and provides a system to better understand the critical features and mechanism of action 
of the protein. 
Introduction 
 Protein trafficking through the ER and Golgi of cells is a coordinated process 
regulated by a number of proteins and lipids.  Proteins such as SNAREs, Rabs, and ARFs 
recruit cargo and promote vesicle curvature.  Lipids such as diacylglycerol (DAG) and 
phosphoinositides play crucial roles in both the physical aspect of vesicle formation and 
in protein recruitment.  DAG is a conical lipid that promotes vesicle budding and recruits 
Golgi signaling proteins (Baron and Malhotra, 2002; Dries et al., 2007).  PtdIns(4)P is 
enriched in the Golgi, and is required for both the activity of the ARF-GEFs such as the 
yeast Gcs1 (Yanagisawa et al., 2002), and the recruitment of proteins necessary for 
vesicle formation and cargo assembly (D'Angelo et al., 2008).  
Phosphatidylinositol (PtdIns)/phosphatidylcholine (PtdCho) transfer proteins 
(PITPs) stand at the interface of phosphoinositide signaling and membrane trafficking  
and are defined by their in vitro ability to transfer PtdCho and PtdIns between membrane 
bilayers in an energy independent fashion. In vivo they possess diverse yet unique 
trafficking roles.  Some PITPs are required for the function of very specialized cell types. 
For example, the plant PITP AtSfh1 regulates PtdIns(4,5)P2 homeostasis in growing root 
hairs by establishing tip-localized PtdIns(4,5)P2 landmarks, and is required to allow 
polarized trafficking in these cells. Loss of AtSfh1 leads to a loss of polarity as indicated 
by a breakdown of  tip-localized Ca2+-influx, a dramatic rearrangement of the 
cytoskeleton and short, sometimes multi-tipped root hairs (Vincent et al., 2005).  The 
Drosophila RdgB protein, which contains an essential PITP domain, is necessary for 
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proper termination of the light response in the eye (Milligan et al., 1997).  The 
importance of the PITP domain is emphasized by the fact that the PITP domain alone can 
rescue the retinal degeneration phenotype.  
 Other PITPs are required for cellular survival and thus carry important house 
keeping functions, such as regulation of Golgi lipids.  Sec14, the major yeast PITP, is 
required for the formation of secretory vesicles at the trans-Golgi network (TGN)  
through regulation of PtdIns(4)P and DAG and it regulates turnover of complex 
sphingolipids in endosomes (Cleves et al., 1991; Kearns et al., 1997; Nemoto et al., 
2000; Mousley et al., 2008; Schaaf et al., 2008). Phospholipid-bound structures that were 
recently solved at high resolution suggest that Sec14 regulates phosphoinositide 
homeostasis by mediating a lipid exchange reaction of PtdIns versus PtdCho at the TGN 
(and potentially other) membranes.  Functional studies indicate that during this exchange 
reaction, Sec14 renders PtdIns a better substrate for phosphorylation by a PtdIns 4-OH 
kinase and thereby overcomes an intrinsic substrate unavailability of membrane-bound 
PtdIns to PtdIns-kinases (Schaaf et al., 2008). This model of Sec14 as a platform for lipid 
exchange is very much in agreement with a model of PITPs as nanoreactors (Ile et al., 
2006), where nanoreactors are defined as platforms that integrate diverse phospholipid 
signaling pathways and present a defined lipid pool.  In the case of Sec14, the 
nanoreactor presents Golgi-localized PtdIns to a downstream lipid-modifying enzyme. 
An important aspect of the nanoreactor concept is that the integration of a phospholipid 
signaling event and the presentation of a specific phospholipid to a phospholipid 
metabolic enzyme results in an organized assembly of phospholipid product as suggested 
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by the presence of specific lipid-binding domains in addition to the PITP domain in 
multidomain PITPs (Ile et al., 2006). 
Interestingly, besides the Sec14 proteins, metazoan genomes encode non-
sequence related PITPs with in vitro properties that are almost identical to Sec14 
(proteins).  Mammals express five metazoan PITPs with yet largely unidentified cellular 
functions (Phillips et al., 2006). One member of this family, the membrane bound PITP 
Nir2, was proposed to have orthologous functions to Sec14 and is also required for 
regulation of DAG levels via the PC synthesis pathway and Golgi trafficking (Litvak et 
al., 2005). PITPα, a soluble representative of this family, is found in the cytosol and 
nucleus of the cell and is not required for cell survival, though nullizygous PITPα mice 
die by two weeks past birth (Alb et al., 2003).  
Another soluble PITP, PITPβ, is understudied, yet what is known suggests that 
the protein plays a critical role in cells (Alb et al., 2002). PITPβ is localized to the trans-
Golgi network and, in addition to the in vitro transfer functions for PtdIns and PtdCho, 
PITPβ can transfer sphingomyelin (SM).  In the present study we aimed to understand the 
cellular function of PITPβ as a prototype of soluble metazoan PITPs and potential key 
player in membrane trafficking. Because of its TGN localization and potential 
housekeeping role in cells, we hypothesized that PITPβ would be required for membrane 
trafficking to or from the TGN, and addressed this question by siRNA-mediated 
knockdown of PITPβ.  We demonstrate that PITPβ is required for cell survival.  The loss 
of PITPβ causes a dispersal of the Golgi network, although Golgi associated proteins 
remain associated with the dispersed Golgi.  At the EM level, the Golgi phenotype 
manifests as swollen Golgi stacks, suggesting the accumulation of cargo.  A trafficking 
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delay in PITPβ-depleted cells was demonstrated by the delayed secretion of pulse labeled 
glycans. These discoveries report a new layers of complexity on how trafficking from the 
Golgi might be regulated in metazoan cells.  
 
Materials and Methods 
Cell culture and siRNA treatment 
 siRNA studies were performed in HeLa, HEK293ad, or immortalized mouse 
embryo fibroblast (iMEF) cells grown in DMEM supplemented with 10% FBS, 100 
µg/ml penicillin, and 100 µg/ml streptomycin.  Three siRNAs against the human PITPβ 
were designed and synthesized by Ambion (Austin, TX).  The sequences of the sense 
strands of these siRNAs are: 
siRNA #1: 5’ GCAUUAUUCCAGUCAGUCAtt 3’ 
siRNA #2: 5’ GCUAGUAAGAAUGAGACUGtt 3’ 
siRNA #3: 5’ CCAGACUUGGGAACAUUAGtt 3’ 
The antisense strands were complementary to the uppercase portion of the siRNA listed 
above, with an additional two nucleotide overhang at the 3’ end. 
Four siRNAs against the mouse PITPβ were designed and synthesized by 
Dharmacon (Thermo Scientific).  The target sequence of these siRNAs are: 
mouse siRNA #1: 5’ GCAGAACAAUUGUAACGAA 3’ 
mouse siRNA #2: 5’ CUACAAAGCUGAUGAAGAC 3’ 
mouse siRNA #3: 5’ UAAGAAGGGUUCCGUCCGA 3’ 
mouse siRNA #4: 5’ CAUUGCAGAUCGAAGUCAA 3’ 
 siRNA treatment of cells was performed according to the protocol for the 
Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA).  Cells were plated at 
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approximately 70% confluence in 24 well plates the day before siRNA transfection.  On 
the day of transfection, 1 μL of Lipofectamine 2000 was added to a tube containing 50 
μL OptiMEM, and 1.5 μL of 20 μM siRNA was added to another aliquot of 50 μL 
OptiMEM.  After 5 minutes, these tubes were mixed and incubated at room temperature 
for 30 minutes.  Cells were washed once in OptiMEM and the Lipofectamine/siRNA 
mixture was added, along with an additional 100 μL OptiMEM.  After 6-8 hours, the 
media was changed to complete DMEM media.  
 Brefeldin A (BFA) treatment was performed 2 days after siRNA treatment by 
replacing the culture media with complete media plus 10 μg/mL BFA for the indicated 
times.  Following BFA treatment, cells were immediately washed, fixed, and stained as 
described below. 
Immunofluorescence 
 After treatment with siRNA, cells were prepared for immunofluoresence as 
follows.  First, cells were fixed in 3.7% formaldehyde for 12 minutes.  Cells were then 
permeabilized with 0.2% Triton X-100 for 4 minutes, washed, and blocked with 2% BSA 
in PBS.  Primary antibody was diluted into 2% BSA/PBS at the following dilutions: 
gm130- 1:400, TGN46- 1:200, COPII- 1:200, Orp9- 1:2000.  DAPI and appropriate 
fluorescent-conjugated secondary antibodies were ordered from Invitrogen and used at 
1:1000. 
 Cells were imaged on an inverted confocal microscope (model 510 meta; Carl 
Zeiss MicroImaging, Inc.; 63× C-Apochromat 1.2 oil immersion lens).  Images were 
processed using the Adobe Photoshop CS2 software. 
Protein trafficking assays 
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 Glycosaminoglycan release assays were performed as described in Litvak et al 
(Litvak et al., 2005).  Briefly, control or PITPβ siRNA-treated cells were washed in 
buffer A (125 mM NaCl, 5 mM KCl, 5.6 mM glucose, 20 mM Hepes-NaOH, pH7.2, 1.8 
mM CaCl2, and 1.8 mM MgCl) and incubated with 1 mM xyloside in buffer A for 15 
minutes at 37ºC.  Cells were labeled with 35S sulfate (80 μCi/mL) for 5 minutes at 37ºC, 
washed with serum-free DMEM, and incubated (chased) with cold medium for various 
periods of time.  The cell media was collected and centrifuged at 12,000 x g for 10 
minutes to remove cells and debris.  To lyse the cells, the monolayers were treated with 
0.1M NaOH for 1 hour at 37ºC.  Glycosaminoglycans were precipitated from cells and 
cell media by incubation with 0.6% condroitin sulphate and 1% cetylpyridinium chloride 
for 12 hours at room temperature.  Samples were spun down at 3000 x g and pellets were 
washed twice in 1% cetylpyridinium chloride in 20 mM NaCl.  Pellets were dissolved in 
2M NaCl and counted in a scintillation counter.  The data is expressed as the ratio of the 
35S-glycosamines in the supernatant to the total 35S-glycosamines (cell pellet plus 
supernatant). 
EM 
 Mock and PITPβ siRNA-treated cells were washed, trypsinized, and centrifuged, 
and the pellets were washed 3 x 10 minutes in 3% glutaraldehyde in sodium cacodylate 
buffer (0.1M sodium cacodylate, 2mM CaCl2, pH 7.4).  The cells were fixed by a 1 hour 
incubation in 1% OsO4 in sodium cacodylate buffer.  The cell pellet was washed 3 x 10 
min in sodium cacodylate buffer and incubated for 30 minutes in the dark in 2% 
uranylacetate/50% ethanol.  Sequential dehydration was performed by 10 minute washes 
in increasing ethanol concentrations (50%, 70%, 80%, 90%, 95%, 100%).  After 
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dehydration, pellets were incubated for 30 minutes with acetone, 1 hour with 1:1 
acetone/Polybed 812 (Polysciences Inc., Warrington, PA), and 24 hours with Polybed 
812.  Pellets were then transferred to fresh Polybed 812 and baked at 60ºC for 48 hours. 
 Sections were cut by an ultramicrotome, placed on 100 μm copper grids, and 
counterstained with Reynold’s Lead Citrate (8 mM Pb(NO3)2, 0.12 M sodium citrate, 
0.16 M NaOH).  Sections were examined at 80kV on an FEI Tecnai 12 electron 
microscope TEM and images were captured using Gatan micrograph 3.9.3 software. 
Cloning of lipid sensors 
A lipid sensor for PI levels was described previously (Liu et al., 2008).  A DAG 
sensor was constructed by cloning the cysteine rich domain (CRD) of PKD (aas 1-355) 
(Rey and Rozengurt, 2001) into pEGFP-C2 using a forward XhoI primer and a reverse 
HindIII primer.  
 
Results 
siRNAs reduce PITPβ levels in human and mouse cell lines 
 Previous studies of PITPβ in mouse have indicated a clear role for the protein in 
embryonic development: matings of PITPβ heterozygous mice yielded no live 
homozygous knockouts (Alb et al., 2002).  Indirect results in ES cells suggested an 
essential housekeeping role of PITPβ (Alb et al., 2002). However, currently there is 
nothing known about the specific function of PITPβ in mammalian cells.  To study the 
function of PITPβ in mammalian cells, we used siRNA to knock down gene expression. 
Three siRNAs against human PITPβ were designed by the Ambion algorithm and 
targeted exons 8, 3 and 6 (by siRNA #1, 2, and 3, respectively).  As an initial test of the 
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efficacy of the siRNAs, RT-PCR was performed on siRNA-treated HEK293Ad and HeLa 
cells.  Cells were treated with mock or PITPβ siRNA, and RNA was collected about 52 
hours after treatment.  In both HeLa and HEK293Ad, all three siRNAs were capable of 
significantly reducing PITPβ levels, knocking down RNA levels of PITPβ by about 40 to 
70 % (Figure 1a). 
As an additional model for PITPβ knockdown, siRNAs were designed against the 
mouse PITPβ.  The siRNAs targeted different exons than the human siRNAs (exons 4/5, 
8, 11, and 7 for siRNA 1-4 respectively).  The mouse siRNAs were tested in 
immortalized mouse embryo fibroblasts (iMEFs) using the same conditions used for the 
human siRNA.  RT-PCR of siRNA-treated iMEFs showed that the siRNAs did not 
reduce PITPβ mRNA levels as effectively as the human system, however one of the four 
siRNAs (mouse siRNA #4) did reduce PITPβ levels by about 30-40 % (Figure 1a).  The 
reduced efficacy of the siRNAs could be due to the siRNA sequences being less effective 
against PITPβ, or the iMEFs could be less responsive than the human cell lines to siRNA 
treatment. 
Because the siRNAs were more effective in human cell types, we focused on 
HeLa and HEK293Ad cells, and examined the effect of the siRNAs on protein levels by 
Western blot.  Protein was collected 52 hours after siRNA treatment, separated by SDS-
PAGE, and transferred to nitrocellulose by western transfer.  The nitrocellulose blot was 
probed with a PITPβ antibody and a GAPDH antibody for normalization.  PITPβ protein 
levels were found to be reduced by about 50% relative to GAPDH in HeLa cells that had 
been treated with either mock or PITPβ siRNA #1, #2, or #3 (Figure 1b).  Thus, the 
treatment with siRNAs leads to a decrease in both mRNA and protein levels of PITPβ. 
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Loss of PITPβ leads to cell death 
 Previous studies using mouse as a model  suggested that PITPβ could be an 
essential housekeeping protein (Alb et al., 2002).  Therefore, we first assessed whether 
reduction in PITPβ levels affected cell survival.  Identification of live cells within a cell 
population can be determined using trypan blue exclusion, as only dead cells can be 
stained with the dye.  Using this method, live cells were counted after siRNA treatment.  
Significant cell death was observed at 2 days after treatment, and few cells survived to 3 
days after siRNA (Figure 1c), corroborating previous studies suggesting that PITPβ has 
an essential activity in mammalian cells. 
Cells with reduced PITPβ levels have dispersed Golgi structures 
 PITPs in several different species have essential roles and are localized at the 
Golgi network, including the yeast protein Sec14p (Bankaitis et al., 1989), the Drosophila 
protein vib (giotto) (Gatt and Glover, 2006; Giansanti et al., 2006), and the mammalian 
protein Nir2 (Litvak et al., 2005).  All of these proteins are thought to be essential for 
regulating phospholipid homeostasis at membrane sites that are competent for the 
formation of secretory vesicles.  Disregulation of lipids at the Golgi often leads to Golgi 
morphological changes and trafficking defects.  Thus, we hypothesized that PITPβ could 
also play a role in regulation of Golgi phospholipids and trafficking.  As an initial test of 
whether PITPβ might have an effect on Golgi function, the Golgi morphology was 
examined in PITPβ siRNA-treated cells.  
Since PITPβ is localized to the trans-Golgi network (TGN), the TGN was 
examined for morphological changes by immunofluorescence.  Initial studies were 
performed with siRNA #2, which had the greatest effect on RNA levels in HEK293Ad 
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and HeLa cells (Figure 1a).  Staining with the TGN marker TGN46 showed that, while 
mock siRNA-treated cells often had a small, compact Golgi, the PITPβ siRNA #2-treated 
cells had a more dispersed or “relaxed” trans-Golgi.  This phenotype was seen in both 
HeLa cells, and, more dramatically, in HEK293Ad (Figure 2a).   
The Golgi is composed of cis, medial and trans stacks that are decorated with 
distinct proteins.  A defect in the trans-Golgi stack is not necessarily seen in the cis or 
medial Golgi.  Therefore, we examined whether the defect was specific to the trans-
Golgi, or whether other Golgi compartments were affected.  Staining of the cells with the 
cis-Golgi marker gm130 revealed that the cis-Golgi, like the trans-Golgi, was more 
dispersed in PITPβ siRNA-treated cells.  The cis-Golgi marker continued to localize in 
very close proximity with the trans-Golgi marker in cells with a dispersed Golgi, 
indicating that Golgi stacks themselves are not disrupted.  Thus, despite the fact that 
PITPβ is localized to the trans-Golgi, the loss of PITPβ affects the morphology of all 
levels of the Golgi stack.  
 As a quantitative assessment of the Golgi phenotype, the Golgi dispersal 
phenotype upon PITPβ knockdown was scored.  HeLa cells were treated with mock and 
PITPβ siRNAs, fixed, and stained with Golgi (anti-gm130) and nuclear (DAPI) markers.  
Images from slides of mock and PITPβ siRNA-treated cells were taken at random, and 
the images were blinded.  Cells in each image were classified as having a “tight”, 
“moderately dispersed”, or “severely dispersed” Golgi.   For each siRNA condition, at 
least 245 cells were counted. 
The clear effect of PITPβ on the Golgi was evident from the compiled cell counts.  
For siRNA #2, which had the greatest effect on mRNA levels, we also saw the most 
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dramatic increase in “severely dispersed” Golgi, and a concomitant decrease in cells with 
“compact” Golgi apparati.  In HEK293Ad cells, the altered Golgi morphology was seen 
with all three PITPβ siRNAs, while in HeLa cells, only siRNAs #2 and #3 caused the 
increase in dispersed Golgi in agreement with a somewhat attenuated effect of siRNA #1 
on mRNA levels in these cells.  The effect of the siRNAs was much stronger in 
HEK293Ad, suggesting that these cells are more sensitive to loss of PITPβ or that 
silencing was more effective (Figure 2b).   
The Golgi phenotype was also examined in iMEFs treated with the mouse 
siRNAs.  The dispersed Golgi phenotype was seen only with mouse siRNA #4, and as 
expected by the weaker reduction in PITPβ levels, the phenotype was also much less 
severe than in the human cell types.  These results indicate that the phenotype is not cell, 
species, or siRNA-specific.  Further, the correlation between level of PITPβ message 
reduction and severity of phenotype supports a dose-dependent role for PITPβ in 
maintaining the integrity of the Golgi. 
The Golgi morphology changes seen by immunofluorescence indicated a role of 
PITPβ in Golgi organization.  The Golgi organizational defect was further characterized 
by ultra thin section electron microscopy.  The Golgi apparatus in wild type cells is easily 
identified by its proximity to the nucleus and its distinctive cisternal stacks.  The mock 
siRNA-treated cells had Golgi apparati that appeared normal, but in the PITPβ siRNA-
treated cells, the Golgi were distended.  Consistent with the immunofluorescence, the 
distension occurred at the cis, medial, and trans levels of the Golgi (Figure 2c). 
Transport from TGN is delayed in PITPβ-depleted cells 
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 Golgi defects seen by immunofluorescence and EM, particularly the swollen 
cisternae, are generally hallmarks of a block or delay in protein transport that results in 
cargo buildup in the Golgi,  (Liljedahl et al., 2001; Godi et al., 2004; Litvak et al., 2005).  
Bulk transport through the Golgi was assessed by tracking the secretion of labeled 
glycosaminoglycans.  Mock and PITPβ siRNA-treated cells were incubated with 
xyloside, a glycosaminoglycan acceptor and pulsed with 35S-sulphate which will be 
incorporated into the glycosaminoglycan modifications.  Trafficking is measured at 
various time points after chase with unlabeled sulphate.  At 20 minutes of chase, PITPβ 
siRNA –treated cells exhibited more than a 2-fold decrease in the release of labeled 
glycosaminoglycans.  In contrast, after 40 minutes of chase, mock and PITPβ siRNA-
treated cells had equivalent amounts of released glycosaminoglycans (Figure 3).  The 
trafficking delay (albeit not complete block in trafficking) caused by knockdown of 
PITPβ could indicate that alternative mechanisms compensate for the lack of PITPβ. 
Alternatively, since knockdown of PITPβ was not complete in our experiments, the delay 
could simply reflect the reduction, but not complete ablation, of PITPβ.  A third 
possibility is that the delay in secretion could be a secondary effect of a retrograde 
trafficking problem. 
PITPβ-depleted cells maintain normal retrograde trafficking 
 Brefeldin A (BFA) is a fungal metabolite that inhibits secretion and leads to the 
collapse of the Golgi into the ER.  It acts by stabilizing an ARF/GDP/ARF-GEF complex 
thus preventing ARF activation and coat recruitment (Peyroche et al., 1999). We 
addressed the question of whether PITPβ-depleted cells were deficient in retrograde 
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trafficking by studying the rate at which the Golgi was reabsorbed into the ER upon 
treatment with BFA. 
 Two days after transfection, PITPβ and mock siRNA-treated cells were subjected 
to BFA intoxication for various time points.  Cells were then fixed and stained with 
gm130.  By 5 minutes after treatment, both PITPβ and mock siRNA cells showed a more 
disperse Golgi.  Because the Golgi network in PITPβ cells is more disperse to begin with, 
the dispersal in PITPβ siRNA-treated cells was more severe than mock after the 5 minute 
BFA treatment.  By 15 minutes, the Golgi collapse was complete under both siRNA 
conditions, with no tight perinuclear Golgi networks visible in mock or PITPβ siRNA-
treated cells.  The similar rate of Golgi dispersal/collapse indicates that there is no large 
scale defect in retrograde trafficking. 
Lipid sensor membrane association is unchanged in PITPβ siRNA-treated cells 
 Analyses in other organisms reveal that PITPs play important roles in integrating 
phospholipid signaling events and regulating phospholipid homeostasis. The ability of 
PITPβ to bind phospholipids, its association with the trans-Golgi network, and its critical 
role in protein trafficking suggest that PITPβ could be regulating phospholipids at the 
TGN in order to promote membrane trafficking.  Two lipids that play known roles in 
protein trafficking from the Golgi are DAG and PtdIns(4)P. DAG recruits protein kinase 
D (PKD), a protein which is required for proper fission of vesicles from the TGN 
(Liljedahl et al., 2001; Baron and Malhotra, 2002).  In addition, PKD also promotes the 
recruitment of PtdIns 4-OH kinase IIIβ, which catalyzes the conversion of PtdIns to 
PtdIns(4)P (Hausser et al., 2005; Hausser et al., 2006).  PtdIns(4)P promotes transport 
from the Golgi through the recruitment of coat adapters, such as AP1 and epsins, and 
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other lipid modifying proteins such as CERT and OSBP (reviewed in (D'Angelo et al., 
2008). 
 Fluorescently tagged lipid sensors were used as a first means of detecting whether 
lipid levels were altered in the TGN of cells where PITPβ levels were reduced.  The 
cysteine rich domain (CRD) region of PKD1 mediates its interaction with DAG (Rey and 
Rozengurt, 2001; Baron and Malhotra, 2002), thus a fluorescently tagged PKD CRD 
domain was used as a DAG sensor.  The sensor was expressed in cells treated with either 
mock or PITPβ specific siRNA, and the cells were fixed and stained with a Golgi marker.  
Images of the stained cells show that, while the Golgi was relaxed in PITPβ siRNA-
treated cells, the GFP-PKD-CRD sensor was still associated with the relaxed Golgi 
(Figure 4). 
 The PtdIns(4)P sensor is based on a similar principal as the DAG sensor.  The 
FAPP1 and FAPP2 proteins have been shown to bind to PtdIns(4)P by its PH domain 
(Godi et al., 2004).  Furthermore, this chimera has successfully been shown to function as 
a bona fide PtdIns(4)P sensor (Godi et al., 2004).  An mCherry-tagged FAPP1 PH 
domain (Liu et al., 2008) was transfected into HeLa cells treated with mock or PITPβ 
siRNA.  As with the DAG sensor, the FAPP1-PH localized to the Golgi in both mock and 
PITPβ siRNA-treated cells (Figure 4).  
Discussion 
 In this chapter, I’ve demonstrated a role for PITPβ in maintaining the structure 
and anterograde trafficking function of the Golgi.  siRNA-mediated knockdown of PITPβ 
in human cell lines leads to a dispersed Golgi that is disrupted at all levels, and ultimately 
cell death.  Anterograde trafficking defects through the TGN are revealed by 
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glycosoaminoglycan pulse chase assays, and these changes are not accompanied by 
delays in retrograde trafficking. 
 As discussed previously, there are several PITPs with critical roles in Golgi 
trafficking.  Most notably, both Sec14p and Nir2 modulate DAG levels through the 
regulation of PtdCho levels (Skinner et al., 1995; Litvak et al., 2005; Xie et al., 2005).  
Sec14p also regulates PtdIns4P levels, but Nir2’s role in PtdIns-4P regulation is less clear 
(Peretti et al., 2008).   
Both DAG and PtdIns4P are attractive targets of regulation for PITPβ.  Cells 
treated with siRNA against Nir2 (which reduces DAG levels) or siRNA against PtdIns-4 
kinase IIα (which reduces PtdIns-4P) exhibit many of the same phenotypes as the PITPβ 
siRNA-treated cells, including the dispersed Golgi and the transport defects (Wang et al., 
2003; Litvak et al., 2005).  Expression of PtdIns4-P or DAG sensors in PITPβ or mock 
siRNA-treated cells showed no major defects in Golgi association of these markers.  
However, because the lipid levels are likely well in excess of what the sensors can detect, 
the sensors may not be sensitive enough to detect several fold changes in lipid levels.  
Rescue experiments (described below), and introduction of short chain lipids could help 
us to determine if lipid deficiencies lead to the Golgi and trafficking defects seen in 
PITPβ siRNA cells. 
One possibility for how PITPβ could function comes from studies of Sec14p.  
Sec14p function requires both PtdIns and PtdCho activity to reside on the same molecule, 
leading to the hypothesis that the exchange of lipids is required for their modification.  
The presentation function of Sec14 (along with findings from plant PITPs) led to the 
proposal of PITPs as nanoreactors – molecules that couple lipid binding subunits with 
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lipid modification enzymes.  This nanoreactor concept could well be extended to PITPβ, 
where PITPβ would act with PtdIns-4(OH) kinase or SM synthase as a nanoreactor, with 
the ultimate result of secretion promotion. PITPβ could require the exchange of any 
combination of PtdIns, PtdCho, and SM for modification of any of these lipids. 
A key way to address whether PITPβ is a nanoreactor and which lipids it acts on 
will be to examine which properties of PITPβ are essential for its function.  We have 
mutants that affect the PtdIns and SM binding ability and the Golgi localization of 
PITPβ, but unfortunately, it has so far proven impossible to rescue the phenotypes of 
PITPβ siRNA-treated cells with wild type PITPβ.  Development of a system where wild 
type PITPβ fully rescues the siRNA phenotypes will open the door to a greater 
understanding of PITPβ function. 
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Figures
 
Figure 3.1:  Several PITPβ siRNAs are capable of reducing PITPβ levels in mammalian 
cells.  A)  RT-PCR was performed on RNA was extracted from mock and PITPβ siRNA-
treated cells.  Levels of PITPβ were assessed by PCR amplification using primers for 
PITPβ and actin (for normalization).  B) Protein lysates were collected from mock or 
PITPβ si-RNA treated cells at 52 hours after siRNA treatment.  Lysates were separated 
by SDS-PAGE, transferred to nitrocellulose, and probed with PITPβ or GAPDH 
antibodies.  C) Reduction of PITPβ levels leads to cell death.  HeLa cells were treated 
with mock or PITPβ siRNAs, and at 1, 2, or 3 days after siRNA treatment, and viable 
cells were identified by their ability to exclude trypan blue dye. 
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 Figure 3.2:  Reduced PITPβ levels lead to changes in pan-Golgi morphology.  A) HEK 
and HeLa cells were treated with a negative control (“mock”) siRNA or PITPβ siRNA 
#2.  Two days after siRNA treatment, cells were fixed, permeabilized, and stained with 
markers for the nucleus (DAPI), trans-Golgi (TGN46; red), and cis-Golgi (gm130; 
green).  Representative images are shown.  B) The effects of siRNA on HEK293Ad and 
HeLa cells were quantified.  HEK293Ad and HeLa cells were treated with mock and 
human PITPβ siRNA #1-3, fixed two days after siRNA treatment, and stained as 
described in (A).  Images of each treatment and cell type were blinded, and the cells in 
each image were scored for Golgi morphology.  Data is from 3 separate experiments are 
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shown and at least 245 cells were counted for each condition.  C) Mock siRNA and 
PITPβ siRNA #2 treated HeLa cells were fixed and prepared for transmission electron 
microscopy at 2 days after siRNA treatment.  Two representative images for each 
condition are shown.  The scale bar corresponds to 0.5 μm. 
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Figure 3.3 (preceding page):  Trafficking through the trans-Golgi is delayed in PITPβ-
depleted cells.  Bulk traffic through the Golgi is measured by a glycosaminoglycan 
release assay.  Cells were treated with mock or PITPβ siRNA, incubated with xyloside, 
pulse labeled with 35S, and chased with cold media for different periods of time.  
Glycosaminoglycans were precipitated from cells and media, and counted.  The data is 
expressed as the percent secretion (counts in the supernatant divided by total counts).  
The assay was performed three times, and the displayed data is from two representative 
experiments performed in triplicate. 
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 Figure 3.4: The localization of lipid binding proteins is unaffected in PITPβ siRNA-
treated cells.  HeLa cells were treated with mock siRNA or PITPβ siRNA #2 and 
transfected with appropriate lipid sensor encoding plasmids at 6 hours after the start of 
siRNA treatment.  Two days after siRNA treatment, cells were fixed, permeabilized, and 
stained with gm130 (red), and for the left panel, also anti-Orp9 (kind gift of Neale 
Ridgway, Dalhousie University).  Representative merged images are shown.   
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Chapter 4 - Phosphatidylinositol Transfer Protein Beta is Required for Structural 
Integrity of Double Cone Cell Outer Segments in Developing Zebrafish 
 
Abstract 
Phosphatidylinositol transfer proteins (PITPs) in yeast coordinate lipid metabolism with the 
execution of specific membrane trafficking pathways in eukaryotic cells.  While there is some 
evidence that the structurally unrelated metazoan-specific PITPs (mPITPs) may also be involved 
in membrane trafficking in higher cells, the mPITPs remain an under-investigated class of 
proteins.  Not only is it unclear what biological activities mPITPs discharge, the mechanisms by 
which these proteins function are also not understood.  The soluble class 1 mPITPs include the 
PITPα and PITPβ isoforms and, of these, the β-isoforms are particularly poorly characterized. 
Herein, we report use of zebrafish as model vertebrate for the study of class 1 mPITP (and 
particularly PITPβ) biological function.  Zebrafish express PITPα and PITPβ-isoforms and a 
novel PITPβ-like isoform (DrPITPγ).  DrPITPβ expression is particularly robust in double cone 
cells of the zebrafish retina, and functional interference experiments demonstrate the two 
DrPITPβ spliceoforms are collectively and specifically required for biogenesis/maintenance of 
the outer segments of double cone photoreceptor cells in developing retina.  By contrast, reduced 
DrPITPα activity is essential for successful execution of early developmental programs.  This 
study reports the initial characterization of the zebrafish class 1 mPITP family, and the first 
functional analysis of PITPβ function in a vertebrate.
Introduction 
The functional compartmentalization of membrane surfaces is an essential feature of the 
strategies by which eukaryotic cells organize both signaling inputs and outputs.  Lateral 
organizations of lipids within membranes represent central principles for such a biochemical 
compartmentalization, and a number of different lipid species are involved in facilitating such 
organization.  Sphingomyelin (SM), cholesterol and other sphingolipids exhibit physical 
partitioning properties critical for formation of lateral heterogeneities (lipid rafts) that exert a 
broad spectrum of biological effects (Rajendran and Simons, 2005).  Phosphoinositides (PIPs), 
the phosphorylated versions of phosphatidylinositol (PtdIns), are also major components of 
membrane signaling systems (Berridge and Irvine, 1989; Majerus, 1992; Fruman et al., 1998; 
Strahl and Thorner, 2007). The involvement of PIPs takes on multiple forms, including roles as 
precursors for generation of soluble and lipid second messengers (e.g. inositol phosphates and 
diacylglycerol, respectively; Nishizuka, 1995; Rhee, 2001), and as binding platforms for the 
recruitment of proteins to appropriate membrane locations(Hurley and Meyer, 2001; Lemmon, 
2003).  The utility of PIPs as binding platforms for the appropriate spatial and temporal 
recruitment of signaling proteins is, in part, a function of the chemical diversities of PIP 
headgroups -- diversities encoded by the number and the positional arrangement of phosphates 
that decorate the inositol headgroup (Irvine and Schell, 2001).  From the perspective of PIPs as 
binding platforms, further diversification of PIP-centric biological outcomes is realized by 
coincidence detection mechanisms that couple the chemical identity of a particular PIP with a 
second protein or lipid binding activity (Ile et al., 2006).  
A newly described coincidence detection mechanism for functional specification of PIP 
signaling involves Sec14-like PtdIns-transfer proteins (PITPs).  Whereas PITPs have been 
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historically interpreted as carrier proteins that mobilize individual lipid molecules (PtdIns and 
phosphatidylcholine; PtdCho) between membrane bilayers in cells (Hsuan and Cockcroft, 2001), 
this view rests solely on an operational in vitro definition of uncertain physiological significance 
(Helmkamp et al., 1974; Wirtz, 1991).  Indeed, evidence from Sec14-like PITPs argues strongly 
for a lipid sensor role for these proteins that is coupled to substrate presentation functions 
required for sufficient PtdIns kinase activity in vivo.  The coupling of sensor/presentation 
activities is realized via heterotypic lipid exchange cycles that allow Sec14-like PITPs to impose 
an instructive regulation of PtdIns kinases – a level of control that cues activation of lipid kinases 
to specific metabolic inputs (Schaaf et al., 2008).  This mechanism is conceptually summarized 
as Sec14-like PITPs serving as nanoreactors for PIP synthesis (Ile et al., 2006).  Structure-based 
predictive bioinformatics suggest Sec14-like proteins link divergent territories of the lipid 
metabolome to PIP signaling in eukaryotic cells (Ryan et al., 2007; Schaaf et al., 2008). 
Whereas Sec14 is an ancient and exclusively eukaryotic structural unit (Phillips et al., 
2006b), expression of a second comprehensively unrelated group of PITPs is essentially 
restricted to the Metazoa (mPITPs; Phillips et al,, 2006b) – with Dictyostelium presenting an 
enigmatic exception (Swigart et al., 2000).  Such an evolutionary restriction identifies these 
mPITPs as signatures of the most complex eukaryotes.  Whether mPITPs fulfill a 
sensor/presentor function resembling that of Sec14-like PITPs, or whether these function 
altogether differently remains an open question.  Indeed, little is confidently known regarding 
their biological functions.  The mPITPs fall into the categories of small cytosolic class 1 versions 
and the large tightly membrane-bound class 2 proteins (Fullwood et al., 1999).  Our studies focus 
on the class 1 mPITPs of which there are three in mammals: PITPα, PITPβ and RdgBα 
(Dickeson et al., 1989; Tanaka and Hosaka, 1994; Fullwood et al., 1999).  The α and β isoforms 
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share ca. 77% primary sequence identity, but assume different localization profiles in cells and 
exhibit biochemical differences in their phospholipid binding/transfer properties (Phillips et al., 
2006a).  RdgBα is only ca 42% identical to PITPα and PITPβ and remains uncharacterized (Lu et 
al., 2001).  Whereas Pitpα0/0 mice have been generated (these develop to birth but suffer from 
complex pathologies that result in neonatal death; Alb et al., 2003), essentially nothing is known 
regarding PITPβ function.  Attempts to generate PITPβ-nullizygous mice, or cell lines, have thus 
far failed (Alb et al., 2002).  The negative data suggest PITPβ executes essential housekeeping 
functions and, given the striking localization of PITPβ to the mammalian trans-Golgi complex, 
such functions are likely executed at the level of the Golgi complex (Phillips et al., 2006a). 
To address the issue of class 1 mPITP (and particularly PITPβ) biological function more 
readily, we employed the experimentally tractable zebrafish (Danio rerio) as model vertebrate.  
Zebrafish express a set of mPITPs resembling that found in mammals with the addition of a 
unique DrPITPβ-like isoform designated DrPITPγ.  Functional interference experiments 
demonstrate DrPITPβ dysfunction evokes specific defects in biogenesis/maintenance of the outer 
segments of double cone photoreceptor cells in developing retina.  These defects are associated 
with altered status of a retinal-specific arrestin (Arr3L) in double cone cells, although reduced 
Arr3L activity does not evoke reciprocal effects; i.e. loss of DrPITPβ, structural derangements in 
double cone cells, or compromised structural integrity of double cone outer segments.  We 
propose DrPITPβ is required for optimal activity of the robust membrane trafficking system 
required for photoreceptor outer segment biogenesis and maintenance.  Finally, in contrast to the 
specific developmental defects scored in DrPITPβ morphants, DrPITPα insufficiencies result in 
early developmental failure.  The collective data describe the initial description of the zebrafish 
class 1 mPITP family, and document the first functional analysis of a PITPβ in a vertebrate. 
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Materials and Methods 
Zebrafish. 
Zebrafish were raised in either the University of Notre Dame Fish Facility or the UNC Zebrafish 
Aquaculture Core Facility.  The strains used were AB and AB/Tu from the University of Oregon.  
 
Polyclonal antibody production and purification.   
The entire coding region of DrPITPβ was amplified using Pfu polymerase (Stratagene) with 
forward and reverse primers 5’- GAATTCGATGGTGCTCATCAAGGA -3’ and 5’- CTC 
GAGTGCCTCATTGTTCGTGAGC -3’, respectively.  The PCR product was cloned into 
pCRScript (Stratagene) and ultimately subcloned into the pET23b prokaryotic expression vector 
(Novagen) at the EcoRI and XhoI sites (corresponding sites in the primers are indicated in bold) 
so that the recombinant protein could be produced with a His8-tag.  Correctness of the 
DrPITPβi2 cDNA subcloned in pET23b was confirmed by nucleotide sequence analysis of the 
entire cDNA region.  The fusion protein was expressed according to the manufacturer’s protocol 
(Novagen), analyzed by Coomassie-stained SDS-PAGE, and purified by electroelution from gel 
slices(Vihtelic et al., 1993).  Rabbits were immunized using 100 μg purified fusion protein per 
injection.  An affinity column was generated by coupling purified PBS-dialyzed DrPITPβi2 
fusion protein (AminoLink Plus; Pierce) to Sepharose beads using neutral coupling buffer (0.1 M 
sodium phosphate, 0.15 M NaCl [pH 7.2]).  Antibodies were immunopurified using this affinity 
column using methods previously described (Vihtelic et al., 1999).   The pan-PITP antibody is a 
rabbit polyclonal immunoglobulin that detects the N-terminal 1/3 of mammalian PITPα and 
PITPβ (a kind gift from Drs. George Helmkamp Jr. and Lynn Yarbrough, University of Kansas 
Med. Ctr.). 
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 Zebrafish PITPβ and rat PITPβ yeast expression vectors.   
Saccharomyces cerevisiae strains employed include CTY1-1A (MATa ura3-52 lys2-801 
his3Δ200 sec14-1ts), CTY1079 (MATa ura3-52 lys2-801 his3Δ200 sec14-1ts spo14Δ), and 
CTY303 (MATa ura3-52 his3Δ200 sec14Δ cki1::HIS3).  Zebrafish cDNA was generated by 
reverse transcription (kit and protocol from Invitrogen, Carlsbad, CA) from RNA collected from 
6 days past fertilization (dpf) zebrafish.  DrPITPα, DrPITPβi1, DrPITPβi2, and DrPITPγ cDNAs 
were amplified by PCR from total cDNA using primers clamped with XhoI and SacII restriction 
sites (Supplementary Table S1).  Rat PITPβ was also amplified by PCR using oligonucleotides 
clamped with XhoI and SacII.  The corresponding PCR products were verified by nucleotide 
sequence analysis and subcloned into the XhoI and SacII restriction sites of yeast episomal vector 
pDR195 to allow expression in yeast under control of the powerful and constitutive PMA 
promoter (Rentsch et al., 1995). 
 
Phosphoinositide analysis 
Yeast cells were grown in minimal media, and mid-logorithmic growth phase cultures were 
labeled overnight with 20 μCi/mL of 3H-inositol.  After a 3 hour heat shock at 37ºC, labeling 
was terminated by addition of 5% TCA (final).  The pellet was washed twice in water and 
disrupted in 4.5% perchloric acid.  The solution was neutralized by addition of EDTA pH 8.0, 
and lipids were extracted with ethanol:water:diethyl ether:1-butanol (15:15:5:1).  Lipids were 
dried down, resuspended in chloroform, and run on TLC using a chloroform: MeOH: water: 
ammonium hydroxide (9.6:8:1.4:1) solution. 
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Phenotypic rescue experiments in yeast. 
Yeast strains were grown to saturation overnight in liquid uracil-free minimal medium or 
complex YPD medium at 26°C with shaking.  Culture densities were subsequently adjusted to a 
25 OD600, and normalized cultures were serially diluted into YPD liquid medium to generate 
the desired-fold dilution series for each culture.  A 5 μl aliquot of each culture dilution series was 
spotted in an ordered array onto a dried YPD agar plate.  The YPD plates were subsequently 
incubated at 37°C for 24 hr and cell growth in each spot was recorded. 
 
Phospholipid transfer assays. 
Phospholipid transfer assays were performed as described (Kearns et al., 1998; Phillips et al., 
1999; Li et al., 2000; Yanagisawa et al., 2002).  Briefly, yeast strain CTY303, which is devoid of 
measurable endogenous PtdIns-, PtdCho- and SM-transfer activities, was transformed with 
episomal pDR195 (negative control), or derivatives harboring rPITPβ, DrPITPβ (i1 and i2), or 
DrPITPγ.  The CTY303 derivative strains were grown to saturation and harvested.  Cell pellets 
were resuspended in spheroplast buffer (1.1 M sorbitol, 10 mM Tris-HCl [pH 7.5]), and cells 
disrupted by vigorous vortexing with glass beads (0.5 mm; Sigma).  Broken cell extracts were 
clarified by serial centrifugation at 1,000 g and 100,000 g, and the 100,000g supernatant 
fractions were clarified by filtration through 0.45 μM diameter pore membranes (Millipore).  
PtdIns- and PtdCho- transfer assays using clarified yeast cytosol were performed as 
described(Aitken et al., 1990).  [1,2-3H]-Inositol, [14C]-PtdCho and [14C]-SM were from 
American Radiolabeled Chemicals, Inc.  All other phospholipids were from Avanti Polar Lipids 
(Alabaster, AL).  SM-transfer assays were performed in the same manner as PtdCho-transfer 
assays with the modification that [14C]-SM was incorporated into donor liposomes. 
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 Protein preparation. 
Yeast CTY303 derivatives carrying vectors driving expression of zebrafish and rat PITP cDNAs 
were cultured overnight in uracil-deficient media.  Culture aliquots (5ml) were collected by 
centrifugation, and the yeast pellets were washed 1X with water and 2X with acetone.  Pellets 
were subsequently air dried, resuspended in Laemmli buffer and disrupted by vortexing with 
glass beads (three one minute bursts of vortexing, with one minute on ice between bursts).  The 
glass beads were pelleted and the supernatant (yeast protein lysate) was collected and boiled 
prior to resolution by SDS-PAGE.  Resolved proteins were transferred to nitrocellulose and 
individually decorated with either anti-DrPITPβ or pan-PITP immunoglobulin, respectively. 
 
Heterologous expression in mammalian cells. 
Expression and immunofluorescence localization of DrPITPβi1, DrPITPβi2, or DrPITPγ in 
mammalian cells was performed as described (Phillips et al., 2006a).  COS7 cells (grown in 
DMEM supplemented with 10% FBS and 1% penicillin/1% streptomycin) were transfected 
using FuGene (Roche Applied Science, Indianapolis, IN), as recommended by the manufacturer. 
 
Frozen section and whole-mount immunolocalization.   
Cryosections of adult albino zebrafish eye were prepared as described (Barthel and Raymond, 
1990; Vihtelic et al., 1999).  Harvested eyes were fixed with 4.0% paraformaldehyde/5.0% 
sucrose in PBS [pH 7.4] at 25°C for 1 hr, embedded in OCT (Sakura Finetek), and sectioned 
using a cryostat.  Stored cryosections (12 μm) were warmed to room temperature (RT), air-dried, 
and rehydrated in TBS (pH 7.5).  Sections were blocked with TBS/5% normal goat serum at RT 
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for 60 min, and incubated with primary antisera diluted in TBS/5% normal goat serum/0.1% 
Triton X-100 at RT overnight.  Primary antibodies were decorated with Cy3- (1:500; Jackson 
ImmunoResearch) or AF488-conjugated (1:500; Molecular Probes) secondary antibodies.  
Negative controls included omission of primary antibody and labeling with pre-immune serum.  
For whole-mount labeling, adult retinas were fixed with 4% paraformaldehyde/5% sucrose/PBS 
at RT for 4 hrs, rinsed in TBS and water (5 min each), plunged into acetone at –20°C for 5 min, 
and serially transferred to water and TBS (Vihtelic and Hyde, 2000). 
For frozen section labeling, embryos were dechorionated using Pronase (1 mg/ml), rinsed 
in water, and fixed in 4% paraformaldehyde/5% sucrose/PBS at room temperature for 20 min.  
Fixed embryos were washed in 5% sucrose/PBS, incubated in 30% sucrose/PBS at 4°C 
overnight, and frozen in OCT.  Embryos for whole-mount labeling were fixed at 25°C for 20 
min, washed in TBS, post-fixed in methanol (5 min, -20°C), and washed in TBS.  Tissues were 
blocked with TBS/5% normal goat serum/1% DMSO/0.1% Triton X-100 overnight at 4°C.  
Retinas and embryos were incubated in diluted primary antibody overnight or for 48 hours, 
respectively.  Antibody staining profiles were developed by washing in several changes of 
blocking buffer (4 hrs total), and incubation with secondary antibodies overnight at 4°C. 
 
In situ hybridization 
Nucleotide probes for DrPITPβ and DrPITPγ expression were generated by amplification of the 
corresponding cDNAs using the appropriate yeast expression vectors (see above) as templates.  
The probe cDNAs were subcloned into pGEM Easy-T® (Promega, Madison, WI) in both 
orientations to create sense and antisense probes.  Vectors were linearized and transcribed using 
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MAXIscript (Ambion, Austin, Texas) and T7 polymerase.  In situ hybridizations were performed 
using standard methods (http://zfin.org/zf_info/zfbook/chapt9/9.82.html) and 28 hpf embryos. 
 
Morpholino injections 
Morpholinos designed for specific inhibition of DrPITP translation were from Gene Tools, LLC 
(Philomath, OR) and had the following sequences: Standard negative control, 5’ – CCTCTTACC 
TCAGTTACAATTTATA – 3’; PITPβMO1, 5’- ACGATATTCCTTGATGAGCACCATC – 3’; 
PITPβMO2, 5’- TTGATGAGCACCATCTTCTTTCCAC –3’; and PITPβMO5-M, 5’- ACCA 
TATTCGTTCATGACCACGATC – 3’; PITPα MO1, 5’- CATGTTATCTCCTTTGCCGCCCC 
GT-3’; PITPα 5mm, 5’- CATCTTATGTGCTTTCCCCCCCCGT-3’; Arr3L MO1, 5’ – TCTTCT 
TGTAAACTTTGTCAGCCAT – 3’; Arr3L 5mm, 5’- TCTTGTTCTAAAGTTTCTCACCCAT -
3’.  All morpholinos were labeled with lissamine at their 3’ ends.  Morpholinos were suspended 
in water to a final concentration of 0.5 mM, and ca. 5 nL was injected into the yolk of 1-4 cell 
embryos.  At 24 hpf, larvae were examined for lissamine fluorescence as indicator of morpholino 
uptake.  Larvae failing to present lissamine staining were discarded.  Lissamine-positive larvae 
were incubated at 28ºC until 72 hpf. 
 
Zpr1 immunoblotting and immunoprecipitation 
Adult eyes were disrupted in homogenization buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 4 mM 
MgCl2, 2 mM EDTA, and 0.2% Triton X-100) supplemented with a protease inhibitor cocktail 
(Complete, Roche Applied Science, Indianapolis, IN).  Insoluble material was sedimented by 
centrifugation at 16,000 g.  Laemmli buffer was added to the supernatants, and each sample was 
denatured by heating at 60°C for 15 minutes.  The denatured homogenates were resolved by 
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SDS-PAGE, protein species were transferred to nitrocellulose, and the blots were subsequently 
developed using the zpr1 monoclonal antibody at a 1:500 dilution. 
 Immunoprecipitations were performed by homogenizing adult eye tissue as described 
above for the immunoblotting experiments.  After the low speed spin, the supernatant was 
collected and cleared with protein A Sepharose beads for 30 minutes.  The beads were pelleted, 
the supernatant was collected, and the cleared supernatant was supplemented with fresh 
Sepharose A beads and zpr1 antibody (1:10 dilution).  The mixture was incubated overnight at 
4ºC with continuous agitation.  The beads were pelleted, washed with lysis buffer and, after the 
final wash, the beads were resuspended in sample buffer.  Controls lacking either antibody or eye 
homogenate were performed in parallel.  All samples were resolved by SDS-PAGE, stained with 
blue-silver (Morgan et al., 2006), and the single visible polypeptide band was excised and 
submitted for mass spectrometry analysis at the UNC Michael Hooker Proteomics Center. 
 Genes encoding candidate zpr1 antigens were recovered from an adult zebrafish retinal 
cDNA library prepared by reverse transcription (Superscript First Strand Synthesis System, 
Invitrogen) of RNA template isolated from adult zebrafish eyes (Trizol; Invitrogen, Carlsbad, 
CA).  ORFs encoding candidate proteins identified by mass spectrometry (arrestin 3-like and β-
actin) were amplified from the cDNA library by PCR.  Primers were designed from sequences 
deposited in NCBI Entrez Nucleotide (arrestin 3 like: BC076177; β-actin: BC063950) and were 
clamped with NotI in the forward primer and XhoI in the reverse primer.  The relevant coding 
sequence of interest was subcloned into pET28 with an N-terminal His8 epitope tag.  Identities of 
subclones were verified by nucleotide sequence analysis. 
 pET28/Arrestin 3-like, pET28/actin, pET28 were transformed into BL21-CodonPlus 
(DE3)-RIL competent cells (Stratagene, La Jolla, CA).  The plasmid-bearing E. coli strains were 
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cultured to mid-logarithmic growth phase in LB media supplemented with 25 μg/mL kanamycin 
and 25 μg/mL chloramphenicol and protein expression was induced with IPTG (200μM final 
concentration).  Bacterial cells were subsequently harvested by centrifugation, resuspended in 
lysis buffer (300 mM NaCl, 50 mM sodium phosphate, pH 7.5), and lysed by three bursts of 
sonication (10 seconds each).  Debris was removed by centrifugation, the supernatant was 
collected, and individual proteins were resolved by SDS-PAGE.  Resolved proteins were 
transferred to nitrocellulose and probed with antibodies directed against zpr1 (Zebrafish 
International Resource Center, Eugene, OR) and actin (Chemicon, Temecula, CA), respectively. 
 
Thin section electron microscopy and histology. 
Three days after fertilization and morpholino injection, zebrafish larvae were fixed overnight at 
4ºC in 2% formaldehyde/2.5% glutaraldehyde/100 mM cacodylate, washed 3 times in 100 mM 
cacodylate and three times in water.  The larvae were dehydrated by a series of ethanol washes 
from 50% to 100% ethanol, a wash in 1:1 xylene/EtOH, and incubation in 100% xylene.  Larvae 
were transferred to embedding media by incubation in a 1:1 xylene/polybed 812, 1:2 
xylene/polybed 812, and 100% polybed 812 series.  The polybed 812 embedded samples were 
baked in molds for two days at 60ºC.  Thin sections were stained with alcoholic uranyl acetate 
and Reynold’s lead citrate, and visualized at 80kV on an FEI Tecnai 12 electron microscope.  
Images were captured using Gatan micrograph 3.9.3 software.  For histological analyses, 3 μM 
sections were cut and stained with 1:1 methylene blue:Azure II. 
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Results 
The zebrafish cohort of class 1 PITPs. 
While a presumptive zebrafish PITPα orthologue has been identified (Xie et al., 2005), no 
reports are available for zebrafish PITPβ.  A protein annotated as homologous to mammalian 
PITPβ is present in both the ZFIN and NCBI databases (reference numbers ZDB-GENE-040426-
895 and NM_200920).  The zebrafish PITPβ gene (DrPITPβ), and its inferred gene product, 
corresponds in sequence and genomic organization most closely to what we refer to as the 
mammalian “alternative spliceoform” – as opposed to the “canonical spliceoform” (Phillips et 
al., 2006a).  Examination of EST and genomic sequences (NCBI UniGene website) reveal that 
DrPITPβ resides on chromosome 10 in the genomic region spanning nucleotides 42,255,368 
through 42,284,830.  Moreover, DrPITPβ undergoes the same exon-skipping splicing events 
exhibited by the mammalian PITPβ transcript (Morgan et al., 2006; Phillips et al., 2006a), and 
two DrPITPβ mRNA spliceoforms are expressed.  These DrPITPβ spliceoforms are herein 
designated in a fashion consistent with the nomenclature of the mammalian spliceoforms.  That 
is, the DrPITPβ identified in the database corresponds to DrPITPβi2 as it is the cognate of the 
mammalian PITPβ alternative spliceoform.  The DrPITPβ spliceoform that corresponds to the 
canonical mammalian PITPβ spliceoform is designated DrPITPβi1. 
Search of the ZFIN database with the RnPITPβ primary sequence as query identified 
another closely-related, yet previously unidentified, PITPβ-like gene on chromosome 3 spanning 
nucleotides 13,898,735 through 13,918,905.  The corresponding primary mRNA transcript 
consists of 11 exons and, when spliced, is predicted to encode a 271 amino acid protein.  The 
presence of ESTs indicates this gene is transcribed and is unlikely to represent a pseudogene.  
We refer to this gene as DrPITPγ (reference numbers: ZDB-GENE-040426-2791, NM_213443).  
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The coding regions of DrPITPβi1 and DrPITPγ share 73% nucleotide sequence identity, and the 
inferred gene products share 78% identity at the primary sequence level (Figure 1A).  As detailed 
information regarding physiological functions of PITPβ in vertebrates remains uncharacterized, 
herein we focus primarily on analyzing physiological roles of the zebrafish PITPβ-like isoforms.   
 
Zebrafish PITPβ-like proteins exhibit PtdIns/PtdCho/SM transfer activities in vitro. 
A heterologous phenotypic rescue assay was used to determine whether the zebrafish PITPβ or 
PITPγ exhibited functional properties consistent with PITPs.  This assay is based on previous 
demonstrations that high-level expression of rodent PITPα or PITPβ (RnPITPβ) rescues the 
growth and secretory defects associated with thermosensitive versions of Sec14 -- the major 
PITP of yeast (Skinner et al., 1993; Tanaka and Hosaka, 1994).  To this end, a sec14-1ts mutant 
yeast strain was transformed with yeast episomal plasmids driving constitutive expression of 
either RnPITPβ (positive control), of DrPITPβ spliceoforms 1 or 2, or DrPITPγ.  The ability of 
these individual plasmids to rescue growth of the sec14-1ts mutant at restrictive temperatures 
(37°C) was then assessed.  The positive control strain expressing the canonical mammalian 
PITPβ (RnPITPβ) grew well under these conditions, as expected (Tanaka and Hosaka, 1994).  
The spot inocula representing 100 to 10-3 dilutions of the original culture exhibited robust 
growth, while the 10-4 spot dilution revealed the growth of single colonies within the inoculated 
area (Figure 1B).  The sec14-1ts negative control strain carrying vector alone was inviable at 
37°C as indicated by its failure to exhibit visible growth in any of the spot inocula.  Plasmids 
driving individual expression of DrPITPβ isoforms 1 or 2, or DrPITPγ, also restored robust 
growth of the into the sec14-1ts mutant at 37°C (Figure 1B).  These data clearly demonstrate that 
all three zebrafish PITPβ-like proteins exhibit functional properties of PITPs. 
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We tested whether the zebrafish PITPβ-like proteins exhibit intrinsic phospholipid 
transfer activities with the biochemical signatures of PITPβs.  In a manner similar to the 
phenotypic rescue experiments described above, DrPITPβ isoforms 1 and 2 and DrPITPγ were 
individually expressed in the cki1 sec14Δ yeast strain CTY303, a yeast strain that lacks 
measurable endogenous PtdIns- or PtdCho-transfer activity and permits facile detection of 
phospholipid transfer activities of heterologous PITPs (Cleves et al., 1991; Skinner et al., 1993; 
Kearns et al., 1998; Li et al., 2000).  Cytosol was prepared from the appropriate cki1 sec14Δ 
derivative strains and was assayed for PtdIns-, PtdCho- and SM-transfer activities. 
As expected, 2 mg of cytosol prepared from the CTY303 vector-only control strain failed 
to present any significant PtdIns-, PtdCho- or SM-transfer activity (Figure 1C).  Cytosol 
containing RnPITPβ (the positive control) strain exhibited robust transfer activities for all three 
phospholipid substrates (Figure 1C).  Incorporation of 2 mg of RnPITPβ cytosol into the assay 
resulted in the in vitro transfer of approximately 16%, 8% and 8% of the total input [3H]-PtdIns, 
[14C]-PtdCho and [14C]-SM from donor to acceptor membranes, respectively.  Similarly, cytosol 
fractions containing DrPITPβi1 or DrPITPβi2 also exhibited comparable levels of transfer 
activity for all three phospholipid substrates relative to rPITPβ control cytosol (Figure 1C).  
While DrPITPγ cytosol also presented robust PtdIns- and PtdCho-transfer activities, SM-transfer 
activity was significantly lower than the activities measured for the mammalian PITPβ or for 
DrPITPβi1 and DrPITPβi2.  Nevertheless, the measured activities were still significantly above 
background.  Given the similar magnitudes of PtdIns- and PtdCho-transfer activities in DrPITPγ 
cytosol relative to DrPITPβi1 or DrPITPβi2 cytosol, these biochemical data suggest DrPITPγ 
exhibits inferior SM-transfer activity.  These results, while not allowing direct comparisons of 
specific activities for PtdIns-, PtdCho- and SM-transfer between rPITPβ and the zebrafish PITPβ-
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like proteins, nevertheless demonstrate that all three of these zebrafish PITPs harbor intrinsic 
biochemical signatures of PITPβs. 
Mammalian PITPα and PITPβs are further distinguished by their intracellular localization 
– mammalian PITPβ isoforms target to TGN membranes whereas PITPα localizes to 
nuclear/cytosolic compartments(de Vries et al., 1995; De Vries et al., 1996; Phillips et al., 
2006a).  By this criterion, the three zebrafish PITPβ-like proteins also score as PITPβs, rather 
than PITPαs.  DrPITPβi1, DrPITPβi2 and DrPITPγ chimeras bearing C-terminal GFP tags 
distributed to Golgi membranes when expressed in mammalian cells -- as did the control rPITPβ-
GFP reporter (Figure 1D).  DrPITPγ-GFP, however, was distributed more broadly than 
DrPITPβi1- and DrPITPβi2-GFP.  This zebrafish-specific PITPβ co-localized with both Golgi 
and ER markers (Figure 1D).  These three localization patterns stand in clear contrast with the 
localization profile of the DrPITPα which, in agreement with previous reports, exhibited a 
predominantly a cytosolic/nuclear distribution (Figure 1D). 
 
Zebrafish PITPβ isoforms stimulate phosphoinositide synthesis in yeast. 
We exploited the yeast system to assess whether DrPITPβi1, DrPITPβi2 and DrPITPγ are able to 
stimulate activity of a PtdIns 4-OH kinase in its native environment.  Using a previously reported 
strategy (Phillips et al., 1999; Schaaf et al., 2008), we took advantage of yeast strains ablated for 
Sac1 PtdIns-4-P phosphatase activity to this end.  Yeast defective in Sac1 activity present a ca. 
10-fold accumulation of PtdIns-4-P relative to isogenic wild-type strains (Guo et al., 1999; Rivas 
et al., 1999), this accumulation is entirely attributable to the activity of a single PtdIns 4-OH 
kinase in yeast (Stt4; (Nemoto et al., 2000; Foti et al., 2001)).  The magnitude of this dramatic 
accumulation is reduced by 50% upon inactivation of the major yeast PITP Sec14 (Figure 2; 
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(Phillips et al., 1999; Rivas et al., 1999; Schaaf et al., 2008)).  The 2.5-fold effect on PtdIns-4-P 
accumulation under conditions of Sec14 insufficiency permits assessment of the ability of a 
heterologous PITP to stimulate PtdIns-4-P synthesis by the Stt4 PtdIns 4-OH kinase.  
Reconstitution of sec14-1ts sac1 yeast with DrPITPβi1, DrPITPβi2 and DrPITPγ fully rescued the 
depressed Stt4 activity of the control sec14-1ts sac1 strain (Figure 2). 
Similar results were obtained when these assays were performed in yeast sec14-1ts sac1 
strains expressing mammalian PITPα and PITPβ.  In both cases, reconstitution of a sec14-1ts sac1 
strain with the mammalian PITP resulted in a ca. 2.5-fold stimulation of Stt4 activity.   This 
effect was abolished by incorporating a TÆD missense substitution for T59 and T58 of PITPα and 
PITPβ, respectively.   PITPαT59D and PITPβT58D are each selectively inactivated for PtdIns 
binding/transfer without compromise of PtdCho- or, in the case of PITPβ, SM-binding/transfer 
activity (Alb et al., 1995; Phillips et al., 2006).  Thus, vertebrate class 1 PITPs are generally able 
to stimulate activity of the yeast Stt4 PtdIns 4-OH kinase in its endogenous setting. 
 
Spatial and developmental expression of DrPITPβ and DrPITPγ. 
RT-PCR was used as readout for zebrafish PITPβ-like gene expression during development (i.e. 
at 6 and 24 hour hpf, at 6 dpf, and in adult fish).  As shown in Figure 3A, both DrPITPβ and 
DrPITPγ transcripts were readily detected at all four stages.  Both DrPITPβi1 and DrPITPγ 
mRNAs were robustly expressed by 24 hpf and, in both cases, these levels were maintained into 
adulthood.  DrPITPβi2 mRNA exhibited a more delayed time course for appearance as robust 
levels were induced at some point between the 24hpf and 3dpf developmental stages.  These data 
indicate that the DrPITPβ mRNA splicing program which produces the mRNA for the canonical 
DrPITPβi1 predominates at the early stages of development, and the exon-skipping splicing 
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strategy that generates the mRNA for the alternative DrPITPβi2 spliceoform is engaged later. A 
more detailed profile was obtained by whole-mount in situ hybridization.  Both DrPITPβ and 
DrPITPγ presented a ubiquitous expression profile throughout the 28 hpf embryo, and DrPITPβ 
expression was particularly robust in the eye (Figure 3B).  As to spliceoform specificity, we find 
both DrPITPβi1 and DrPITPβi2 are expressed in the eye, with DrPITPβi2 exhibiting higher 
expression (Supplementary Figure S1).  In the experiments described below, all readouts 
employed fail to distinguish between these two spliceoforms, and all subsequent manipulations 
affect both.  As a result, we henceforth refer to these two proteins collectively as DrPITPβ. 
 
Characterization of a DrPITPβ-specific polyclonal antibody. 
To more precisely determine the pattern of DrPITPβ expression in adult retina, polyclonal 
antibodies were raised against purified recombinant DrPITPβi2.  The specificity of the affinity-
purified antibodies was tested in several ways.  First, immunoblotting experiments probing yeast 
lysates expressing DrPITPβi1, DrPITPβi2 or DrPITPγ demonstrated the DrPITPβ polyclonal 
antibodies readily detect both DrPITPβi1 and DrPITPβi2, but detect DrPITPγ only very poorly 
(Figure 3C).  Moreover, these same experiments demonstrated DrPITPα does not immunoreact 
with the anti-DrPITPβ serum at all.  A pan-PITP antibody detected all isoforms in these same 
lysates (Figure 3C).  Second, the immunopurified antibodies detect a protein with an apparent 
molecular mass of ca. 35 kDa in zebrafish retinal extracts (Figure 3C), an apparent mass in 
reasonable agreement with the 32 kDa calculated from the DrPITPβi1 and DrPITPβi2 primary 
sequences.  When zebrafish retinal extracts were probed with pan-PITP antibodies which detect 
mammalian PITPα and PITPβ isoforms (Skinner et al., 1993; Alb et al., 1995), one 35 kDa 
immunoreactive species was detected (Figure 3C).  This species exhibited the same mobility by 
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SDS-PAGE as the DrPITPβi1 and DrPITPβi2 polypeptides.  These data demonstrate the affinity-
purified anti-DrPITPβ antibodies specifically report DrPITPβi1/DrPITPβi2 without significant 
interference from DrPITPγ or DrPITPα. 
 
DrPITPβ expression in adult zebrafish retina is restricted to photoreceptor cells. 
Like other vertebrates, the zebrafish retina is composed of six neuronal cell types whose cell 
bodies are arranged into three nuclear layers.  These nuclear layers are clearly separated from 
each other by two sharply defined synaptic (plexiform) layers.  The photoreceptors, which 
consist of the rod and cone cells, form synapses in the outer plexiform layer (OPL) with second 
order neurons of the inner nuclear layer (INL).  Zebrafish possess three different cone cell types: 
the short single, long single and the double cone cells.  Each double cone cell is comprised of a 
long and short member and, whilst these members are fused along most of their lengths, these 
maintain individual cell structures such as outer segments and synaptic pedicles.  In vertical 
retinal sections, the rod outer segments are most proximal and are adjacent to the pigmented 
epithelium, while the various cone cell types reside in a layer between the elongated rod outer 
segments and the more distally located rod nuclei of the outer nuclear layer (ONL).  Each cone 
cell type assumes a signature morphology and location within the cone cell layer.  Proceeding 
from the ONL proximally towards the rod outer segment layer, the short single cones, long 
single cones and double cone cells are each localized in distinct and identifiable rows. 
Immunolocalization of DrPITPβ in frozen sections of adult zebrafish retina revealed 
expression is restricted to the photoreceptor layer with the most intense labeling localized to the 
OPL (Figures 4A and B).  To determine if the DrPITPβ profile corresponded to rod or cone 
photoreceptors, rhodopsin immuno-labeling was performed to mark the rod outer segments 
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(ROS).  In frozen sections dual-labeled for rhodopsin and DrPITPβ, the DrPITPβ-positive cells 
(including their relatively short triangular outer segments) were positioned distal to the ROS 
layer (Figure 4C).  These data assign DrPITPβ expression to cone photoreceptor cells (Figure 
4C).  Because the most intense DrPITPβ staining in the retina was associated with the OPL, we 
examined the preparations in greater detail to determine whether DrPITPβ expression was most 
highly concentrated in the photoreceptor synaptic terminals, or whether it was localized in the 
proximal processes of INL cells (e.g. in bipolar or horizontal cells).  Dual-label experiments, 
using α-tubulin as a marker to define structural organization of the OPL-proximal and -distal 
extents of the plexiform layer, clearly identified DrPITPβ-labeled processes as cone cell synaptic 
pedicles.  The staining profiles were inconsistent with labeling of the smaller rod spherules.  
These DrPITPβ-labeled processes were intimately associated with the proximal α-tubulin-
positive structures, which likely represent bipolar cell dendrites (Figure 4D).  Even at this 
resolution, invaginating α-tubulin-stained processes were occasionally observed to be partially 
surrounded by DrPITPβ-stained pedicles (data not shown). 
The cone photoreceptor localization of DrPITPβ was examined at higher resolution 
(Figure 4E).  Similar to the dual-labeled retina in vertical section (Figures 4C and D), the most 
intense DrPITPβ labeling was associated with expansive photoreceptor terminals (Figure 4E).  
Furthermore, the faint outer segment signal was restricted to a single row of cone cells, whose 
outer segments were located adjacent to the ROS layer.  This arrangement is consistent with that 
of double cone cells.  We failed to detect DrPITPβ staining in either the long or the short single 
cone outer segments, although these cell structures were plainly visible within the plane of the 
sections.  The small number of DrPITPβ-labeled cone pedicles, relative to the total number of 
cone cells in this section, corresponded to the number of labeled outer segments. 
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 DrPITPβ is primarily expressed in double cone photoreceptor cells. 
The outer segment and synaptic pedicle-labeling patterns both suggest DrPITPβ expression is 
restricted to a single cone cell type – most likely double cone cells.  To more precisely assign the 
identity of the DrPITPβ-expressing cone cells, monoclonal antibody (mAb) zpr-1 was used as 
specific double cone cell label.  MAb zpr-1 decorates an uncharacterized antigen associated with 
the plasma membrane of double cone cells (termed zpr-1 or Fret43), but not the other 
photoreceptor types (Larison and Bremiller, 1990) (Figure 4F).  Dual-labeling of frozen retinal 
sections with mAb zpr-1 and affinity-purified anti-DrPITPβ serum yielded extensively 
overlapping signals that were most apparent in the region of the synaptic pedicles (Figure 4G, 
arrowheads).  These profiles strongly suggest DrPITPβ expression is primarily confined to the 
double cone cells.  We further examined the co-localization of zpr-1 and DrPITPβ in retinal 
whole-mount preparations (Figure 5).  At the edge of the retinal tissue, dissociated 
photoreceptors were observed in vertical profile (Figure 5, Panels A-C).  In every case that a 
double cone cell was identified by zpr-1 staining (Figure 5B), that cell also expressed DrPITPβ 
(Figure 5, Panels A and C). 
When viewed from a tangential perspective, zebrafish cone cells are uniquely arrayed in a 
crystalline-like mosaic whose pattern is repeated across the entire retina.  In this arrangement, the 
short and long single cones alternate within single rows.  These rows alternate, in turn, with rows 
composed exclusively of double cone cells.  The rod photoreceptors randomly fill in the spaces 
between the regularly arranged cone cells.  Focusing at the level of the photoreceptor cell 
synaptic termini, zpr-1 and DrPITPβ both reside in cells arranged in repeating rows (Figure 5, 
Panels D-F).  Merge of the images reveals complete correspondence between zpr-1 and 
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DrPITPβ-containing cells (Figure 5F).  When viewed from this focal perspective, it was apparent 
that each labeled pedicle actually consisted of the fused pedicles of the two members of the 
double cone cell pair.  Closer inspection revealed that, in some instances, the zpr-1 and DrPITPβ 
profiles overlapped in the terminal of a single member of a double cone cell pair.  These results 
confirm DrPITPβ is primarily expressed in double cone cells, and is not highly expressed in 
short- or long- single cone cells.  The data further suggest that, at least in some cases, 
DrPITPβ expression is restricted to one member of the double cone pair.  Finally, no 
unambiguous DrPITPβ expression was detected in double cone pair outer segments in these 
sections (data not shown).  These data suggest DrPITPβ is enriched in synaptic pedicles, but it 
remains formally possible that a minor DrPITPβ pool also associates with outer segments 
 
DrPITPβ insufficiencies result in loss of double cone cell outer segments. 
The specific expression profile in the zebrafish retina suggests DrPITPβ executes developmental 
or phototransduction activities in double cone cells.  To this end, the consequences of DrPITPβ 
insufficiency on double cone function were determined.  Two DrPITPβ morpholinos were 
employed in these studies (MO1 and MO2; see Materials and Methods).  Efficacy was 
determined by injection of each morpholino into 1-4 cell zebrafish zygotes, lysates were 
subsequently prepared from 3 dpf larvae, and DrPITPβ levels were quantified by SDS-PAGE 
and immunoblotting.   Both MO1 and MO2 injection strongly reduced DrPITPβ expression 
relative to uninjected controls (Figure 6A).  These reductions were not recorded when either of 
two independent negative control morpholinos were injected  – one a scrambled morpholino 
from GeneTools (Philomath, OR) and the second an MO1-like morpholino with 5 mismatches 
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(MO5-M) (Figure 6A).  The sequences for the negative control morpholinos are detailed in the 
Materials and Methods. 
Embryos injected with DrPITPβ MO1 or MO2 and the negative control MOs were 
examined for morbidity and morphological deficiencies.  No differences were recorded in the 
viabilities of MO1 or MO2-injected morphants at 3 dpf relative to negative controls.  There were 
also no dramatic developmental or morphological defects/delays in DrPITPβ morphants relative 
to controls in that time window (data not shown).  That MO1 and MO2 injection effectively 
compromised DrPITPβ expression in retina was evident in examination of retinal cryosections of 
3dpf larvae.  DrPITPβ immunostaining was strongly reduced in DrPITPβ morphants, relative to 
controls (Figure 6B).  In keeping with the specific DrPITPβ retinal expression profiles, no 
derangements in the expression or organization of single cone cell and rod cell opsins (blue opsin 
and rhodopsin, respectively) were observed in DrPITPβ morphant larvae (Supplementary Figure 
2).  Those data indicate DrPITPβ insufficiencies fail to obviously affect development of those 
photoreceptor cell types that do not express this protein. 
DrPITPβ insuffiencies were accompanied by strong reductions in staining of double cone 
cells by mAb zpr-1, however.  The majority of DrPITPβ morphant larvae presented faint or 
undetectable zpr-1 staining, while negative control larvae all exhibited moderate to strong zpr-1 
staining (Figure 6B).  With > 14 larvae analyzed for each morpholino injected, 60% of the 
uninjected and 72% of the MO5-M mismatch control retinas presented strong zpr-1 expression.  
By contrast, only 21% of the MO1 and MO2 retinas showed strong zpr-1 expression.  The retinal 
cryosections were also probed for green opsin -- an independent double cone marker.  In contrast 
to the case of zpr-1, green opsin staining was unaffected in DrPITPβ morphants (Figure 6C).  
With at least 10 morphants examined, 82% and 90% of MO1 and MO2 injected larvae presented 
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robust green opsin staining, respectively.  This is compared to 93% and 81% of the unchallenged 
larvae and those insulted with the 5 mismatch control MO, respectively.  These data indicate that 
not all double cone cell markers are affected in the face of reduced DrPITPβ expression. 
A decrement in one double cone cell marker, but not another, might reflect a 
developmental defect or delay.  To address this possibility, the status of Müller glial cells was 
examined using glutamine synthase as marker.  Müller cell development precedes that of double 
cone cells, and these glial cells protect and nourish retinal cells (Bringmann et al., 2006).  
Glutamine synthase expression was unaffected in the either MO1- or MO2-derived DrPITPβ 
morphants (90% and 100% present glutamine synthase staining, respectively) as indicated by 
comparisons of the morphant staining profiles to those presented by uninjected or MO5-M 
injected controls (83% and 100%, respectively) (Figure 6D).  These data suggest no general 
delay in retinal development under conditions of reduced DrPITPβ expression. 
 
DrPITPβ-deficient double cone cells present outer segment defects. 
Consistent with the developmental marker experiments, histological analyses of DrPITPβ and 
control morphant eyes reported no major anatomical abnormalities in DrPITPβ morphant retinae 
(6 larvae from each morphant or control class were analyzed).  Since the majority of ONL cells 
at 3 dpf are cone cells, significant double cone cell loss was expected to manifest itself in large 
reductions in numbers of nuclei.  IMF staining of nuclei reported no obvious change in numbers 
of nuclei in DrPITPβ morphant ONL, however.  Histological examinations did reveal a modest 
disorganization of the ONL in DrPITPβ morphants compared to controls.  Specifically, the 
distances between the RPE and the nuclei of ONL exhibited greater variation in DrPITPβ 
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morphants compared to controls, and organization of the ONL cells was less regular (Figure 7A).  
These modest structural abnormalities diagnosed more subtle double cone cell defects. 
Ultra-thin-section electron microscopy (EM) was used to examine double cone cell 
morphology in more detail in DrPITPβ morphants at 3 dpf.  Multiple sections (>25) and at least 
four morphant and control larvae were examined in these analyses.  The EM images consistently 
reported a significant decrement in the numbers of properly assembled outer segments in 
DrPITPβ morphants, as opposed to control embryos where these were easily identified (Figure 
7B).  Using the signature triangular outer segment morphology as hallmark for double cone cells, 
these photoreceptor cells were clearly recognized in 96% of the thin sections derived from 
retinas of embryos injected with the MO5-M control, while identifiable double cone cells were 
scored in only 20% and 24% of MO1- and MO2-injected DrPITPβ morphant sections, 
respectively (Figure 7B).  We note that the double cone cell outer segment deficiencies in 
morphant larvae disappeared by 5 dpf, at which time morphant retinas were indistinguishable 
from controls and DrPITPβ protein expression was restored to normal levels (data not shown).  
These data indicate that outer segment defects associated with DrPITPβ insufficiencies are 
corrected upon DrPITPβ resupply.  Collectively, the EM and histology data suggest DrPITPβ 
morphants produce properly fated double cone cells which present structurally compromised 
outer segments during the window of time that DrPITPβ levels are below functional threshold. 
 Impaired outer segment biogenesis/maintenance is expected to manifest itself in a 
compromised phototransduction.  To that end, the electrophysiological response of morphant and 
control larvae to red light was measured.  The technical demands of the electrophysiological 
experiment require use of 5 dpf larvae, however, and no significant differences in the photo-
responses of morphant vs control retinas were recorded (Supplementary Figure S3).   As the 
 155
outer segment derangements that accompany DrPITPβ insufficiencies are not apparent at this 
stage, the data do not address functionality of the structurally impaired outer segments under 
conditions of DrPITPβ deficit.  However, these experiments do demonstrate that the delay in 
biogenesis of morphologically normal outer segments in fish recovering from DrPITPβ 
deficiencies does not compromise the ultimate production of functional outer segments. 
 
zpr-1 antigen is retinal arrestin 3-like protein. 
The specific loss of zpr-1 staining in DrPITPβ morphant double cone cells is striking given there 
are no perturbations in expression of other photoreceptor cell markers.  These data suggest a 
functional linkage between DrPITPβ and zpr-1, thereby emphasizing the need to identify the 
uncharacterized zpr-1 antigen.  To this end, mAb zpr-1 was used as affinity reagent to purify its 
cognate ligand from zebrafish retina and to subsequently determine its molecular identity.  
Immunoblotting experiments demonstrate mAb zpr-1 recognizes a single ca 45 kDa protein in 
lysates of adult zebrafish retina (Figure 8A).  Similarly, mAb zpr-1 immunoprecipitates a single 
45 kDa species from the same tissue.  The immunoprecipitation was specific given the fact that 
recovery of that species was dependent on both mAb zpr-1 and retinal homogenate (Figure 8B).  
The purified species was excised from the gel and subjected to MALDI-TOF mass spectrometry.  
Two candidate proteins were identified – the 39.5 kDa Danio rerio arrestin 3-like (Arr3L) and 
the 41.5 kDa Danio rerio β-actin.  The candidates were assigned with high confidence from 20 
and 17 individual peptide matches, respectively (Supplementary Table S2).   
 That Arr3L is a retinal-specific arrestin made it an attractive candidate for the zpr-1 
antigen.  To assign zpr-1 molecular identity, Arr3L and zebrafish β-actin polypeptides were 
individually produced in E. coli using a pET28 protein expression vector (see Materials and 
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Methods).  Immunoblotting experiments with mAb zpr-1 demonstrated an immunoreactive 
species of the expected molecular mass in bacterial lysates containing Arr3L (Figure 8C).  No 
mAB zpr-1 immunoreactive species were detected in lysates prepared from vector-only controls, 
nor from bacteria expressing zebrafish β-actin.  In the latter case, anti-actin serum readily 
detected the expressed recombinant actin polyppetide.  With regard to arrestin specificity, mAb 
zpr-1 failed to detect the closely-related arrestin Arr3, nor was there detectable immunoreactivity 
of mAb zpr-1 with recombinant zebrafish Sag and Zgc:66109 retinal arrestins, or with the 
ubiquitously expressed Arr2b arrestin (Supplementary Figure S4). 
 Independent confirmation that zpr-1 antigen is indeed Arr3L was obtained from 
experiments where Arr3L expression was specifically targeted by morpholino-mediated 
silencing.  Injection of embryos with an Arr3L-directed morpholino exerted no obvious 
developmental effects (data not shown), but such challenge eliminated staining of double cone 
cells in morphant larvae by mAb zpr-1.  This effect was not recapitulated in unchallenged 
embryos, or in embryos insulted with the cognate 5-mismatch control morpholino.  Moreover, in 
contrast to the reciprocal case where DrPITPβ morphants were strongly impaired for zpr1-
immunostaining (see above), Arr3L morphant retinas supported robust expression of both green 
opsin and DrPITPβ -- as was also apparent in retinas culled from uninjected embryos, or 
embryos challenged with the 5-mismatch morpholino (Figure 8D).  Futhermore, the green opsin 
and DrPITPβ staining profiles in morphant vs control retinas were very similar – suggesting loss 
of Arr3L function does not evoke general defects in retinal ultrastructure.  Finally, the retinal 
phenotypes associated with Arr3L- and DrPITPβ deficiencies were different in one other 
important respect.  Whereas DrPITPβ insufficiencies impair double cone cell development (as 
assessed by monitoring of outer segment ultrastructure), Arr3L morphant retinas presented well-
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formed outer segments (Figure 8E).  These data argue that outer segments deficits in DrPITPβ 
morphants do not derive from Arr3L dysfunction.  Rather, structural impairments of outer 
segments and altered Arr3L (zpr-1) status are consequences of reduced DrPITPβ activity. 
 
Arr3L transcription in DrPITPβ morphants. 
The phenotypes associated with DrPITPβ deficiency -- reduced Arr3L and defective double cone 
cell outer segment morphology -- potentially diagnose any of several defects.  Double cone outer 
segments may fail to form correctly, or may not be effectively maintained in DrPITPβ 
morphants.  Since Arr3L engages light-activated opsins in outer segments, derangement of these 
structures could promote Arr3L degradation.  Alternatively, DrPITPβ morphants may exhibit 
partial defects in double cone cell lineage determination with accompanying defects in 
transcriptional programming.  In such case, transcription of ARR3L, and of genes encoding other 
factors that contribute to outer segment biogenesis or maintenance, might be compromised. 
To distinguish between these general possibilities, ARR3L mRNA levels in DrPITPβ 
morphants were compared to those of uninjected embryos, or embryos injected with the MO5-M 
control morpholino.  Total RNA was isolated from embryos injected with DrPITPβ morphlinos.  
Because morpholino efficacy varies from morphant to morphant, RNA was prepared from three 
independent sets of morphants.  Each set included larvae derived from embryos injected with 
DrPITPβ-directed morpholinos MO1 and MO2, from embryos injected with the five mismatch 
control morpholino, and from uninjected embryos.  RT-PCR analyses estimated relative ARR3L 
mRNA levels.  In all cases, the RT-PCR assay scored similar levels of ARR3L mRNA in MO1- 
and MO2-derived DrPITPβ morphants relative to the mismatch morpholino and uninjected 
negative controls (Figure 8F).  These data indicate Arr3L transcription is not impaired in 
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DrPITPβ-deficient double cone cells – further supporting the conclusion that the structurally 
compromised double cone cells of DrPITPβ morphants are properly fated. 
 
DrPITPα morphants arrest early in development. 
The rather subtle developmental phenotypes associated with DrPITPβ morphants raised the 
question of whether the DrPITPγ and DrPITPα isoforms discharge more significant 
developmental functions in zebrafish.  Embryos injected with morpholinos directed against 
DrPITPγ failed to present significant increases in morbidity, or obvious morphological or 
developmental deficiencies (data not shown).  The lack of a suitable DrPITPγ -specific antibody 
with which to independently assess DrPITPγ protein levels in the presumptive morphants 
precludes confident interpretation of these negative data.  By contrast, interference with DrPITPα 
expression levied an early developmental arrest in the interval between 80% epiboly through the 
bud stage (8-10 hpf) (Figure 9A).  Until the point of arrest, DrPITPα morphants followed 
developmental trajectories that were indistinguishable from those of embryos insulted with the 
mismatch control morpholino (Figure 9A).  DrPITPα morphants remained in an apparent state of 
terminal developmental arrest for 24 hpf without exhibiting obvious signs of degeneration or 
structural decay normally associated with loss of viability.  By 48 hpf, however, the 
unambiguous indicators diagnostic of morbidity were on display in all morphants (Figure 9B). 
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Discussion 
Herein, we describe the initial characterization of the zebrafish class 1 mPITP family, and 
document the first functional analysis of a PITPβ in a vertebrate system.  We report zebrafish 
express a set of mPITPs that recapitulates the cohort found in mammals – i.e. a DrPITPα and two 
directly paralogous spliceoforms of DrPITPβ.  Zebrafish also express a unique DrPITPβ-like 
isoform not found in mammals which we designate DrPITPγ.  Biochemical characterization of 
each individual protein species confirms their identification as PITPβs.  Functional interference 
experiments, while uninformative for DrPITPγ, demonstrate collective DrPITPβ spliceoform 
function is not essential for general zebrafish development.  Rather, the DrPITPβs are 
specifically required for photoreceptor outer segment biogenesis/maintenance in the double cone 
cells of developing retina.  Moreover, DrPITPβ insufficiencies result in altered status of the 
retina-specific arrestin Arr3L in double cone cells.  The specific developmental defects levied by 
reduced DrPITPβ function are in stark contrast to the consequences of diminished DrPITPα 
function.  DrPITPα insufficiencies lead to early developmental failure and, ultimately, loss of 
viability of the terminally arrested embryo.  The collective data demonstrate DrPITPβ and 
DrPITPα isoforms discharge distinct developmental functions in zebrafish.  While DrPITPα is 
required for progression through early embryonic development, we propose DrPITPβ supports 
the high capacity membrane trafficking pathway required for outer segment biogenesis and 
maintenance in double cone photoreceptor cells. 
  
The panel of zebrafish class 1 PITPβs 
Zebrafish express a DrPITPα and three class 1 mPITPs with properties characteristic of PITPβ 
isoforms.  Two of these proteins represent DrPITPβ spliceoforms that correspond to the 
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‘canonical’and ‘non-canonical’ PITPβ spliceoforms that differ only in their extreme C-terminal 
sequences (Morgan et al., 2006; Phillips et al., 2006a).  The zebrafish cognates are DrPITPβi2 
and DrPITPβi1, respectively.  Using the canonical mPITPβ (DrPITPβi1) sequence as standard, 
the exon-skipping event that distinguishes these spliceoforms affects a window defined by the 
last fifteen residues of the canonical mPITPβ.  The alternative splicing event introduces five 
amino-acid substitutions into that region and incorporates one additional residue (Phillips et al., 
2006a).  In addition to the ‘canonical’ and ‘non-canonical’ DrPITPβ sliceoforms, zebrafish 
express a novel isoform (DrPITPγ) from a distinct structural gene highly homologous to the 
DrPITPβ structural gene at the nucleotide level.  DrPITPγ also shares a high degree of primary 
sequence with DrPITPβ spliceoforms. 
A battery of functional data identifies DrPITPβi1, DrPITPβi2 and DrPITPγ as PITPs of 
the β-isoform class.  First, each individual protein exhibits unambiguous PtdIns-, PtdCho- and 
SM-transfer activities in vitro.  Of the three, DrPITPγ harbors the least robust SM-transfer 
activity, but this activity is nonetheless significant.  Second, heterologous expression of each 
individual protein in yeast with a functionally thermosensitive PITP (the sec14-1ts gene product) 
phenotypically rescues the conditional growth defects associated with the sec14-1ts lesion.  
Third, the phenotypic rescue of the sec14-1ts mutation by DrPITPβi1, DrPITPβi2 and DrPITPγ is 
accompanied by restoration of stimulated PtdIns-4-phosphate synthesis by the Stt4 PtdIns 4-OH 
kinase – thereby establishing these particular class 1 mPITPs as functional potentiators of PtdIns 
kinase activity.  That PtdIns-binding is essential for vertebrate class 1 PITP α- and β- isoforms to 
stimulate PtdIns kinase is amply demonstrated by the inability of mutants specifically impaired 
for PtdIns-binding/transfer, to effect such a stimulation.  While potentiation of PtdIns kinases is a 
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consistent feature of PITPs, the heterologous context of the result has important implications for 
mechanisms of class 1 mPITP function (see below). 
 
DrPITPβ and double cone cell development 
DrPITPβ and DrPITPγ isoforms exhibit similar temporal expression profiles.  In situ 
hybridization experiments, although reporting a ubiquitous spatial expression profile for the 
DrPITPβs and DrPITPγ, score particularly robust DrPITPβ expression in the developing eye.  Of 
the two DrPITPβ spliceoforms, the ‘non-canonical’ DrPITPβi2 is the more highly expressed in 
that organ.  Moreover, the alternative splicing program that generates DrPITPβi2 engages later in 
development than the one which produces the ‘canonical’ DrPITPβi1.  As we have yet to 
demonstrate a clear functional distinction between the two DrPITPβ spliceoforms, it remains 
unclear why a splicing program switch is engaged in this manner.  The functional significance of 
enhanced DrPITPβi2 expression in retina, relative to that of DrPITPβi1, is also not obvious.  This 
enhancement may simply reflect an idiosyncracy of the larger splicing properties of the tissue -- 
rather than a specific requirement for DrPITPβi2 vs DrPITPβi1 activity in retina. 
Restriction of DrPITPβ expression to double cone cells, where the protein(s) distribute 
predominantly to the synaptic pedicles, is striking.  Functional interference data are congruent 
with the DrPITPβ expression profile.  While DrPITPβ morphants progress through larger 
developmental processes normally, morphologically recognizable double cone cells do not form 
in these animals.  All available data suggest double cone cells are fated correctly (green opsin, a 
specific marker for double cone cells, is produced in morphant retinas), but these photoreceptor 
cells present structural derangements associated with impaired biogenesis/maintenance of outer 
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segments.  These defects are associated with loss of immunoreactivity of double cone cells with 
the previously uncharacterized zpr-1 antigen – another specific marker for double cone cells. 
Herein, zpr-1 is identified as Arr3L, and the linkage between DrPITPβ dysfunction, 
defective outer segment morphology in double cone photoreceptor cells, and altered status of a 
double cone cell-specific arrestin, is a compelling one.  Transcription of the ARR3L gene is not 
compromised in DrPITPβ morphants, and we believe it most likely that Arr3L is destabilized in 
DrPITPβ-insufficient retina. Because the detection method employs a monoclonal antibody, 
other possibilities cannot be excluded – e.g. an altered Arr3L modification profile that interferes 
with mAb zpr-1 immunoreactivity, or altered Arr3L regulation at the translational level.  
Regardless, the developmental photoreceptor cell defects associated with DrPITPβ 
insufficiencies are reversible.  DrPITPβ recovery reconstitutes the retina with morphologically 
normal and functional double cone cells. Moreover, the relationship between DrPITPβ and 
Arr3L expression is not reciprocal.  Arr3L morphants do not present loss of DrPITPβ expression 
in the retina, nor do these result in structurally compromised double cone outer segments.   
Vertebrate rod and cone cell outer segments are composed of an extensive assembly of 
intricate membraneous discs/lamellae subject to a vigorous course of continuous self-renewal 
(Bok and Young, 1972; Young, 1974).  As such, the outer segment establishment/maintenance 
program relies on a high capacity membrane trafficking system which renders it exquisitely 
sensitive to perturbations in membrane trafficking.  Localization of mPITPβ isoforms to the 
trans-Golgi network, and the abilities of DrPITPβ isoforms to localize to mammalian Golgi 
membranes in heterologous expression studies, suggests a potential mechanism for how 
diminution of DrPITPβ activity evokes structural derangement of outer segments.  DrPITPβ 
insufficiencies may subtly compromise Golgi function in double cone cells and evoke significant 
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defects in opsin transport from that organelle.  Reduced incorporation of material into the outer 
segment via biosynthetic trafficking is expected to result in outer segment loss if membrane 
protein turnover in those structures is sustained at normal rates (Figure 10).  In mammalian rod 
cells, the SARA FYVE domain adaptor protein responds to PtdIns-3-P cues, and cooperates with 
the syntaxin 3 t-SNARE, to drive a vesicle fusion process required for outer segment membrane 
disc formation and maintenance of outer segment integrity (Chuang et al., 2007).  Given the 
ability of DrPITPβs to potentiate the activities of PtdIns kinases, one attractive scenario is 
DrPITPβs support an analogous PtdIns-3-P/SARA-dependent pathway in zebrafish double cone 
cells.  In that regard, we note an uncharacterized ORF annotated as encoding a zebrafish SARA 
homolog is present in both the ZFIN and NCBI databases (ZFYVE9; reference numbers ZDB-
GENE-030131-1426 and CAN88231, respectively; resides on chromosome 2 in the genomic 
region spanning nucleotides 14,608,532-14,643,375). 
While this model has its attractive features, it is not directly congruent with the primary 
localization of DrPITPβ to the synaptic pedicle.  The pool of Golgi membranes most proximal to 
the outer segment lies within the double cone cell inner segment.  One possibility is a minor pool 
of DrPITPβ does indeed reside in the inner segment, and is associated with Golgi membranes in 
that locale, or is transiently associated with the outer segments themselves, but that the steady-
state DrPITPβ distribution is more concentrated (and more easily detected) in the synaptic 
pedicle.  A second possibility is DrPITPβ is sequestered from the inner segment and plays no 
direct role in double cone Golgi function there.  Rather, DrPITPβ may indirectly coordinate 
lipid-derived signaling inputs in the synaptic pedicle with inner segment membrane dynamics 
(Fig. 10).  It is a reasonable proposition that the expensive outer segment biogenesis/renewal 
processes would somehow be coordinated with the synaptic activity of the double cone cell. 
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 Functional diversification of class1 DrPITPβ and DrPITPα isoforms 
The data report unexpectedly limited developmental functions for zebrafish DrPITPβs.  What 
level of functional redundancy exists between the various DrPITP isoforms?  From the 
perspective of DrPITPγ, no clear resolution to this question presents itself at this time.  DrPITPα 
and the DrPITPβ spliceoforms are functionally distinct, however.  The retina developmental 
phenotypes associated with DrPITPβ insufficiencies are manifest without overt interference with 
DrPITPα function.  Reciprocally, interference with DrPITPα activity results in an early and 
terminal developmental arrest in the face of DrPITPβ and DrPITPγ expression.  Taken together, 
the data are consistent with a growing body of evidence to indicate that the biological activities 
of individual PITPs are functionally specialized.  In that regard, it will be of considerable interest 
to determine the basis of developmental failure in DrPITPα morphants.  It also deserves special 
emphasis that the terminal phenotypes associated with class 1 mPITPα insufficiencies are 
dramatically different in mice as compared to zebrafish.  In contrast to the catastrophic early 
developmental failure observed in DrPITPα morphants, the cognate mouse nullizygotes develop 
to birth, and are born alive at Mendelian frequencies as anatomically correct neonates, but expire 
shortly thereafter (Alb et al., 2003).  Thus, the results reported herein only demonstrate that 
DrPITPα and DrPITPβ discharge very different functions during zebrafish development, but also 
that vertebrates utilize diverse biological strategies for the employ of paralogous class1 PITPs. 
 
Mechanistic implications for class1 PITP function in metazoans 
Finally, whatever the biological coupling may be for any individual class 1 mPITP, it is a 
common theme that these proteins interface with PtdIns kinases.  The data reported herein 
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provide new information pertinent to the mechanisms by which class 1 mPITPs potentiate PtdIns 
kinase activities.  Do class 1 mPITPs execute this stimulation via roles as bona fide transfer 
proteins (Wirtz, 1991), or do these proteins serve as nanoreactors in the fashion proposed for the 
Sec14-like PITPs (Ile et al., 2006)?  It is currently presumed that class 1 mPITPs are carrier 
proteins that supply membranes engaged in PIP signaling with PtdIns so that the signaling circuit 
can be recharged (Hsuan and Cockcroft, 2001).  This PtdIns supply model posits mPITP-
dependent transport of PtdIns from its site of synthesis in the ER to the signaling membrane, and 
that forward PtdIns flow is counterbalanced by back-transfer of PtdCho to close a vectorial 
phospholipid transfer loop.  There is no evidence to support such a vectorial transfer pathway in 
vivo, and the model poses the additional difficulty that it is effectively impossible to disprove. 
One distinction between PtdIns-supply and nanoreactor models, however, is that PtdIns surfeit is 
predicted to abolish requirements for mPITP-mediated PtdIns-supply mechanisms for 
stimulating PtdIns kinases.  By contrast, nanoreactor mechanisms for mPITP-mediated 
potentiation of PtdIns-kinases should be apparent under conditions of PtdIns excess.  That 
DrPITPs and mammalian class 1 mPITPs enhance PtdIns kinase activity in yeast (i.e. an 
organism whose bulk membrane PtdIns load is ca. 25% of total glycerophospholipid by mass; 
McGee et al., 1994) indicates class 1 PITPs can operate in nanoreactor mode.  Whether class 1 
mPITPs do so in their native setting is obviously more difficult to discern, and no final 
conclusion can yet be reached regarding this matter.  Nevertheless, the principle is established.  
The remarkable fact that vertebrate mPITPs evolved separately from yeast PITPs, yet can still 
productively stimulate yeast PtdIns kinase activities, demonstrates no privileged interaction is 
required between the PITP and the kinase for stimulation.  It now remains to decipher the larger 
developmental signaling pathways that interface with DrPITPβs and DrPITPα in zebrafish. 
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Figure legends 
 
 
Figure 4.1.  DrPITPβ and DrPITPγ isoforms.  A)  A ClustalW phylogenetic grouping of 
presumptive zebrafish DrPITPα, DrPITPβi1, and DrPITPγ is shown.  DrPITPγ scores as a PITPβ 
isoform.  B)  Zebrafish PITP cDNAs were subcloned into the multicopy yeast URA3 expression 
vector pDR195 where heterologous PITP gene expression is driven by a powerful constitutive 
promoter.  Each individual expression construct was transformed into the yeast strain CTY-1-1A 
(ura3-52, sec14-1ts).  Ten-fold dilution series were prepared from saturated liquid cultures 
normalized to similar cell densities and dilution spotted onto rich YPD solid media in parallel.  
One set of YPD plates was incubated for 48 hours at 30º (permissive for sec14-1ts) and 37ºC 
(restrictive for sec14-1ts). Both DrPITPβ isoforms and DrPITPγ phenotypically rescued growth of 
the sec14-1ts yeast strain at 37ºC.  C)  In vitro lipid transfer activities of presumptive zebrafish 
PITPβ-like proteins.  Transfer assays score mobilization of radiolabeled PtdIns, PtdCho, or SM 
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substrate between distinct membrane bilayer systems.  Clarified cytosol prepared from yeast 
strain CTY303 (sec14Δ cki1) expressing each protein of interest served as protein source.  
Cytosol from CTY303 carrying an empty vector served as a negative control, while 
corresponding cytosol containing rat PITPβi1 was included as a positive control.  The data 
shown is a single transfer assay, performed in triplicate that is representative of at least three 
independent experiments.  The phospholipid-transfer substrate inputs for these assays were: 
21,799 cpm [3H]PtdIns; 13,426 cpm [14C]PtdCho; 12,645 cpm [14C]SM;.  Background values 
(buffer control) for these respective transfer assays were 1324, 1404 and 1038 cpm.  D)  
Localization of zebrafish PITPβ-like isoforms in mammalian cells.  COS7 cells expressing GFP-
tagged versions of zebrafish PITPs were fixed, permeabilized, and stained with antibodies that 
detect the cis-Golgi (gm130; blue) and the ER (BiP; red).  Representative profiles for GFP 
expression or antibody staining are shown in the left panels, and the merged images are shown in 
the right panel. 
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 Figure 4.2.  PI synthesis in yeast (in progress)  (A) Isogenic yeast strains (sec14-1ts Δsac1) 
expressing empty vector (pDR195), pDR195 (Sec14), and the zebrafish PITPs (A; DrPITPα, 
DrPITPβi1, DrPITPβi2, and DrPITPγ) or the mammalian PITPs (C; RnPITPα and RnPITPβ and 
T59D mutants) were labeled to steady-state with 3H-inositol.  After a 3 hour shift to 37ºC, lipids 
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were extracted, separated by 1 dimensional thin layer chromatography, and quantified by 
densitometry (B, D). 
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 Figure 4.3.  Temporal and spatial expression of DrPITPβ and DrPITPγ.  A) DrPITPβ and 
DrPITPγ are expressed at all ages tested.  RNA was collected from zebrafish at 6 and 24 hours 
past fertilization (hpf), 6 days past fertilization (dpf), and from adult fish.  The RNA was reverse 
transcribed, and the respective cDNAs (template) amplified using primers directed against 
DrPITPβ, DrPITPγ, and actin sequences.  The amplified cDNAs reflect relative mRNA 
abundance in each sample, and amplification of products was both dependent on template and 
reverse transcriptase (RT).  B) In situ staining of DrPITPβ and DrPITPγ expression profiles.  In 
situ hybridization analyses were performed on 28 hpf fish using specific antisense probes for 
DrPITPβ and DrPITPγ mRNAs, respectively. Sense probes were used as negative controls, as 
were “mock” controls where probe was omitted.  Both DrPITPβ and DrPITPγ were expressed in 
a wide range of tissues throughout the adult fish, and DrPITPβ is most highly expressed in the 
eye.  C)  Characterization of DrPITPβ antibody.  Individual DrPITPs were expressed in yeast, 
lysates were prepared, resolved by SDS-PAGE, transferred to nitrocellulose, and probed with 
either anti-DrPITPβ serum (top panel) or a control pan-PITP antibody (bottom panel) as 
indicated.  To detect total PITPs in the eye, a blot with the same samples was probed with the 
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NT1/3 pan PITP antibody.  This blot indicates that at least 2 species of PITP are expressed in the 
zebrafish eye.  Protein extracts from zebrafish (Dr) or murine (Mm) eyes were also probed with 
these respective antibodies. 
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Figure 4.4.  DrPITPβ immunolocalization in the adult zebrafish retina. Panel A depicts an adult 
retina cryosection labeled with the anti-DrPITPβ immunoglobulin. The labeling is confined to 
the photoreceptor layer (PL) and the outer plexiform layer (OPL).  Panel B represents a negative 
control section labeled with pre-immune serum.  Panel C shows a double-label experiment using 
where profiles of DrPITPβ (green; anti-DrPITPβ antibodies) and the zpr-1 marker (red; mAb zpr-
3; labels the rod outer segments -- ROS) are visualized.  Panel D represents a double-label image 
showing staining profiles for DrPITPβ (red) and α-tubulin (green).  Panel E is a high 
magnification image of a DrPITPβ staining profile revealing the intense signal in the 
photoreceptor synaptic pedicles (arrows) in the OPL.  Panel F highlights the zpr-1 staining 
profile (visualized via the mAb zpr-1 antibody), which specifically marks double cone cells.  
Panel G is a merged double-label image comparing DrPITPβ (green) and zpr-1 staining profiles 
(red).  The data shown in panels F and G show were from frozen retinal sections.  Arrowheads in 
Panels F and G point to the double-labeled cone cell synaptic pedicles. Abbreviations: PL, 
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photoreceptor layer; INL, inner nuclear layer; GCL, ganglion cell layer; ROS, rod outer 
segments; OPL, outer plexiform layer; IPL, inner plexiform layer; DCOS, double cone cell outer 
segments. Scale bars are 50 μm in all panels except Panel E (25 μm). 
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 Figure 4.5.   DrPITPβ and the double cone cell-specific zpr-1 antigen co-localize in adult retina. 
Panels A-C depict dissociated double cone cells labeled both with anti-DrPITPβ serum and mAb 
zpr-1.  Panel A shows the DrPITPβ profile, Panel B the zpr-1 profile, and Panel C is a merged 
image.  Arrows identify double cone cell synaptic pedicles. Panels D-F show DrPITPβ and zpr-1 
staining profiles in retinal wholemounts at the level of cone cell synaptic pedicles.  Panel D 
depicts the DrPITPβ profile, Panel E the zpr-1 (i.e. double cone cell) profile, and Panel F the 
merge.  Arrows highlight the same individual labeled cone pedicles in each panel. There is 
perfect correspondence between DrPITPβ and zpr-1 signals at the level of double cone cell 
synaptic terminals. Scale bars -- 50 μm. 
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 Figure 4.6.  Reduced DrPITPβ expression results in loss of zpr1-staining.  A) Morpholinos 
(DrPITPβ -directed morpholinos 1 and 2, a 5 mismatch control version of βMO1, and a non-
specific negative control) were injected into 1-4 cell stage embryos.  Three days after 
fertilization, embryos were disrupted, solubilized in sample buffer, proteins resolved by SDS-
PAGE, and transferred to nitrocellulose.  Blots probed with anti-DrPITPβ immunoglobulin 
reveal that βMO1 and βMO2, but not the controls, depress DrPITPβ protein levels.  B-D) 
 176
Morphants were fixed at 3 dpf, embedded in OCT, and sectioned.  Sections containing retina 
were stained for B) DrPITPβ and zpr1 antigen, C) green opsin, or D) glutamine synthase.   
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 Figure 4.7.  DrPITPβ morphants present double cone cell structural defects. A)  Control and 
DrPITPβ morphants (3dpf) were fixed and dehydrated.  After embedding in Polybed 812 resin, 
3μm sections were cut and stained with 1:1 methylene blue:Azure II.  No gross structural defects 
are observed in morphant eye sections relative to control.  B)  Ultrathin sections were stained 
with uranyl acetate and lead citrate, and visualized by electron microscopy.  Outer cone cells are 
clearly recognized in the control by their well-formed and distinctive outer-segments (indicated 
by red arrows).  These structures are absent, or otherwise unrecognizable, in morphant retina.   
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 Figure 4.8.  Identification of zpr1 antigen as arrestin-3-like.  A) mAb zpr1 detects a ~50 kDa 
antigen in the adult zebrafish eye.  Lysate of adult zebrafish eye was fractionated by SDS-PAGE, 
the resolved species transferred to nitrocellulose, and zpr-1 antigen identified by immunoblotting 
with mAb zpr1.  B)  A 50 kDa species is immunoprecipitated from adult zebrafish eye lysates.  
The lysates were precleared by incubation with protein A beads and re-incubated with mAb zpr1 
and protein A beads.  Proteins bound to the beads were resolved by SDS-PAGE.  Two controls 
were included: sample without lysate, and sample without mAb zpr1.  The species indicated with 
an arrow was uniquely recovered from the complete incubation, and was excised for 
identification by mass spectrometry.  C)  The previously uncharacterized zpr1 antigen is arrestin 
3-like.  Open reading frames of the two candidates for zpr1 antigen identified by MALDI-TOF 
mass spectrometry, β-actin and arrestin-like 3, were subcloned into pET28, and expressed in 
bacteria.  Clarified lysates prepared from bacteria expressing each individual protein were 
resolved by SDS-PAGE, transferred to nitrocellulose, and blotted with mAb zpr1 or anti-actin 
immunoglobulin as indicated.  Lysates prepared from bacteria carrying the pET28 vector alone 
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served as negative control.  D) Arr3L morphants present reduced Arr3L immunoreactivity 
without affecting DrPITPβ expression. Embryos (1-4 cell stage) injected with morpholino 
against Arr3L, or the corresponding 5 mismatch control morpholino (MO5-M), were examined 
at 3 dpf for Arr3L, green opsin, and DrPITPβ staining.  E)  Arr3L morphants present normal 
outer segment morphologies.  Morpholino-injected embryos were fixed and prepared for ultra-
thin section electron microscopy.  Sections from at least 3 fish were examined and representative 
images are shown.  Outer segments are indicated with a red arrow.  F)  ARR3L gene expression 
is not impaired in DrPITPβ morphants.  Embryos were injected with morpholinos against 
DrPITPβ (DrPITPβ MO1 and MO2) or corresponding negative controls (MO5-M and non-
specific negative control).  RNA was collected by Trizol extraction from 3 of each of the 
morphant categories, RNA was reverse-transcribed, and PCR amplification of the resulting 
cDNA was performed using primers specific for ARR3L sequences.  DrPITPγ and Dr-actin 
sequences were amplified as normalization controls.  For all primer sets, a water control (“- 
cont”) was included.  A representative morphant data set is shown. 
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Figure 4.9.  DrPITPα morphants fail at an early stage of development.  A) Zebrafish embryos 
were injected with DrPITPα-directed (DrPITPα MO1) or corresponding 5 mismatch control 
(DrPITPα MO5-M) morpholinos at the 1-4 cell stage, and brightfield images were taken at the 
indicated hpf.  At 24 hours, images were also taken in the red fluorescence channel to identify 
embryos containing the lissamine-tagged morpholino.  B)  At 48 hours past fertilization, control 
and morpholino injected embryos were classified as viable or inviable based on visual 
inspection.  Data are from three independent experiments, and p-values relative to the uninjected 
control are indicated (* p>0.1; ** p<0.02). 
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 Figure 4.10.  DrPITPβ function in double cone cell outer segment biogenesis and maintenance.   
(I)  DrPITPβ cooperates with a PtdIns 3-OH kinase to promote PtdIns-3-phosphate production on 
the outer segment.  PtdIns-3-phosphate serves as a landmark on the outer segment membrane 
that facilitates SARA-regulated docking and fusion of opsin-containing vesicles to the outer 
segment (acceptor compartment).  (II)  DrPITPβ cooperates with what would likely be a PtdIns 
4-OH kinase, at the level of the double cone cell Golgi complex, to promote formation of opsin-
 183
containing vesicles that will ultimately fuse to outer segment discs in a SARA-regulated manner.  
(III)  DrPITPβ regulates signaling in the synaptic pedicle and the robustness of this signaling is 
transduced from the synaptic pedicle to outer segments.  In this model, DrPITPβ may promote 
formation/fusion of synaptic vesicles and, in the absence of proper synaptic signaling, the outer 
segment of the cone cell is not maintained.  In all three scenarios, Arr3L protein stability is 
suggested to be dependent on its association with functional outer segments. 
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 Supplementary Figure S1 (Figure 4.11) – All PITP isoforms are expressed in the adult 
zebrafish eye.  Total RNA was extracted from an adult zebrafish eye, and reverse transcribed 
into cDNA.  PCR amplification was performed with primers specific for DrPITPα, DrPITPβi1, 
DrPITPβi2 or DrPITPγ sequences. 
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 Supplementary Figure S2 (Figure 4.12) – Blue opsin and rhodopsin expression are unaffected 
in DrPITPβ morphants.  Zebrafish embryos injected with negative control morpholino or 
DrPITPβ MO1 were fixed, embedded, and cryosectioned at 3 dpf.  Sections through the center of 
the retina were stained for zpr1 and the rod cell opsin (rhodopsin) (left panels), or the single cone 
cell marker blue opsin (right panel).  Blue opsin and rhodopsin staining are present in both 
control and morphant eye sections, while mAb zpr1-staining is seen only in the control. 
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 Supplementary Figure S3 (Figure 4.13) –  At 5dpf, DrPITPβ morphants display no defects in 
electroretinograms (ERGs) measuring their response to light.  Zebrafish embryos were injected 
at the 1-4 cell stage with control or DrPITPβ morpholinos, and the ERG was performed at 5 dpf.  
Following a flash of light, recordings from all of the fish indicated a rapid response (“b-wave”) 
of similar magnitudes followed by a recovery to baseline.  Data are representative of at least 10 
ERGs performed on 2 sets of morphants. 
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 Supplementary Figure S4 (Figure 4.14) –  MAb zpr1 only detects Arr3L, and not other retinal 
and ubiquitously expressed arrestins.  The open reading frame of ARR3L and five additional 
zebrafish arrestins were PCR amplified from an adult zebrafish cDNA library with primers also 
encoding an HA epitope-tag.  The PCR products were subcloned into a yeast expression vector 
(pDR195) and transformed into yeast.  Lysates were prepared from the resulting yeast strains, 
lysate proteins were separated by SDS-PAGE, transferred to nitrocellulose, and probed with 
mAb zpr-1 and anti-HA.  Though all of the arrestins were expressed (as detected by the HA 
antibody), only Arr3L was detected by mAb zpr1. 
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 primer name sequence (5' to 3') 
PITPalpha XhoI for AAACTCGAGATGTTGATAAAGGAGTTTCG 
PITPalpha SacII rev AAACCGCGGTCATTCATCTGCGGCAGACATCCC 
PITPbeta XhoI for AAACTCGAGATGGTGCTCATCAAGGAATATCG 
PITPbeta i1 SacII 
rev AAACCGCGGCTACTCTTCAGATGCTGTTGTGCCTC 
PITPbeta i2 SacII 
rev AAACCGCGGTCATTGTTCGTGAGCAGCACTGG 
PITPgamma XhoI 
for AAACTCGAGATGGTACTCATCAAGCAATACCAGG 
PITPgamma SacII 
rev AAACCGCGGCTAGTCCTCGCCCGCTTTCATCCC 
 
Supplementary Table S1 – Primers used to amplify zebrafish PITP structural genes. 
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 Supplementary Table S2 – MALDI-TOF mass spectrometry of 
mAb-zpr1 ligand.  The gel-purified polypeptide species 
specifically precipitated from the adult zebrafish eye by mAb 
zpr-1 (Figure 8) was submitted for analysis by mass 
spectrometry.  Two proteins were identified from tryptic digests 
of the submitted sample, and the summary analytical report is 
shown. 
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Chapter 5 - Discussion 
In the present work I addressed two main questions: 1) What is the function of metazoan 
PITPs and PITPβ in particular?  2) What distinguishes PITPβ from PITPα?  In this 
discussion, I will review my findings and present areas for further study.   
Distinction between PITPα and PITPβ in mammals  
 In Chapter 2, I addressed several factors that distinguish mammalian PITPα from 
PITPβ.  We were able to show that PITPβ localizes primarily to the trans-Golgi network 
(TGN) and that its localization is independent of the phospholipid-bound state of PITPβ. 
The question remains, however, of which features are essential for the unique properties 
of the molecule.  Based on known properties of PITPα and PITPβ, we hypothesized that 
either localization or binding of sphingolmyelin (SM) are the distinguishing features of 
PITPβ. SM is the major sphingolipid in mammals and is synthesized at the TGN from 
ceramide and phosphatidylcholine by sphingomyelin synthase.  A PITPβ loss of function 
system is necessary to test the importance of these features. 
PITPβ in mammalian cells 
 We have found that, in mammalian cells, PITPβ plays a role in maintaining the 
structure and anterograde trafficking function of the Golgi.  The reduction of PITPβ 
levels by siRNA ultimately leads to cell death.  The Golgi and trafficking phenotypes, 
along with known properties of PITPβ lead us to propose that PITPβ regulates lipid 
levels in the Golgi.  What role might PITPβ play in Golgi lipid regulation?   
With our recent development of an siRNA-mediated knockdown system for 
PITPβ in human cell lines (chapter 3), we are now in a unique position to address the role 
of PITPβ at the Golgi and in lipid regulation through the following questions: i) Are the 
individual phospholipid binding/ transfer activities and in particular the sphingomyelin 
(SM) transfer/binding activity essential properties of PITPβ?  To this end, we have 
generated PtdIns binding mutants that still retain their ability to bind PtdCho/SM and SM 
binding mutants that retain their ability to bind PtdIns and PtdCho (Chapter 2, Alb et al., 
1995; Tilley et al., 2004). ii) If both SM and PtdIns binding activities are individually 
required for PITPβ function, we can investigate whether SM and PtdIns lipid binding 
properties have to reside in cis in order to reconstitute a functional PITPβ. iii) How 
important is Golgi localization of PITPβ in order to rescue Golgi morphological defects 
and trafficking defects associated with lack of PITPβ?  The outcome of these questions 
will help us to understand the molecular mechanism by which PITPβ and metazoan 
PITPs in general might execute biological function.  
A requirement for lipid binding activities in cis (e.g. SM and PtdIns) would 
suggest that, similar to Sec14, PITPβ mediates a lipid exchange reaction in which one of 
the exchanged lipids becomes a better substrate for a downstream lipid-modifying 
enzyme. In the case of Sec14, an absolute requirement for binding of PtdIns and PtdCho 
in cis and cumulative evidence that Sec14 genetically interacts with PtdIns 4-OH kinases 
and is required for the biosynthesis of PtdIns(4)P led to a model in which PtdIns is 
presented to a PtdIns 4-OH kinase during an exchange reaction with PtdCho (Schaaf et 
al., 2008).  
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With regard to the function of PITPβ, we can only speculate at this point. Could 
PITPβ function in a similar manner to Sec14?  Is exchange of PtdIns with PtdCho or SM 
a prerequisite to make PtdIns vulnerable for PtdIns 4-OH kinase attack? Structurally, the 
PITPs and Sec14 molecules are distinct, and it would seem that PITPβ does not share the 
same mechanism of action with Sec14.  PtdIns, PtdCho, and SM bind in essentially the 
same site of the PITP molecules, unlike the distinct headgroup binding sites in Sec14. 
However, structural considerations - lipid close to the protein surface (as in the case of 
Sec14) versus deep ligand or different lipids with almost identical atomic coordination, as 
in the case of PtdIns, PtdCho and SM in PITPs, have limited significance as long as 
exchange intermediates and the topology of the exchange reaction remain unknown.  In 
addition, functional data in yeast indicate that, like Sec14, PITPs increase PtdIns(4)P 
levels, suggesting a potential role of PITPs to present PtdIns to a PtdIns 4-OH  kinase, at 
least in heterologous systems (Chapter 4).  
If PITPβ did have the lipid presentation mechanism of Sec14, likely presentation 
scenarios could either be that PITPβ presents PtdIns to PtdIns kinases like Sec14, or it 
presents PtdCho to SM synthase during a PL exchange reaction ultimately regulating 
DAG levels.  Presentation of SM to the SM synthase would decrease DAG levels and 
increase PtdCho levels, which is inconsistent with the functional data indicating a role for 
PITPβ in allowing trafficking from the Golgi, though of course this function cannot yet 
be ruled out.   
In order to fully investigate the presentation scenario proposed above, we would 
need to develop a PtdCho binding mutant of PITPβ.  Because the PtdIns and PtdCho 
headgroups bind at the same site of the PITP molecule and the PtdIns headgroup is larger, 
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it has so far been impossible to identify a PtdCho binding mutant.  Rescue experiments 
with the PtdIns and SM will still give important insight into the functions of these 
molecules.  For example, if both PtdIns binding/transfer and SM binding/transfer 
activities are individual required for PITPβ function, but, unlike Sec14 these binding 
activities can be combined in trans (e.g. by co-expression of different PL-binding 
mutants) to reconstitute a functional PITPβ, this result would be more indicative of an in 
vivo transfer role of PITPβ where vectorial transfer of substrate is required for biological 
function. An example for this reaction mechanism has been described for the ceramide 
transfer protein CERT (Hanada et al., 2003). In this latter case, vectorial transfer of 
ceramide from the ER to the Golgi to deliver the substrate for the SM-synthase is an 
essential property of the protein (Hanada et al., 2009). 
Future experiments to test whether the phenotypes in PITPβ siRNA-treated cells 
could be attributed to changes in lipid levels could be done by increasing levels of 
relevant lipids (through addition of membrane-permeable short chain lipids) to see if the 
Golgi phenotypes are rescued.  If increasing lipid levels rescued effects due to loss of 
PITPβ, a more direct role for PITPβ in presenting lipid could be tested in biochemical 
assays. A PtdIns-kinase assay has been established in our lab (Schaaf et al., 2008), and 
this assay or a similar assay with purified sphingomyelin synthase could be performed.  
SM-synthase performs the interconversion of PtdCho and ceramide with SM and DAG, 
so purified sphingomyelin synthase would be used to look at modification of either SM or 
PtdCho. 
Alternatively, alterations in lipid composition of PITPβ siRNA- treated cells 
could be analyzed. Experiments with lipid sensors did not show large scale changes in 
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lipid levels, but changes below the detection limits of the sensors could still affect 
trafficking.  Direct measurements of lipid composition of subcellular compartments 
would be helpful, however Golgi-membranes cannot be easily isolated without 
introducing artifacts during lipid extraction.  Measuring total cell lipid extracts might 
hide potentially significant alterations in Golgi PL composition.  A potential 
breakthrough in this regard might come from recent advances in immunoisolation 
procedures for recovery of specific membrane compartments combined with a novel 
quantitative shotgun lipidomics approach by improved mass-spectrometric techniques 
(Klemm et al., 2009).   
Rescue of loss of PITPβ-associated phenotypes 
A prerequisite to investigate the functional activity of mutant proteins is a 
functional rescue experiment in PITPβ siRNA-treated cells. First attempts to establish 
this rescue system failed. Potential reasons for the difficulties to rescue siRNA-treated 
cells are that the levels of the rescue protein are too high or too low.  Varying levels of 
expression have been tested, but perhaps all were outside the correct range.  Additionally, 
PITPβ may require specific control of its expression not provided by plasmid rescue.   
The total cDNA of PITPβ (with 5’ and 3’ UTR) is currently being cloned, with hopes that 
the UTRs will provide the additional level of expression regulation. The cell 
culture/siRNA system may not be the ideal system for rescue experiments, if, for 
example, the siRNAs interfere with proper expression of the rescue plasmids.  An 
additional weakness of the siRNA system is that not every cell has the same level of 
PITPβ knockdown, making it difficult to assess both phenotypes and rescue.  With these 
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limitations in mind, the mouse system may be a better system to both see phenotypes and 
perform rescue. 
The conditional knockout (or “floxed”) PITPβ mice or ES cells are an ideal 
system to address PITPβ function.  In Appendix A, I describe the construction of a vector 
where critical exons of PITPβ are flanked by loxP sites.  In the presence of the cre 
molecule, the DNA sequence between the loxP sites is excised by site-specific 
recombination.  The advantage of this system over the siRNA system is that PITPβ 
expression can be completely and irreversibly removed, and we can study what happens 
in a true “loss of function” situation.  In addition, because of the different mechanism and 
level of loss of PITPβ expression, rescue experiments may be more easily performed. 
PITPα and PITPβ in zebrafish 
Since the rescue experiments of PITPβ siRNA-treated cells proved to be difficult 
and are still in an somewhat initial state, we investigated PITP function in zebrafish, 
which has the advantages of a well established, effective method of reducing protein 
expression (morpholinos), and easy detection of early developmental defects. 
 We found that DrPITPβ expression is particularly strong in double cone cells of 
the zebrafish retina, and that the two DrPITPβ spliceoforms are collectively required for 
the biogenesis or maintenance of the outer segments of double cone photoreceptor cells 
in the developing retina.   Reduction of PITPβ levels by morpholino (MO) injection has 
no effect on the survival or gross morphology of the fish up to 3 dpf.  Effects are seen in 
the eye, but, based on the ubiquitous expression of PITPβ as shown by in situ 
hybridization, it seems possible that other organ systems might be affected as well.  In 
contrast, a minimal level of DrPITPα activity is essential for successful execution of 
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early developmental programs.  Zebrafish treated with PITPα MO arrest at ~10-12 hpf, 
and die by 48 hpf.  Unlike MmPITPβ, DrPITPα does not appear to be required for cell 
survival, since cells survive and divide for the initial stages of development.  In addition 
to PITPα and PITPβ homologues, zebrafish have an additional member of the soluble 
PITP cohort, which we’ve termed PITPγ.  So far, the function of DrPITPγ is unknown, 
though we hypothesize that it could perform the housekeeping function performed in 
mammals by MmPITPβ.  
Despite the similar lipid transfer properties of zebrafish and mammalian PITPα/β 
orthologue pairs, PITPα and PITPβ orthologues in zebrafish have very different 
functions than their mammalian counterparts, which suggests that functional differences 
between PITPα and PITPβ may depend on more than just localization and SM binding 
ability.  Further proof that biochemical properties and localization may not define the 
function of the PITPs comes from the identification of PITPγ, a novel PITP with the same 
properties of PITPβ.  Though its function has not yet been shown, PITPγ is unlikely to 
share the same specific function of PITPβ. 
Using zebrafish to understand PITPs 
 The ablation of PITPs in zebrafish provides unique loss of function phenotypes, 
and a new way to understand PITPs.  The early arrest phenotype of PITPα morphants is 
particularly interesting.  At the point of arrest, a number of key events are occurring in 
the development of the animal, including neural tube and tail bud formation.  Is PITPα 
involved in either of these events? To answer this question, the expression patterns of a 
number of developmental markers should be determined.  Key markers would be flh, a 
transcription factor involved in neural tube closure (Talbot et al., 1995); ntl, which is 
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required for both neural tube closure and tail formation; ph2α which is expressed at the 
time and site of tail bud formation (Komoike et al., 2005), and myoD, to determine if 
somites have begun to form (Pownall et al., 2002). 
The expression patterns of PITPα mRNA (http://zfin.org/cgi-
bin/webdriver?MIval=aa-fxallfigures.apg&OID=ZDB-PUB-040907-
1&fxallfig_probe_zdb_id=ZDB-CDNA-040425-1670) at later stages are consistent with 
sites of PITPα function in mouse (e.g. brain and intestine).  One possibility is that 
DrPITPα has similar roles to MmPITPα in adult fish, but has an additional role in a 
developmental process.  I propose to test this hypothesis by injecting a small dose of 
zebrafish PITPα mRNA (with silent mutations to make it resistant to the morpholino) 
along with the morpholino.  mRNA is generally degraded more quickly than a 
morpholino, thus the net effect would be an early “burst” of PITPα expression, followed 
by PITPα null conditions.  This experiment could give an initial idea of what 
processes/tissue systems PITPα is required for once the stage of the initial arrest is 
passed. 
Our findings are somewhat at odds with a work published by the Xiong group 
showing that PITPα morpholino injection leads to axon guidance defects.  Our results 
show that zebrafish injected with standard doses of PITPα morpholino do not survive to 
the stage indicated by (Xie et al., 2005).  However, this discrepancy might be simply 
explained by a dose dependent effect of MO application.  In our hands, zebrafish 
embryos that receive low doses of PITPα morpholino can survive for longer periods of 
time, and we hypothesize that these were the conditions that were employed in the work 
mentioned above.  If this is indeed the case, the finding would be consistent with recent 
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work carried out in mouse, where even 50-80% reduction of PITPα levels leads to 
neuronal phenotypes (Hamilton et al., 1997; Alb et al., 2003), M. Boukhelifa, 
unpublished data).  
The function of PITPγ remains an open and intriguing question.  Since MmPITPβ 
is essential in mammalian cells, and neither MmPITPα nor MmPITPβ are essential in 
zebrafish, we hypothesize that PITPγ could be essential in zebrafish.  Alternatively, 
another molecule (perhaps another less closely related member of the PITP family) might 
perform the function of the mammalian PITPβ in zebrafish.  We have attempted to study 
the function of PITPγ by morpholino knockdown. However, our results (lack of any 
phenotype) are difficult to interpret since we cannot assess knockdown efficiency (data 
not shown).  In future experiments, we would like to address the problem of assessing 
knockdown in one of two ways.  A splice site morpholino, which prevents proper 
splicing, and thus proper expression of a gene, could be employed, since efficiency of 
splice site morpholinos can be determined by RT-PCR.  Alternatively, a PITPγ-specific 
antibody could be generated. These antibodies could not only be used to investigate 
efficiency of the MO knockdown by western blot analyses but also (dependent on the 
quality of the antibody) to study the subcellular localization within zebrafish cells.  
If loss of PITPγ has an early embryonic lethal phenotype, it could serve as a good 
system to test rescue of PITP function in zebrafish. In contrast, the PITPβ morphant is 
not ideal for rescue experiments since injected (resistant) mRNAs will likely degrade by 
the time the eye phenotype is seen.  A PITP morphant with an early phenotype could be 
used to determine the essential functions of the PITP by employing localization mutants, 
PL-binding mutants and chimeras. 
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DrPITPβ in the zebrafish eye, like the MmPITPα in the mammalian intestine is 
an example of PITP function in a specialized system.  Interestingly, PITPs in the eye, the 
intestine, and the brain all function in polarized cell types with high membrane turnover 
requirements, suggesting a common function or mechanisms for the mammalian PITPα 
and the zebrafish PITPβ. 
Further studies of PITPβ in the zebrafish eye are complicated by the fact that 
morpholinos are only effective in the first several days of development, and the eye is 
difficult to study at this age.  To better understand the phenotype of PITPβ, and whether 
any other organs are affected, it would be useful to get or make a PITPβ knockout line.  
Libraries of zebrafish with viral insertions that can disrupt genes have been developed by 
Znomics (Portland, Oregon).  Several lines with insertions in the PITPβ gene are 
available. Even though insertions could only be identified in introns and promoter 
regions, they may be sufficient to disrupt gene expression.  If gene expression is indeed 
substantially reduced in these lines, we can not only investigate the effect of reduced 
PITPβ on the maintenance of the outer segments of double cone photoreceptor cells, but 
also ask whether these cells can develop at all in the absence of PITPβ.  Any potential 
impairment of cone cell formation or development could also be further investigated by 
electrophysiology, and we can confirm (or refute) whether the loss of double cone cells 
leads to a decreased electrophysiological response, as we would predict. 
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Appendix A: Mouse models of PITPβ 
Part I: Gene trap mouse 
Materials and Methods 
Cell culture 
 The following gene trap ES cells were ordered from the Sanger Institute for 
Genomic Research (SIGTR): AG0287, CD0139, AR0037, and AQ0491.  Gene trap and 
unmodified ES cells were cultured as described previously (Alb et al., 2002) in DMEM 
supplemented with 50 μg/mL Penn-Strep, 2 mM L-glutamine, 15% FBS, 1 mM sodium 
pyruvate, 1X non-essential amino acids, LIF, and β-mercaptoethanol. 
Gene trap cassette localization 
 Genomic DNA and cDNA were prepared from 60 mm dishes of ES cell line using 
the Qiagen AllPrep DNA/RNA mini kit.  PCR to determine the trapped exon was 
performed on gene trap ES cell cDNA with the βgeo1 reverse primer, and forward 
primers in exons 3-9 (sequences in Table m1).  The intronic insertion site of the gene trap 
was identified using the βgeo2 reverse primer and forward primers in intron 7 (relevant 
primer sequences shown in Table m1).  The PCR product of the i710500f and βgeo2 
reverse primers was sequenced to find the exact site of insertion. 
Injection of ES cells and identification of gene trap mice 
 ES cell injection was performed by the University of North Carolina Animal 
Models Core.  The AR0037 ES cell line was injected into E3.5 C57BL/6 embryos, which 
were implanted into pseudopregnant females.  Chimeric male progeny were mated to 
wild type females to identify males capable of germ line transmission.   
Results 
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Three gene trap ES cell lines target to intron 7 
 Though previous studies indicated that PITPβ was required for normal 
development, the knockout line was not ideal for screening embryos, and we have not 
been able to stage a careful analysis of the age of lethality.  Identifying the exact stage of 
lethality is critically important to our understanding of PITPβ’s function.  Very early 
embryonic lethality would suggest a housekeeping role for PITPβ, while mid-gestation 
lethality would indicate a specific developmental role for PITPβ.  I therefore attempted to 
create a new, easily screenable knockout model for PITPβ. 
Several companies and institutions have generated libraries of knockout mice 
using a method developed by Zambrowicz et al and Wiles et al (Zambrowicz et al., 1998; 
Wiles et al., 2000).  In this method a DNA cassette is electroporated into ES cells and 
will randomly incorporate into the genome.  The cassette contains a splice acceptor site, a 
neomycin resistance gene and a β-gal expression gene, followed by a transcription 
termination site.  In cells where the cassette inserts into an intron, the splice acceptor site 
diverts normal splicing, preventing expression of the wild type protein.  Instead, cells 
express a neomycin resistance gene and β-gal, permitting the screening of cells with a 
gene diverting insertion.  Reverse sequencing from the gene trap identifies the gene that 
is “trapped” by the insertion.  In addition to providing a “ready to use” knockout mouse 
model, these mice can be used to study expression patterns of a gene, since β-gal is 
expressed under the gene’s promoter. 
A search of the Sanger Institute Gene Trap Resource online database of available 
gene trap lines (http://www.sanger.ac.uk/PostGenomics/genetrap/) with PITPβ sequence 
found 5 lines reported to trap in PITPβ (search performed in August 2005).  One of these 
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lines with a reported insertion in intron 1 (line RRC161 from Bay Genomics) had been 
previously analyzed in the lab.  Despite a clear insertion site in intron 1 in the RRC161 
line, and consistent splice diversion in ES cells, the gene trap did not divert splicing in 
mice (Phillips, unpublished data).  Thus, this line cannot be used to create a knockout 
mouse model.  Of the remaining four lines, sequencing results on the SIGTR website 
indicated that the gene trap was after exon 6 for one line (CD0139) and after exon 7 for 
the other three lines (AG0287, AR0037, and AQ0491).  We ordered all four lines in order 
to confirm the site of gene trap insertion and choose the best line for our experiments.   
We first checked the ES cell cDNA to confirm that the splice trap interrupted the 
PITPβ gene.  The cell lines were expanded, and cDNA was prepared from a plate of the 
cells.  Using the 100f and 200f forward primers in exons 3 and 4 of PITPβ and a reverse 
primer in the gene trap, I amplified a clear band from three of the four ES cell lines 
(AG0287, CD0139, and AR0037).  PCR amplification from line AQ0491 cDNA using 
the 100f and 200f primers did not yield product, indicating that the gene trap does not fall 
in PITPβ (data not shown).  Thus, this line was not studied further.   
We then performed PCR analysis to confirm that the insertion diverts splicing 
after the reported exon.  PCR amplification with primer 400f from exon 7 of PITPβ 
yeilded product for all three lines, but primers 500f and 600f, from exon 8 and exon 9, 
respectively, do not yield product (Figure m1).  The gene trap in line CD0139 had 
previously been reported to fall in intron 6, but the PCR results indicate that the trap falls 
in intron 7.  This inconsistency was likely a consequence of poor sequencing on the 
SIGTR website where exon 7 was not detected. 
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Since the gene trap insertion lines allow expression of exons of a gene before the 
insertion site, we investigated whether the three exon 7 trapping lines would be suitable 
knockout models.  We examined which portion of PITPβ would be expressed in the three 
lines trapping after exon 7, and found that Exons 1-7 of PITPβ express 152 amino acids 
of the protein.  Based on previously published crystal structures(Yoder et al., 2001; 
Vordtriede et al., 2005), this fragment would not be expected to form a complete lipid 
binding pocket.  Thus, we expect that an intron 7 gene trap insertion would act as a 
knockout.  
Determination of the intronic location of gene trap in AR0037 
 It is necessary to identify the intronic site of the gene trap insertion in order to 
design a genomic DNA (gDNA) PCR screen that can efficiently identify gene trap 
heterozygous mice.  gDNA was prepared from the three PITPβ splice trap lines, and 
screened by PCR using reverse primers in the gene trap and forward primers in intron 7.  
Forward primers were designed at every 1-1.5 kb in the first 11.5 kb of the 21.7 kb intron 
7.  Only one line had the gene trap inserted within the first 11.5 kb: AR0037 (Figure m1).  
Forward primers i7 8500f, i7 9500f and i7 10500f but not i7 11500f gave products, and 
the products of the i7 8500f, 9500f, and 10500f primers increased by approximately 1000 
bp, as expected from the placement of the primers.  Sequencing of the i7 10500f  forward 
and gene trap reverse primer PCR product indicated that the gene trap was inserted 
around nt 10797 of intron 7, with much of the targeting vector present before the gene 
trap cassette.   
Based on the sequence information, I designed PCR screening primers.  The 
forward primer was the i7 10500f primer described above, and the reverse primers 
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(pGTOlxRr1 and pGTOlxRr2) were designed to fall in the pGTOlxr targeting vector, 
about 500 base pairs upstream of the PITPβ intron 7 insertion site.  The i7 10500f primer 
with both pGTOlxr reverse primers works on genomic ES cell DNA, providing two sets 
of primers that could be used to screen mice for the presence of the gene trap insertion. 
AR0037 ES cells generate chimeric mice but do not transmit through the germline 
 AR0037 ES cells were grown up and injected into E3.5 embryos by the UNC 
Animal Models core.  Two injections of separate batches of cells were performed, 
yielding 14 chimeric mice.  The chimeras were mated with wild type mice, and 12 of the 
14 chimeras produced offspring.  A total of approximately 50 litters of mice were born 
from matings of the chimeras, and none of these mice were agouti, indicating that 
germline transmission of the gene trap did not occur.  Possible reasons for the lack of 
germline transmission and future directions with the gene trap mouse project are covered 
in more detail in the discussion. 
 
Part II: Transgenic PITPα/β mouse 
Materials and Methods 
Creation of a targeting vector to modify PITPα BAC 
 A PITPα BAC was modified to replace its C-terminal tail using the techniques 
and vectors described in ((Liu et al., 2003)).  Three fragments were cloned into the pL452 
targeting vector: two flanking regions of PITPα and the coding sequence for the PITPβ 
C-terminal tail.  pL452 has two multiple cloning sites (MCSs) on either side of a floxed 
kanaymycin gene; the kanamycin gene allows for selection of integrated pL452.  
Flanking regions were cloned by PCR and inserted into MCS 1 and 2.  The PITPβ DNA 
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(encoding the C-terminal tail) intended for recombination into the BAC was synthesized 
by annealing of complementary primers that corresponded to 32 bp of PITPα intron 11 
followed by PITPβ exon 12 (up to the stop codon) and the 30 nt of PITPα after its stop 
codon (all relevant primers shown in Table m2).  This fragment was ligated into MCS2 of 
the PL452 vector (fig. m2). 
 The PITPα BAC was transformed into DY380 bacteria (DH10B [λc1857 (cro-
bioA< >tet)])(Liu et al., 2003).  Heat inducible recombination enzymes in the 
DY380/PITPα strain were induced by a 15 minute incubation at 42ºC before 
transformation of a linearized pL452 targeting vector.  The recombination enzymes 
promote homologous recombination between the pL452 and the BAC, and colonies 
where recombination had occurred were selected by growth on chloramphenicol (for the 
BAC) and kanamycin (for the recombined region of PL452).  Recombined colonies were 
then transformed into EL350 (DH10B [λc1857 (cro-bioA< >araC-PBADcre)]).  Activation 
of the arabinose-inducible Cre caused recombination of loxP sites and removal of the 
kanamycin cassette.  Removal of the kanamycin resistance gene was confirmed by the 
inability of streaked colonies to grow on 25 μg/mL kanamycin/25 μg/mL 
chloramphenicol plates.  Modified regions of the final PITPα/β BAC were sequenced to 
confirm that recombination had occurred correctly. 
Modification of PL452 to target PITPα PAC 
 In order to allow recombination in a kanamycin resistant PAC, PL452 was 
modified to replace the kanamycin resistance gene with a chloramphenicol resistance 
gene.  The chloramphenicol resistance gene (cat) was amplified from a pRIL plasmid 
(Stratagene, Cedar Creek, TX) with primers containing sites for BssHII and RsrII.  The 
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cat gene was inserted into the BssHI and RsrII sites, disrupting the coding region of the 
kan gene.  The colonies were screened for their ability to grow on chloramphenicol and 
not kanamycin. 
 The PITPα PAC (P1 clone 4232; a gift from Bruce Hamilton, University of 
California at San Diego) was targeted in the same manner as the BAC, except that where 
kanamycin was previously used, chloramphenicol was used instead, and vice versa. 
Injection and screening of PITPα/β mice 
 The BAC and PAC were separately injected into C57BL/6JxC3H hybrid 
pronuclei at the University of North Carolina Animal Models Core.  Potential transgenic 
animals were screened by PCR using a forward primer specific to the inserted region of 
the PITPβ tail (5′-cgtaagaagggttccgtccgaggcacgtcgg-3′), and a reverse primer in PITPα 
(5′-gcagataacttcctctcagcataacaagggac-3′). 
Results 
Generation of PITPα/β BAC 
 The C-terminal tail of PITPs is thought to play a critical role in their function.  
The C-terminal tail decreases the affinity of PITPα for membrane binding, and increases 
its rate of transfer.  In addition, crystal structures and biochemical data indicate a change 
in the position of the C-terminal tail upon binding to the membrane(Tremblay et al., 
1996; Yoder et al., 2001; Schouten et al., 2002; Tilley et al., 2004; Tremblay et al., 
2005).  One of the regions of highest divergence between PITPα and PITPβ is at the C-
terminal tail, and we recently showed that, in the context of a PITP molecule, the C-
terminal tail of PITPα and PITPβ is sufficient to determine their localization(Phillips et 
al., 2006).  Further, a reported interaction between PITPα (but not PITPβ) and the DCC 
 214
receptor occurs via the C-terminal region of PITPα (Xie et al., 2005).  Thus, we 
hypothesize that the C-terminal tail of PITPα is critical for some or all of the 
physiological roles of PITPα. 
In order to test the hypothesis that the C-terminal tail is critical for the function of 
PITPα, we created constructs that can be used to generate a PITPα/β transgenic mouse.  
In order to preserve as many of the regulatory regions of the gene as possible, the 
constructs were created in a PITPα BAC and PAC.  Bacterial artificial chromosomes 
(BACs) or P1 artificial chromosomes (PACs) contain up to 300 kb, therefore the entire 
genomic sequence of the gene (introns and exons), along with surrounding genomic 
sequence are present in the BAC/PAC. 
 The PITPα BAC/PAC was modified to contain the PITPβ tail using 
recombineering techniques(Liu et al., 2003).  In this technique, a targeting vector, containing 
the PITPβ C-terminal tail flanked by PITPα sequence, is used to recombine the PITPβ 
tail into the PITPα BAC/PAC. 
 The PITPα/β chimeric BAC was made and injected first, since the resistance of 
the BAC (chloramphenicol) was compatible with the resistances of the pL452 targeting 
vector (ampicillin and kanamycin).  The pL452 vector was linearized, and induced to 
recombine with the PITPα BAC.  The final PITPα/β BAC was confirmed by digests and 
sequencing, and submitted to the UNC Animal Models Core for injection into pronuclei.  
Screening of BAC PITPα/β transgenic mice yielded no positives 
 In order to determine whether mice have an integrated transgene, I developed a 
PCR screen using a forward primer in the PITPβ tail, and a reverse primer in the PITPα 
BAC.  This PCR screen could detect as little as 20 pg of BAC, even in the presence of 
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mouse tail DNA (Figure m2).  Three sets of injections with the BAC were done, with a 
total of 57 mice screened.  Despite control PCRs indicating that the DNA preparations 
were of good quality, the BAC could not be detected by PCR in any of the mice. 
Using a PAC to generate PITPα/β mice 
 Because of the large size of BACs, they sometimes do not integrate easily into the 
genome.  The UNC Animal Modles Core was also unsuccessful in recent injections of 
BACs for other labs, suggesting that BACs were not the best way to make this mouse.  
Our lab has successfully made transgenic mice in the Animal Modles Core using PACs 
(Alb et al., 2007), and so a PITPα  PAC was modified to contain a PITPβ tail. 
 Unlike the BACs, which are chloramphenicol resistant, PACs are kanamycin 
resistant.  Because the first step of the recombineering requires separate selection for both 
the targeting vector (which is kanamycin resistant) and the BAC/PAC, it impossible to 
use the same recombineering strategy for PACs.  To circumvent this problem, the 
targeting vector was engineered to contain a chloramphenicol resistance gene that 
disrupts the normal kanamycin resistance.  Recombineering was then performed as 
before, and the integrity of the PAC was confirmed. 
PAC mice 
 The PITPα/β PAC was injected into fertilized oocytes as before.  The same PCR 
screen was used to screen mice.  54 mice from 4 litters were screened, and none of the 
mice were positive for the transgene.   
One possible reason for the lack of transgenic mice is that the PAC is partially 
integrated and/or there is selection against expression of the PITPα/β chimera.  To 
determine if the PAC itself is present, primers in the PAC backbone were used to PCR 
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mouse tail gDNA.  Of the 10 gDNA samples tested with these primers, none were 
positive for the PAC backbone (data not shown).  This indicates a likely technical 
problem with injection of the PAC, rather than a specific problem with the targeted 
region of the PAC. 
 
Part III: Floxed PITPβ mouse 
Materials and Methods 
Generation of a floxed PITPβ targeting construct 
 Recombineering was used to clone genomic DNA into a plasmid, for use as a 
targeting construct.  Regions of DNA corresponding to nt 4607-5011 of intron 3 and nts 
2725-3119 of intron 7 of PITPβ were cloned into pBluescript.  The pBluescript/βintrons 
was linearized between the two genomic regions using the PstI site, and co-electroporated 
into the DY380 bacteria strain with a BAC containing PITPβ (number RP23 212N4).  
Recombination enzymes were activated as described earlier, and putative positive 
colonies were identified by screening for ampicillin resistance indicating that the 
pBluescript is intact.  Positives were then further screened by PCR using primers in the 
genomic region, and digestion for those that contained the entire genomic region from 
intron 3 to intron 7. 
 Two loxP sites and a neo cassette were incorporated into the genomic DNA 
region of the plasmid in the following way.  The neomycin reisistance gene was inserted 
in an orientation opposite to that of the PITPβ gene, since normal expression of neomycin 
did not occur when the gene was inserted in the forward direction (data not shown).  The 
first loxP site was included in a primer that amplified the 3’ end of a crippled neo 
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resistance gene (Tybulewicz et al., 1991).  Both the forward and reverse neo primers 
included KpnI sites, and the loxP/neo was ligated into a KpnI site in intron 3, and 
colonies were selected for those that had the loxP/neo ligated in the proper orientation.  
The second loxP site was created by synthesis of complementary primers corresponding 
to the loxP sequence: 5′- ATAACTTCGTATAGCATACATTATACGAAGTTAT -3′ 
with HpaI sites at both ends.  It was ligated into an HpaI site in intron 6 of PITPβ. 
 An hsv-tk gene was also included in the targeting construct to allow for negative 
selection.  The hsv-tk gene was amplified with primers containing NotI sites at both ends, 
and the hsv-tk was cloned into a NotI site in the pBluescript MCS 3’ to the targeting 
construct.   
The integrity of the plasmid was confirmed by digests with several different 
enzymes, which yielded bands of expected sizes.  To prepare the DNA for 
electroporation, 20-30 μg of the targeting construct was linearized with AhdI, 
precipitated, washed in 70% EtOH and resuspended in sterile water. 
Targeting ES cells 
 Approximately 2 x 107 ES cells were electroporated in the presence of linearized 
DNA using resistance of ∞, 250 μF capacity and 300 V.  Selection with 200 mg/mL 
G418 and 2 mM gangcyclovir was begun 24 hours after electroporation.  Colonies were 
clearly visible by 10 days after selection, and were picked and grown in individual wells. 
Screening ES cells for homologous recombination of floxed PITPβ 
 ES colonies were screened by Southern blot.  Genomic DNA was collected from 
p12 wells of ES cells using the Promega nuclei lysis and protein precipitation reagents.  
Approximately 10 μg of DNA was cut with SspI, separated on a 1.0% agarose gel, and 
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transferred to nitrocellulose membrane.  Probes corresponding to nt 768 to 1079 or 2728 
to 3004 of the floxed PITPβ targeting construct were PCR amplified and labeled by 
random primer extension with a 32P labeled dATP.  Standard Southern conditions for 
hybridization and washes were used (see ((Alb et al., 2002))), and blots were exposed on 
a phosphoimager screen for 2-7 days. 
Results 
An inducible knockout model of PITPβ 
 Previous evidence from our lab suggests that PITPβ is an essential protein in 
cells.  Homozygous null PITPβ mice do not survive to birth, and lethality likely occurs 
early in embryogenesis.  Unsuccessful attempts to make homozygous knockout ES cells 
suggest that loss of PITPβ may be lethal to cells.  Because it is difficult to assess cell 
lethality in a mouse model and difficult to get sufficient and reproducible knockdown by 
siRNA in cell culture systems, I created a genetic, inducible PITPβ knockout model.  In 
this system, exons 4-7 of PITPβ are flanked by loxP sites.  Upon treatment with the cre 
recombinase, the loxP sites recombine and intermediate regions are removed.  Exons 4-7 
encode regions of PITPβ that are likely critical for normal folding and function.  In 
addition, the removal of these exons causes a frame shift and an early termination of the 
PITPβ message.  Thus, after cre treatment, this model should serve as a functional 
knockout of PITPβ. 
While this model is made by genetic modification of mouse ES cells, its primary 
purpose is for study at the cellular level.  If PITPβ is essential, we can see the immediate 
effects of loss of PITPβ in cells leading up to cell death.  If PITPβ is not essential, we can 
still assess effects on the cell (such as changes in cell cycle, trafficking ability, etc.) after 
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acute loss of PITPβ.  Finally, should PITPβ prove to be not essential for cell growth, the 
cells can be used to generate a floxed-PITPβ mouse, and the role of PITPβ in various 
developmental stages and tissues can be assessed with cre containing mice. 
 An inducible knockout was created by homologous recombination of a targeting 
construct.  The targeting construct contained regions of PITPβ flanking a selection 
cassette and loxP sequences inserted before and after essential exons of PITPβ (Figure 3).  
The region for targeting was obtained by recombineering.  Small fragments 
corresponding to the 5′ and 3′ ends of the targeting regions were cloned into pBluescript 
(Stratagene, Cedar Creek, TX) and used to “capture” the entire targeting region from a 
PITPβ BAC.  loxP sites were inserted in intron 3 and intron 7, and a neo resistance gene 
was inserted in the reverse direction directly after the intron 3 loxP site.  An hsv-tk gene 
was ligated at the end of the targeting region. hsv-tk will not recombine into the genome 
if homologous recombination has occurred, and its presence causes sensitivity to 
gancyclovir, thus the insertion of hsv-tk provides a mechanism for negative selection. 
 The construct was linearized and electroporated into ES cells.  Positive selection 
was performed with G418 and gancyclovir was used for negative selection.  From five 
electroporations, a total of 289 colonies were isolated and screened.  Initially, primers and 
conditions to perform a PCR screen were tested.  Because of the large size of the 
fragment to be amplified (>4 kb), the PCR screen proved unreliable, and colonies were 
instead screened by Southern blot. 
 A southern blot strategy was developed where we could look for a 1.882 kb shift 
in a genomic fragment due to the integration of neo.  We cut genomic DNA with SspI 
which, in the targeted region of the genome, would yield a wild type fragment of 10.83 
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kbp.  If the targeting construct (with neo) recombined properly, the fragment would be 
12.712 kbp for one of the two copies of the genes.  The probe used to detect the genomic 
DNA fragments was PCR amplified from intron 3 of PITPβ.  This region is not in the 
targeting construct, but is within the same 10.83 kb SspI fragment. 
 Genomic DNA from the 289 ES cell colonies was digested, separated, transferred 
and probed.  We got clear Southern blot results for about 200 colonies, and only 2 
colonies had two bands of similar intensity and correct sizes.  Further screening with 
additional probes, however, indicated that these colonies were not correctly targeted.   
The low targeting efficiency of this construct (0.5%) is likely a result of the 
genomic localization of the PITPβ locus.  Screening of more colonies would likely yield 
a properly targeted, floxed PITPβ allele, however, because of results with siRNA in 
human cell lines, which addressed many of the same questions proposed for this project, 
the floxed PITPβ line was not pursued further. 
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Tables 
 
 
primer name primer sequence purpose 
β-geo1 from Jim Alb rev screen in gene trap 
cassette 
β-geo2 from Jim Alb rev screen in gene trap 
cassette 
β 100f aactggtggtggagaaggaa cDNA forward primer 
β 200f gagaagggacagtacacac cDNA forward primer 
β 400f aaaccgttgaaattgtccac cDNA forward primer 
β 500f gaccctgcattattccattcagtc cDNA forward primer 
β 600f aagtggtgggggctgcagag cDNA forward primer 
i7 n1f gtgagtactccttgatgtgtccc intron 7 forward primer 
i7 1500f gaaggagtgttcctctttctcc intron 7 forward primer 
i7 3000f ggctactggtttgctgtagattgc intron 7 forward primer 
i7 4500f gtggtgtgttgaagtctcccac intron 7 forward primer 
i7 5500f gagttgaaaatcttcattctc intron 7 forward primer 
i7 6500f gccctcccggatgtctggagcc intron 7 forward primer 
i7 7500f ggtggcatcagccaagcctgggc intron 7 forward primer 
i7 8500f ctgggtgccgtttcactgcgtgtgc intron 7 forward primer 
i7 9500f gtcaggaccaccactgtgcatgccc intron 7 forward primer 
i7 10500f ccttctgaaggcagcagaaccatcc intron 7 forward primer 
i7 11500f cggttaggggcattgtgtcgatgcc intron 7 forward primer 
pGT0lxr rev 1 GCTGAGGATGAGGGAGCAG
GGC 
reverse in gene trap vector, 
for mouse screening 
pGT0lxr rev 2 CCCGGCGCTCTTACCAAAGG
GC 
reverse in gene trap vector, 
for mouse screening 
 
Table A.1- Primers used for characterization of Gene trap Mouse 
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primer sequence purpose 
gen1 5′ 
SacII 
AAACCGCGGGAGGTGGGTGGATTTCTGGG
TTTG 
cloning PITP alpha 
region of homology 
gen1 3′ 
NotI 
AAAGCGGCCGCGCTTTTGTTGCTGATGGA
ACTTTACC 
cloning PITP alpha 
region of homology 
gen2 for 
EcoRI 
AAAGAATTCCTTTCAATTTCCTTCTGCTTT
TTCTGTTGCAGATGCGTAAGAAGGGTTCC
GTCCGAGGCACGTCGGCTGCTGATGCCTA
GCGC 
PITPbeta tail with 
PITPalpha intronic 
DNA 
gen2 rev 
BglII 
AAAAGATCTGGTACTTACAGTGCAGAAAG
GGCGGTGGCGCTAGGCATCAGCAGCCGA
CGTGCCTCGGACGGAACCCTTC 
PITPbeta tail with 
PITPalpha intronic 
DNA 
gen3 5′ 
BglII 
AAAAGATCTGAGCTGTTGTCAGTGGGCTT
GGGTCCTC 
cloning PITP alpha 
region of homology 
gen3 3’ 
SalI 
AAAGTCGACGCCTAGCTAGCACGCACACA
GGCCTGGGTG 
cloning PITP alpha 
region of homology 
 
Table A.2 – Primers used for construction of BAC/PAC transgenic 
mouse 
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Figures 
 
 
 
Figure A.1 – Three out of four PITPβ gene trap lines trap after exon 7. (A) A 
schematic of the gene trap indicates the critical features of the gene trap and several of 
the key primers (green text).  Introns, exons, and primer locations are not drawn to scale.  
(B)  Using forward primers in the PITPβ cDNA and a reverse primer in the gene trap 
(βgeo1), PCRs indicated that the gene trap fell within intron 7 (i.e. trapped after exon 7).  
(C) PCR reactions with forward primers in intron 7 and a reverse primer in the gene trap 
(βgeo2) showed that the gene trap in line AR0037 fell in the region of nt 10500-11500.  
Sequence analysis of the i710500 and βgeo2 PCR product indicated that the insertion site 
was around nt 10797. 
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 Figure A.2- A BAC/PAC was modified by recombination techniques to create a 
transgenic PITPα/PITPβ mouse.  (A) A diagram of the PITPα and targeting plasmid 
are shown with introns indicated as a line (BAC/PAC) or in gray (targeting diagram), and 
exons in darker blue (PITPα) or yellow (PITPβ).  The three fragments that were cloned to 
create the targeting construct are indicated by blue Roman numerals, and arrows indicate 
primers used to PCR screen animals carrying the transgene. (B) A PCR screen was 
developed to screen for animals carrying the transgene using primers indicated by arrows 
in part A.  This PCR was sensitive and specific, picking up a band of the expected size 
from 20 pg BAC/PAC in the presence of mouse tail DNA. 
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Figure A.3 – A targeting vector to create a conditional PITPβ knockout mouse is 
constructed.  (A) The targeting region of the PITPβ targeting construct is composed of a 
genomic region starting in intron 3 and ending in intron 6.  loxP sites, indicated in blue, 
were inserted in intron 3 and intron 6.  A neo cassette (yellow) was inserted after the loxP 
site in intron 3.  (B) A typical Southern blot for screening ES cell colonies.  Genomic 
DNA is prepared from colonies grown in 12 well plates, and digested with SspI.  The 
blotted DNA is probed with a fragment of PITPα that is outside of the targeting construct.  
In this Southern, there are several samples with multiple bands, but only one of them 
(142) has bands of equal intensity and of approximately the correct sizes.  Further testing 
of this line indicated that it was not targeted. 
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Appendix B: Record of Plasmids generated 
 
Part I: pRE plasmids 
 
pRE 
number 
previou
s name 
short name resista
nce 
description 
empty vectors 
pRE 1300 KI111 EGFP N1 Kan clonetech, EGFP at C-
terminus of protein 
pRE 1301 KI102 EGFP C2 Kan EGFP at N-terminus of 
protein 
pRE 1302 KI103 pBluescript SK +/- (pSK) Amp 
pRE 1303 KI117 BL21 Cam Codon-Plus RIL - for 
protein expression 
(isolated from BL21) 
pRE 1304 KI234 RSVrev (LL) Amp plasmid required for 
lentilox virus 
expression 
pRE 1305 KI235 RRE (LL) Amp " 
pRE 1306 KI236 vsv-g (LL) Amp " 
pRE 1307  pLL5.0 Amp 
pRE 1308  pCMV-HA Amp 
pRE 1309  pCDNA3.1 Amp 
pRE 1310  pDsRed-N1 Kan 
pRE 1311  pML2 mCherry N1 
pRE 1312  pL452 Amp 
  
mammalian PITPbeta mutants (in pEGFP-N1 unless otherwise specified; mutants 
made in betai1 (beta trad) unless otherwise specified) 
pRE 1313 KI200 PITPbeta i1-GFP Kan rat PITPbeta in pEGFP-
N1 (C-terminal GFP) 
pRE 1314 KI201 PITPbetai2-GFP Kan alternative spliceoform 
of pitp beta from 
mouse, C-term GFP 
pRE 1315 KI206 ratPITPbeta i1-mCherry Kan rat beta with mCherry 
at C-terminus of 
protein 
pRE 1316 KI207 mousePITPbetai2-mCherry Kan rat beta alt with 
mCherry at C-terminus 
of protein 
pRE 1317  GFP betai1 CT Kan 
pRE 1318 KI202 GFP-beta 2CT Kan last 2 helices of PITP 
beta (trad), N-term 
GFP 
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pRE 1319  PITPbetai1 W202A Kan 
pRE 1320  PITPbetai1 W203A Kan 
pRE 1321  PITPbetai1 
WW202/203AA 
Kan 
pRE 1322  PITPbeta L224F Kan 
pRE 1323  PITPbeta I220L L224F Kan 
pRE 1324 KI302, 
pRE779 
ratPITPbeta T58D Kan pRE779; T58D 
introduced in 772 
pRE 1325  PITPbeta F107A Kan 
pRE 1326  PITPbeta FF107/108AA Kan 
pRE 1327  human PITPbeta Kan 
pRE 1328  PITPbeta box 1,2,&3 to 
alpha 
Kan 
pRE 1329  pRE 955 Kan aaab hybrid in EGFP-
N1 (mislabeled in old 
stock list) alpha aas 1-
182, beta aas 183-272 
pRE 1330  pRE 956 Kan bbba hybrid in EGFP-
N1 (mislabeled in old 
stock list) beta aas 1-
181, alpha aas 182-272 
  
pRE 1331 KI232 PITPbetai1/IRES/GFP in 
pEGFPN1 background 
Kan bicistronic expression 
of beta and GFP in high 
expression pEGFP/N1 
backbone. 
pRE 1332 KI233 PITPbetai2/IRES/GFP in 
pEGFPN1 background 
Kan same as above.  Cloned 
from pLL5.5 with __ 
and NotI into pEGFP 
pRE 1333  PITPbetai1/IRES/mCherry 
in pEGFP backbone 
Kan bicistronic expression 
of beta and mCherry in 
high expression 
pEGFP/N1 backbone. 
pRE 1334  PITPbetai2/IRES/mCherry 
in pEGFP backbone 
Kan bicistronic expression 
of beta and mCherry in 
high expression 
pEGFP/N1 backbone. 
  
pRE 1335 KI301 si-resistant rat beta Kan 4 silent mutations to 
make 772 resistant to 
siRNA 
pRE 1336 KI303 ratPITPbeta T58D (pRE 
779), si-resistant 
Kan 4 silent mutations 
pRE 1337 KI304 SM-mut si-resistant 
(I220L,L224F) 
Kan 4 silent mutations 
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pRE 1338 KI305 955 si-resistant Kan 4 silent mutations 
pRE 1339 KI306 mbeta-alt si-resistant Kan 4 silent mutations 
pRE 1340  PITPbeta/alpha (box 1,2,3 
to alpha) si-resistant 
Kan 4 silent mutations 
pRE 1341  956 si-resistnat Kan 4 silent mutations 
  
pRE 1342 KI307 PITPbeta/WW202,203AA, 
T58D 
Kan in pEGFP 
pRE 1343 KI308 PITPbeta/WW202,203AA, 
221,224 (SM) muts 
Kan in pEGFP 
pRE 1344 KI309 beta/alpha/T58D Kan in pEGFP 
pRE 1345  beta/alpha WW202,203AA Kan 
pRE 1346  beta W203A T58D Kan 
pRE 1347  beta W202A T58D Kan 
pRE 1348  beta/alpha SM Kan 
pRE 1349  beta/alpha L224F Kan 
  
pRE 1350  PITPbeta QDPK T58D Kan 
pRE 1351  PITPbeta KQE T58D Kan 
pRE 1352  PITPbeta MTD T58D Kan 
pRE 1353  PITPalpha KGSR to KGPR Kan 
pRE 1354  PITPalpha KGSR to 
KGAR 
Kan 
pRE 1355  PITPalpha KGSR to 
KGER 
Kan 
  
myc plasmids from 
Scott 
pRE 1356  myc-PITPalpha Amp 
pRE 1357  myc-PITPalpha KGSR Amp 
pRE 1358  myc-PITPbeta Amp 
pRE 1359  myc-PITPbeta S262A Amp 
pRE 1360  myc-PITPbeta S165A 
S262A 
Amp 
pRE 1361  myc-PITPbeta QDPK Amp 
pRE 1362  myc-PITPbeta S165A Amp 
  
pLL 
plasmids 
 
pRE 1363  pLL4.0/sh4/ratPITPbeta i1 Amp 
pRE 1364  pLL/sh4/mousePITPbeta i2 Amp not sure whether these 
are in pLL4.0 or 5.0 
pRE 1365  pLL/sh4/PITPalpha/beta Amp " 
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pRE 1366  pLL/sh4/PITPbeta/alpha Amp " 
pRE 1367  pLL/sh4/PITPbeta T58D Amp " 
pRE 1368  pLL/sh4/PITPbeta I220L 
L224F 
Amp " 
pRE 1369  pLL/sh3/ratPITPbeta i1 Amp " 
  
zebrafish plasmids 
pRE 1370  pEGFP/zfPITPalpha Kan 
pRE 1371  pEGFP/zfPITPbetai1 Kan 
pRE 1372  pEGFP/zfPITPbetai2 Kan 
pRE 1373  pEGFP/zfgamma Kan 
pRE 1374 KI210 myoD Amp from Suk-Won for in 
situ control; cut with 
XbaI to linearize 
pRE 1375 KI211 zfPITPbeta in pGEM Amp isoform 2, no 
restriction sites added; 
in ISH antisense 
direction (gene in same 
direction as T7 
promoter) 
pRE 1376 KI212 zfPITPbeta in pGEM Amp isoform 2, no 
restriction sites added; 
in ISH sense direction 
(gene in opposite 
direction to T7 
promoter) 
pRE 1377 KI213 zfPITPgamma in pGEM Amp cloned into pGEM 
using SalI/SacII 
(XhoI/SacII for vector, 
so SalI and XhoI sites 
lost); in ISH sense 
direction (gene in 
opposite direction to T7 
promoter) 
pRE 1378 KI214 zfPITPgamma in pGEM Amp no restriction sites 
added; in ISH antisense 
direction (gene in same 
direction as T7 
promoter) 
pRE 1379 KI230 pET28/zf actin Kan candidate for zpr1 
antigen - not actual 
antigen 
pRE 1380 KI231 pET28/zf arrestin-like 3 Kan zpr1 antigen. cloned 
using pET28 his sites, 
so 6 His tags 
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pGEM  
pRE 1381  pGEM (empty) Amp 
pRE 1382  pGEM/COS7beta Amp 
pRE 1383  pGEM/KanMX Amp 
pRE 1384  pGEM/loxP Amp 
pRE 1385 KI203 pGEM/HpaI_loxP (6) Amp loxP flanked by HpaI 
sites 
pRE 1386  pGEM/human PITPbeta Amp 
  
protein expression plasmids 
pRE 1387 KI229 pET28 Kan for protein expression 
pRE 1388  pET28/ratPITPalpha Kan 
pRE 1389  pET28/ratPITPbetai1 Kan 
pRE 1390  pET28/ratPITPbetai2 Kan 
pRE 1391  pET28/ratPITPalpha C95A Kan 
pRE 1392  pET28/ratPITPbetai1 
C94A 
Kan 
  
Drosophila plasmids  
pMT:Drosophila 
expression, 
metallothionein 
promoter; see 
Invitrogen catalog 
number: V4120-20 
(modifed by Steve 
Rogers) 
pRE 1393  pMT Amp Modification from 
Steve: EcoRI-GFP-
NotI, EcoRI ACC delta 
TG 
pRE 1394  pMT/ratPITPbeta i1 Amp 
pRE 1395  pMT/mouse PITPbeta i2 Amp 
pRE 1396  pMT/vibrator Amp 
pRE 1397  pMT/vibrator WF to AA Amp 
pRE 1398  pMT/vibrator G262D, 
R265K 
Amp 
pRE 1399  pGEM/vibrator (with stop 
codon) 
Amp 
pRE 1400  pGEM/vibrator G262D, 
R265K 
Amp 
  
floxed PITPbeta 
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mouse 
pRE 1401 KI219 pSK/floxed beta v4.28 Amp neo in reverse, loxP at 
3' of gene, works for 
targeting 
pRE 1402 KI108 pPNT targeting vector; has 
crippled neo and hsv-
tk; 
http://www.med.umich.
edu/tamc/mta.html#pP
NT 
pRE 1403 KI109 neo KpnI (pRE 561) Amp crippled neo for 
homologous 
recombination 
  
PITPalpha/beta BAC and PAC 
pRE 1404 KI204 pSK/beta_gen2 Amp genomic fragment for 
recombineering 
pRE 1405 KI205 pSK/beta_gen3 Amp second genomic 
fragment for 
recombineering 
pRE 1406 KI209 BAC B4 in DY380 Cam a PITPalpha BAC 
recombineered so that 
the C-terminal tail is 
beta (last alpha exon 
replaced with last beta 
exon) 
pRE 1407 KI215 pL452/cat 8 Amp, 
Cam 
cat (chloramphenicol 
resistance gene) cloned 
into Kan.  Vector is 
now resistant to cam, 
but not Kan (for 
recombineering into 
PACs 
pRE 1408 KI216 pL452/cat 11 Amp, 
Cam 
same as above 
pRE 1409 KI217 pL452/gen1,2,3 cat 4 Amp, 
Kan 
targeting construct for 
alpha BAC 
pRE 1410 KI218 pL452/gen1,2,3 cat 13 Amp, 
Cam 
same as 1408/1409, 
except with sequence to 
make alpha/beta hybrid 
PAC 
pRE 1411 KI220 PI4232 in DY380 Kan PITP alpha PAC 
pRE 1412 KI221 PI4232 in DY380 Kan 
pRE 1413  PAC B_ (in DH5alpha) 
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lipid 
markers 
 
pRE 1414 KI227 pML2-FAPP-PH Amp from Lydia, mCherry 
pRE 1415  TAPP1-GFP Kan from Amelia Lindgren 
pRE 1416  GRP-GFP Kan from Amelia Lindgren 
pRE 1417  PLCdelta-GFP Kan from Amelia Lindgren 
pRE 1418  FAPP1-GFP Kan from Amelia Lindgren 
pRE 1419  GFP-PKD-CRD Kan mine - see chapter 3 
pRE 1420  PLC-PH-GFP Kan? from Scott 
pRE 1421  PLD-PH-GFP Kan? from Scott 
  
other 
vectors 
 
pRE 1422 KI224 PKD1-KD Amp PKDs with dominant 
negative kinase dead 
mutations, human? 
from Vivek Malhotra, 
tubulates Golgi? 
pRE 1423 KI225 PKD2-KD Amp 
pRE 1424 KI226 PKD3-KD Amp 
pRE 1425 KI228 vsvg-mCherry Kan? from Lydia, cloned 
from vector from Sima 
Lev, ts mutation 
  
more mammalian PITPbeta muts 
pRE 1426  betai2 CT Kan 
pRE 1427  betai2 2CT Kan 
pRE 1428  betai2 2CT S262P Kan 
pRE 1429  772-1 IL220,224LF Kan C-term box 1, 2 or 3 to 
alpha and SM muts 
pRE 1430  772-2 IL220,224LF Kan " 
pRE 1431  772-3 IL220,224LF Kan " 
pRE 1432  772-1 E247K Kan C-term box 1, 2 or 3 to 
alpha and PI muts 
pRE 1433  772-2 E247K Kan " 
pRE 1434  772-3 E247K Kan " 
pRE 1435  pEGFP/PITPbetai1 K105A Kan 
pRE 1436  pEGFP/PITPbetai1 K201A Kan 
pRE 1437  pEGFP/PITPbetai1 
KK201,208AA 
Kan 
pRE 1438  pEGFP/PITPbetai1 F71A Kan 
pRE 1439  pEGFP/PITPbetai1 
VR72,73AA 
Kan 
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pRE 1440  pEGFP/PITPbetai1 
MI74,75AA 
Kan 
pRE 1441  pEGFP/PITPbetai1 
W202A 
Kan 
pRE 1442  pEGFP/PITPbetai1 
W203A 
Kan 
pRE 1443  pEGFP/PITPbetai1 
MI74,75AA 
WW202,203AA 
Kan 
pRE 1444  pEGFP/PITPbetai1 
WW202,203II 
Kan 
pRE 1445  pEGFP/PITPbetai1 
WW202,203FF 
Kan 
pRE 1446  pEGFP/PITPbetai1 KQE 
(box 1) WW202,203AA 
Kan 
pRE 1447  pEGFP/PITPbetai1 KQE 
(box 1) WW202,203FF 
Kan 
pRE 1448  pEGFP/PITPbetai1 QDPK 
(box 2) WW202,203AA 
Kan 
pRE 1449  pEGFP/PITPbetai1 QDPK 
(box 2) WW202,203FF 
Kan 
pRE 1450  pEGFP/PITPbetai2 C270D Kan 
pRE 1451  pEGFP/PITPbetai2 S267A Kan 
pRE 1452  pEGFP/PITPbetai2 
CDD270-272DA 
Kan 
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Part II: pCTY plasmids (yeast expression) 
 
pCTY 
number 
previous 
name 
short name resista
nce 
description 
pCTY2025 pCTY1079 yEP/pSec14/PITPbeta Amp high copy 
plasmid with 
Sec14 promoter 
pCTY2026  1079/WW201,202AA Amp  
pCTY2027  1079/WW201,202II Amp  
pCTY2028  1079/WW201,202FF Amp  
pCTY2029  1079/MI74,75AA Amp  
   
pCTY2030 pCTY1095 yEP/pPGK/PITPbeta Amp high copy 
plasmid with 
PGK (strong) 
promoter 
pCTY2031  1095/WW201,202AA Amp  
pCTY2032  1095/WW201,202II Amp  
pCTY2033  1095/WW201,202FF Amp  
pCTY2034  1095/MI74,75AA Amp  
pCTY2035  1095/L224F Amp  
pCTY2036  1095/I220L Amp  
     
pCTY2037  pPGK/PITPbetai2 Amp  
pCTY2038  pPGK/human PITPbeta Amp  
     
pCTY2039 pCTY1096 yEP/pPGK/PITPalpha Amp high copy 
plasmid with 
PGK (strong) 
promoter 
pCTY2040  1096/L221I Amp  
pCTY2041  1096/C95A Amp  
pCTY2042  1096/F225L Amp  
    
pCTY2043 pCTY1080 yEP/pSEC14/PITPalpha Amp high copy 
plasmid with 
Sec14 promoter 
pCTY2044  pCTY1080/WW202,203
AA 
Amp 
     
pCTY2045  PITPalpha 
WW202,203AA 
Amp in unknown 
yeast expression 
vector 
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(probably 
yEP/pPGK) 
pCTY2046  pCTY1109/WW AA Amp 
pCTY2047  pCTY1092/WW AA Amp 
   
pCTY2048  yCP lac 33-1 Amp empty vector 
pCTY2049  yEPlac 195 Amp 
   
pCTY2050  pDR195 Amp 
pCTY2051  pDR195/PITPbeta i1 Amp 
pCTY2052  pDR195/PITPbeta i2 Amp 
pCTY2053  pDR195/PITPbetai1 
C95A 
Amp 
pCTY2054  pDR195/human 
PITPbeta 
Amp 
  
pCTY2055  pDR195/alpha Amp 
pCTY2056  pDR195/alpha GFP Amp from Emily 
pCTY2057  pDR195/alpha LL GFP Amp from Emily 
pCTY2058  pDR195/alpha C95A 
225C 
Amp 
   
pCTY2059  yEPlac195/beta-GFP Amp 
   
pCTY2060  pDR195/zebrafish 
PITPalpha 
Amp 
pCTY2061  pDR195/zebrafish 
PITPbeta i1 
Amp 
pCTY2062  pDR195/zebrafish 
PITPbeta i2 
Amp 
pCTY2063  pDR195/zebrafish 
PITPgamma 
Amp 
pCTY2064  pDR195/zebrafish 
PITPalpha T58D 
Amp 
pCTY2065  pDR195/zebrafish 
PITPbeta i1 T58D 
Amp 
pCTY2066  pDR195/zebrafish 
PITPbeta i2 T58D 
Amp 
pCTY2067  pDR195/zebrafish 
PITPgamma T58D 
Amp 
  
pCTY2068  pDR195/Sec14 Amp 
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pCTY2069  pCTY705 Amp 
pCTY2070  pCTY706 Amp 
pCTY2071  pCTY705 R65A T236D Amp GFP Sec14 with 
PI-binding 
mutations 
pCTY2072  pCTY705 S173I T175I Amp GFP Sec14 with 
PC-binding 
mutations 
pCTY2073  pCTY705 M177W 
V194W 
Amp GFP Sec14 with 
pinched closed 
mutations 
  
pCTY2074  pLac33/Hyde CDIPT Amp zebrafish PI 
synthase; 
cloned for 
tetrad analysis 
for Taylor in 
David Hyde's 
lab 
pCTY2075  pLac33/wt CDIPT Amp  
pCTY2076  pLac33/LOP CDIPT Amp loss of function 
mutation for 
CDIPT 
pCTY2077  pDR195/Hyde CDIPT Amp cloned by 
Taylor (all 
CDIPT in 
pDR195) 
pCTY2078  pDR195/wt CDIPT Amp 
pCTY2079  pDR195/LOP CDIPT Amp 
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From Litvak et al Nat Cell Biol. Volume 7 | Number 3 | March 2005 
 
Washing buffer: 
125 mM NaCl, 5 mM KCl, 5.6 mM glucose, 20 mM Hepes-NaOH, pH 7.2, 1.8 mM 
CaCl2 and 1.8 mM MgCl2 
 
Washing buffer + 1mM xyloside 
0.1N NaOH 
Chondroitin sulphate (final: 0.6%) 
Cetylpyridinium Chloride (final: 1%) 
1% Cetylpyridinium chloride in 20 mM NaCl 
2M NaCl 
 
1.  Plate cells in 6 well plates and treat with siRNA 
2.  Wash with washing buffer, and incubate with washing buffer + xyloside for 15 min. at 
37ºC 
3.  Pulse-label with 80 μCi /ml of [35S]sulphate for 5 min at 37 °C. 
4.  Wash with serum-free DMEM, and incubate at 37 °C for ___(Litvak: 20, 40, and 60 
min.; Godi: 10, 15, 20, 30 min.) in serum-free DMEM containing 0.1% bovine 
serum albumin.  
5.  Recover the supernatant from the cell media by centrifugation at 12,000 g for 10 min. 
6.  Extract the cell monolayers with 0.1 M NaOH for 1 h at 37 °C.  
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7. Precipitate cell supernatants and extracts by incubation for 12 h at 24 °C by the 
addition of chondroitin sulphate and cetylpyridinium chloride (0.6% and 1% final 
concentrations, respectively).  
8.  Centrifuge the samples at 2,600 g for 10 min, wash precipitates twice with 1% 
cetylpyridinium chloride in 20 mM NaCl. 
9. Dissolve pellets in 2 M NaCl at 37 °C.  Measure radioactivity in a scintillation counter. 
Data is expressed as the ratio of the 35S-glycosaminoglycans in the supernatant to the 
total 35S-glycosaminoglycans (cell pellet plus supernatant). 
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Immunoprecipitation 
Solutions: 
5X Pull down lysis buffer   50 mL
100 mM Tris, pH7.4   5 mL of 1 M stock 
750 mM NaCl    18.75 mL of 2M stock 
20 mM MgCl2    2 mL of 0.5M stock 
10 mM EDTA    1 mL of 0.5M stock 
1% TritonX-100   500 μL 
 
Protocol: 
(Based on Upstate protocol) 
1.  Scrape cells into 1X Pull down buffer and put on orbital shaker for 15 minutes at 4ºC. 
2.  Wash agarose beads with PBS and make into a 50% slurry with IP buffer 
3.  Preclear lysate by adding 100 μL beads and shaking for 10 minutes at 4ºC. 
4.  Spin down lysate/beads, and collect cleared supernatant. 
5.  Incubate lysate, fresh beads, and antibody at 1:50 overnight at 4ºC. 
6.  Spin down beads and discard supernatant.  Wash 3-4 x 15 minutes in lysis buffer. 
7.  Resuspend beads in sample buffer and boil.  Spin down and run supernatant on a gel. 
 
Protein G- mouse 
Protein A - rabbit 
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siRNA protocol (Lipofectamine) 
 
1.  Plate cells at 60-80% confluency the day before siRNA treatment. 
2.  Into an eppendorf tube, add 50 μL OptiMEM and 1 μL Lipofectamine 2000 (or 
Lipofectamine) per 24 well.  Mix gently and incubate at RT for 5 minutes. 
3.  Into another eppendorf, add 50 μL OptiMEM and 1.5 μL 20 μM siRNA per 24 well 
well.  Mix gently. 
4.  Add contents of tube with siRNA to tube with Lipofectamine.  Incubate for 20-30 
minutes at RT (in hood). 
5.  Wash cells with OptiMEM.  Add 100 μL of OptiMEM to each well (this provides 
enough volume to cover the cells).  Add contents of tube to well. 
6.  After 4-8 hours, remove siRNA solution and add complete DMEM.  Time of 
incubation with siRNA varies with cell type and siRNA. 
7.  Assay cells 24-72 hours after siRNA. 
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Generation of chemical competent cells (RbCl-method) 
(GS 2008) 
 
1. Inoculate fresh single colony in 4 mL LB and grow at 37°C over night. 
2. Dilute 1 mL of overnight culture in 1L of LB (or YETM) media and grow at 28°C 
(or lower) temperature to OD 0.5 
3. Chill cells on ice for 5 - 10 min and spin in pre-chilled centrifuge at 1700 g for 10 
min. From this moment on never let cells warm and never vortex them! 
4.  Discard supernatant and resuspend pellet carefully (only swirling, no vortexing!) 
in 20 – 30 mL cold TFB1. Transfer cells to smaller tubes (e.g. 50 mL blue cap 
conical tubes) and spin at 1100 g for 10 min. 
5. Discard supernatant carefully (pellet will be very loose) and add approx 20 mL of 
TFB2. Carefully resuspend and incubate cells on ice for 15 – 30 min. 
6. Aliquot cells (we do 50 μL) in eppendorf tubes (on ice) using a multipipette. 
Close tubes and transfer to dry ice/ethanol mixture (use Styrofoam box) to snap 
freeze cells. Store cells at -80°C. 
 
Transformation (heat shock) 
1. Thaw cells on ice (5 – 10 min). Never let cells warm before heatshock! 
2. Add 1-5 μL plasmid (ligation…) and mix by flicking and incubate for 5-10 min. 
3. Heat shock for 35 seconds at 42°C in waterbath (do not use heated metal blocks).  
4. Immediately put on ice and incubate for 3-5 min. 
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5. Add 800 μL prewarmed LB media (no antibiotics) and incubate for 1h at 37°C 
while shaking. (For increased efficiency use 10 mL Falcon tubes). 
6. Plate cells on selective plates  
 
Solutions: 
YETM (1L) 
5 g Yeast Extract 
20g Tryptone 
10 g MgSO4*7H2O 
 
TFB1 (for 200 mL) 
0.59 g KAc (30 mM 
2.42 g RbCl (100 mM) 
0.29 g CaCl2 * 2H2O (10 mM) 
1.98 g (MnCl2) * 4H2O (50 mM) 
30 mL glycerol (15% v/v) 
 
Adjust to pH 5.8 with acetic acid (not KOH!). Filter sterilize and store refrigerated at 4°C 
 
TFB2, (for 200 mL) 
0.42 MOPS (10 mM) 
2.21 g CaCl2 * 2H2O (75mM) 
0.24 g RbCl (10 mM) 
30 mL glycerol (15% v/v) 
Adjust to pH 6.5 with KOH. Filter sterilize and store refrigerated at 4°C 
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PC/SM transfer assay 
1.  Calculate amounts of lipid, heart mitochondria, and SET buffer: 
 lipid: 8μL cold PC/2μL hot PC (SM) per 20 assays 
 heart mito: 15 μL/assay (currently – differs per prep) 
 total volume: 200 μL/assay + negative control+total+3-4 extra for error 
2.  Add 0.25, 0.5, 1 mg cytosol plus lysis buffer for a total volume of 500 μL.  Make 
blank with 500 μL lysis and no protein. 
3.  Add appropriate amount of lipids to Falcon tube, dry down under nitrogen gas. 
4.  Sonicate lipid on ice: 1 minute sonication, 1 minute rest on ice. 
5.  Dounce homogenize BHM ~5 times. 
6.  To lipids, add bovine heart mitochondria and lysis buffer.  Add 200 μL of 
lipid/BHM/lysis buffer mixture per tube and mix.  Save 200 μL of lipid/BHM/lysis buffer 
for total count. 
7.  Incubate for 30 minutes at 37ºC. 
8.  During incubation, cool 14.3% sucrose solution in syringes. 
9.  After incubation, place samples on ice.  Using 18 gauge needle, add 500μL 14.3% 
sucrose under the sample.  Do not mix sucrose and reaction. 
10.  Spin for 10’ at 12-14K (I prefer 14K/max). 
11.  Aspirate supernatant.  Remove as much supernatant as possible, but do not aspirate 
pellet. 
12.  Add 100 μL 10% SDS to each tube.  Resuspend by pipetting as much as possible.  If 
pellet does not fully dissolve (normally it won’t), either leave O/N at room temperature or 
boil for 5’. 
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13.  Transfer the contents of the tube to a scintillation vial with 5 mL scint fluid.  If 
samples were boiled, wash reaction tube with 100 μL methanol and transfer to scint vial. 
14.  Count samples on a 14C setting. 
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PI transfer assay 
1.  Calculate amounts of lipid, rat liver microsomes, and lysis buffer. 
 lipid: 25 μL PI/PC per sample 
 RLM: 35 μL/assay (currently – differs per prep) 
 total volume: 500 μL/assay + negative control+total+3-4 extra for error 
2.  Add appropriate amount of lipids to Falcon tube, dry down under nitrogen gas. 
3.  Sonicate lipid on ice: 1 minute sonication, 1 minute rest on ice.   
4.  Add 0.5, 1, 2 mg cytosol plus lysis buffer for a total volume of 500 μL. Make blank 
with 500 μL lysis buffer and no protein. 
5.  Add 200 μL 0.2M NaAc pH 5 (or pH 5.2) to tube of RLM.  Spin down 10 minutes at 
setting 10.   
6.  Resuspend pellet in 1 mL lysis buffer.  Dounce homogenize 10 times. 
7.  In 50 mL conical tube, mix lipids, RLM and lysis buffer. 
8.  Add 500 μL of lipid/RLM/lysis buffer mixture per tube.  Mix. Save 500 μL mixture 
for total count. 
9.  Incubate for 30 minutes at 37ºC. 
10.  After incubation, put samples on ice and stop reaction by adding 200 μL 0.2 M NaAc. 
11.  Spin 10’ setting 10 (4ºC or RT OK). 
12.  Count 1 mL of supernatant in 10 mL of scintillation fluid. 
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Tail preps 
(from Jim Alb) 
 
1.  Make master mix for dissolving tails.  Use glass pipettes to dispense. 
Per tail:  500 μL Nuclei Lysis solution 
  100 μL 1M Tris pH 7.5 
  10 μL Proteinase K (for O/N digestion; 20μL for several hour digestion) 
2.  Add 600 μL of master mix per tail. 
3.  Make sure tail is in solution, vortex, and incubate at 55ºC for several hours-O/N. 
4.  Add 200 μL of protein precipitation solution. 
5.  Mix and put on ice for at least 10 minutes. 
 Æ to stop at this point, put tubes in freezer 
6.  Spin 5 min. at max speed.  Prep tubes for next step. 
7.  Pour into tubes with an equal volume of isopropanol (~600μL). 
8.  Mix 10-12x and spin 5 min. at max speed. 
9.  Wash 1x with 70% EtOH (200-500μL).  Spin 5 min. at max speed. 
10.  Dry upside down for 30-45 min.  Flip tubes and continue drying for ~1 hour (or until 
mostly dry) 
11.  Add 200 μL of sterile water and incubate at RT with DNA overnight.  (If necessary, 
can be put at 37ºC for several hours, though resuspension won’t be as good.) 
12.  Use 1μL per PCR 
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Transforming DY380 recombineering bacteria strain 
From: P Liu, NA Jenkins, and NG Copeland, Genome Research 13:476-484, 2003. 
 
Activation of recombination enzymes (heat shock) 
1.  Grow O/N culture of DY380.   
2.  Dilute 0.5 mL of culture into 10 mL of low-salt LB.  Grow for 2-3 hours.  (Turn on 
42º shaking H2O bath at this time.) 
Note: I’ve used this amount of cells for 2 transformations, though the protocol seems to 
say that you should use the entire 10 mL for one transformation. 
3.  Transfer 10 mL cultures to 42ºC and shake for 15 minutes. 
4.  After heat-shock, place cultures on wet ice and shake to cool quickly.  Leave on ice 
for 5 minutes. 
5.  Spin down cultures and go to step 3 of the next protocol. 
 
Transformation 
1.  Grow cells in 5 mL of LB broth (low salt recommended) O/N at 30ºC (not greater than 
32ºC!). 
2.  Before beginning, put sterile H2O on ice. 
3.  Spin down bacteria and resuspend in 888 μL of ice cold water. 
4.  Transfer to a pre-chilled eppendorf, and centrifuge for 15-20 seconds at RT. 
5.  Place tubes on ice and aspirate the supernatant. 
6.  Wash cells two more times with cold water as before. 
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7.  Pellet cells and resuspend in 50 μL cold water.  Transfer to a pre-cooled 
electroporation cuvette with a 0.1 cm gap. 
8.  Add DNA.  They recommend 1 μL of BAC DNA (100 ng) or 1 ng of plasmid DNA.  
I’ve added more plasmid DNA and had success. 
9.  Electroporate under the following conditions: 
 -1.75 kV 
 -25 μF 
 -pulse controller set at: 200 Ω 
 Time constants will usually be around 4.0 
10.  Add 1.0 mL of LB to cuvette, transfer to blue-cap tube (or other sterile tube), and 
incubate at 32ºC for 1 hour. 
11.  Plate entire transformation. 
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Yeast FM4-64 labeling 
 
1.  Grow up yeast strains in YPD/selective media.  Shift to restrictive temperature for 2 
hours. 
2.  Label: Resuspend 4 OD in 100 μL media and label with 10 μM FM4-64 for 5-15 min 
at 25º or 37º. 
3.  Wash: wash cells 1-2 times and resuspend in 200 μL YPD (10-20 OD600 U/mL). 
4.  Chase: 10’, 20’, 30’ (pilot experiment). 
5.  Stop endocytosis: spin down cells, resuspend in ice cold media, add energy poison (1 
mM NaAz, 1 mM NaF), and keep on ice. 
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Immunofluorescent Staining of Yeast: SDS Permeabilization Method 
modified from: 
P. Brennwald 
June 1993 
 For More information and alternative methods see: "Immunoflourescence 
Methods for Yeast" by Pringle et.al on pg. 565 in Guide to Yeast Genetics and Molecular 
Biology edited by Guthrie and Fink (Vol. 194 of Methods in Enzymology). 
 
Materials: 
 
 1)  1.0M KPO4 pH 6.5 :  Make by mixing 33 mls of 1M K2HPO4 with 67 mls of 1M 
KH2PO4 
 2)  0.1M KPO4 pH 6.5 
 3)  0.1M KPO4 pH 7.5: Make 500 mls by mixing 41.7 mls of 1M K2HPO4 and 8.3 
mls of 1M KH2PO4 with 450 mls of ddH2O 
 4)  37% Formaldehyde 
 5)  KS Buffer: 0.1 M KPO4 pH 7.5/1.2 M Sorbitol 
 6)  Zymolyase 100T:  5 mg/ml solution in 0.1M KPO4/0.5% -
 mercaptoethanol 
 7)  -mercaptoethanol 
 8)  HS Buffer: 0.1 M Hepes pH 7.4/1.0 M Sorbitol 
 9)  HS/SDS Buffer: 0.1 M Hepes pH 7.4/1.0 M Sorbitol/0.5% SDS 
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10)  0.1 % Polylysine (MW >300,000; Sigma Cat. No. P-1524) Stored in 1ml or 10 ml 
aliquots at -20°C.  After thawing microfuge aliquot for 5 min. at 4°C before adding to 
slides. 
11) Multiwell teflon masked slides (Carlson Scientific Inc. Peotone IL. 
Cat.No.100806) 
12) PBT Buffer: PBS with1 mg/ml BSA and 0.02% Tween 20 
13) Primary Antibodies:  Affinity purified polyclonal antibodies or monoclonal 
antibodies from cell culture supernatant (not  from ascites fluid).  Dilutions must be 
determined emperically for each primary but common ranges are for affinity purified sera 
1:10 to 1:100 in PBT Buffer. For cell culture supernatants 1:1 to 1:5 dilutions are 
normally used (if cell supernatants were concentrated by ammonium sulfate precipitation 
then 1:10 to1:50 dilutions are often used).  After diluting in PBT buffer spin secondary in 
microfuge (at 4°C) for 5 min to pellet any debris. 
14) Secondary Antibodies: Jackson Immunoresearch Laboratories makes high quality 
secondary antibodies which are good for both single and double labeling experiments. 
We've been using: Texas Red conjugated AffiniPure Donkey Anti-Mouse IgG 
 (Cat#715-075-141) and Fluorescein (DTAF) conjugated AffiniPure Donkey Anti-
Rabbit IgG (Cat#711-015-132).  They are sent as freeze-dried powder which should be 
reconstituted with ddH2O according to directions and then aliquoted into 50 l/tube 
(marked with name of Ab and Date) and frozen on dry ice and stored in the "Secondary 
Antibodies" Box in the -80°C  Freezer. After thawing an aliquot keep it at 4°C--it 
should be  good for about a month.  These secondary Abs work very well for both 
double and single labeling and should be used at 1:50 to 1:100 dilutions each (in PBT 
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buffer). After diluting in PBT the solution should be microfuged for 5 min at 4°C to 
remove any precipitates that may have formed. 
 
Method: 
 
1)   Grow up 2 x 5 mL of yeast to OD 0.5-0.8 
2) Fix yeast directly in the culture by adding to each 5 mls of culture: 0.5 mls of 1.0 
M KPO4 pH 6.5 and 0.6 mls of 37% Formaldehyde directly to the culture flask.  Incubate 
at room temperature with gentle shaking for 30 min.   
3)  Transfer an amount of cells that is equal to about 2.5-5 OD599 units and spin for 5 
min.  
4) Aspirate off the supernatant and resuspend each pellet in 2.5 mls of 0.1 M KPO4 pH 
6.5 and transfer to a 15 ml centrifuge tube.  Add 0.3 mls of formaldehyde to each tube 
and incubate at room temperature for 1.5 hrs with gentle rocking. 
5)  Harvest fixed cells by centrifuging at for 5 min..  Aspirate off supernatant and 
resuspend in 2.5 mls of 0.1 M KPO4 pH 7.5 and repeat spin.  Aspirate off sup. and 
resuspend cells in 2.5 mls of 0.1 M KPO4/1.2 M sorbitol.  Fixed cells can now be stored 
overnight (or for several days) at 4°C. 
6) Prepare Zymolyase solution by dissolving 2-5 mg of Zymolyase in 0.1 M KPO4 
pH 7.5 to give 5 mg/ml solution. Add β-mercaptoethanol to 0.5 % (i.e. 5 μl/ml), mix by 
gently vortexing and let sit at room temp. for 20-30 min to dissolve. 
7)  Harvest fixed cells at 2.2K RPM for 5 min.  Aspirate off supernatant and 
resuspend in 0.5 ml of 0.1 M KPO4 pH 7.5/1.2 M Sorbitol.  
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8)  Transfer cells to a 13x100 mm glass culture tube (i.e. blue capped tubes). Add 22.5 μl 
of 5 mg/ml Zymolyase solution and 2.5 μl of β-mercaptoethanol and incubate at 30°C for 
30 min with occassional mixing by finger-flicking. 
9)  Harvest spheroplasts for 5 min.  Resuspend cells in 1.5 mls of HS Buffer and spin.  
Aspirate off supernatant and repeat wash one time.  
10) To permeabilize cells resuspend spheroplasts in 1.5 mls of HS/SDS and incubate 
at room temperature for 5 min.   
11)  Centrifuge for 5 min and resuspend cells in 1.5 mls of HS Buffer and spin.   
12)  Aspirate supernatant and repeat wash with HS Buffer.  Resuspend cells in 0.5 ml of 
HS Buffer.  Do not store the cells for more than a few hours at this stage. 
13) Set up an aspirator with "pulled" pasteur pipette at the end near to where the 
slides are to be processed to speed up the washing procedures.   
14) Prepare slides by adding 20 μl of 0.1% polylysine to each well and incubate for 5-10 
min. Aspirate off and wash each well 3 times with one drop of ddH2O. 
15)  Place 20 μl of spheroplasted/permeabilized cell suspension on each well.  
Incubate for 5-10 min.  Aspirate each well and add one drop per well of PBT Buffer. 
Repeat twice and let sit while primary Ab dilutions are prepared. 
16) Prepare dilutions of primary antibodies in PBT and microfuge before use. Add 20 
μl of diluted primary antibody and transfer slides to a plastic box with a moistened paper 
towel at the bottom.  Incubate 60-90 min. 
17)   Carefully remove slides from box to benchtop for washing.  To wash slides 
rapidly, hold aspirating pipette in one hand and another pastuer pipette with a rubber bulb 
containing PBT Buffer in the other hand.  For each well aspirate the liquid and then add 
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one drop of PBT, aspirate add PBT, repeat this twice (leaving the well with a drop of 
PBT) and then move on to the next well.  It is important that the wells do not dry out 
once antibodies have been added.  Once all the wells have been washed move on the next 
slide.  Then repeat this entire procedure twice so that each well has been washed at least 
nine-times.  This may seem excessive but it often dramatically increases the quality of the 
images obtained and once you get the hang of using both hands it can be done fairly 
quickly. 
18) Wrap plastic box used for primary Ab incubations in foil so it is light tight.  Place 
slides inside and place 20 μl of secondary antibody in each well.  Incubate for 60-90 min 
at room temperature. 
13) Wash the wells as before with a total of at least 9-10 washes of PBT Buffer.  
Aspirate the wells dry after the last wash and let air dry underneath a piece of foil (make 
a tent) for 10-15 min. 
14) Place 4 evenly spaced small drops of mounting medium in between the two 
columns of wells in the middle of the slide.  Carefully place the coverslip over the slide 
and let mounting medium spread. Seal the slides with nailpolish, let dry 10-15 min.  Then 
rinse off slides with ddH20, dry with a kimwipe and view immediately or store in dark at 
-20°C.  
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Zebrafish in situ hybridization 
from: Parichy lab and C. Moens protocols 
 
Probe preparation All steps after 1b to be performed RNase free 
1. cDNA template preparation 
a. linearize cDNA by digesting with appropriate restriction enzyme for 2 hr, 37 °C 
Typically digest enough DNA so it can be used for multiple riboprobe syntheses, e.g.: 
• 20 ug plasmid DNA + nano H20 174 μl 
• 10x restriction enzyme buffer 20 μl 
• BSA 2 μl 
• restriction enzyme (10U/ul) 4 μl 
Avoid using restriction enzymes (e.g., Sac I, Kpn I, Pst I) that leave a 3’ overhand, as this can 
result in inappropriate transcription of sense RNA that may contribute to background. 
b. add equal volume phenol-chloroform-isoamyl alcohol (pH 8.0); vortex 10 sec; 
centrifuge 
at maximum speed 5 min 
c. remove aqueous (upper) phase to new RNase-free 1.5 ml tube (do not disturb interface 
between phases) 
d. add 0.1x volume 3 M sodium acetate pH 5.2 and 2.5x volume 100% ethanol; vortex 
and 
leave on ice 15 min 
e. centrifuge at maximum speed 15 min at room temperature 
f. remove supernatant and add 1 ml 70% ethanol; centrifuge at maximum speed 5 minutes 
at room temperature; draw off supernatant, air dry briefly 
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g. resuspend in nano H20 at 1–2x original volume that you took from your plasmid prep 
h. check cutting efficiency and determine template concentration on a 1% agarose gel 
Run 0.1 μl of sample on gel (dilute 1 μl DNA into 9 μl TE, then dilute 1 μl of this into 9 μl TE). 
Run alongside 250, 500 ng lambda–Hind III to estimate concentration. Make sure that templates 
are completely linearized, as circular DNA will result in probes including the vector sequence 
i. store cut DNA at –20 °C 
2. Riboprobe synthesis 
a. Ambion … kit 
b. stop the reaction and precipitate the probe by adding: 
• 0.5 M EDTA, pH 8.0 2.0 μl 
• 4 M LiCl 2.5 μl 
• 100% EtOH 75.0 μl 
c. place at –80 °C, 10 min to overnight ; spin at maximum speed 30 min 
d. remove supernatant and wash with 70% EtOH; spin 5 min; remove supernatant and air 
dry briefly 
e. resuspend by vortexing in 100 μl nano H20; add 1 μl Superasin RNase inhibitor 
 
Check riboprobe quality on an agarose/MOPS/formaldehyde gel (optional): 
prepare gel: 
• 33 ml nano H20 
• 4 ml 10X MOPS buffer2 
• 0.6 g agarose 
melt in microwave and when cool enough to touch add 2.2 ml 37% 
formaldehyde, swirl, and pour immediately; cover gel box while gel sets 
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prepare samples: 
to PCR tubes, add: 
• 3 μl RNA loading buffer3 
• 2 μl nano H20 
• 1 μl riboprobe 
prepare an extra tube as above for RNA ladder (stored at –80 °C) 
heat all tubes at 65 °C for 15 min; quick chill on ice 
It is essential to denature the single stranded RNA molecules, which otherwise will 
migrate as a smear or as irregular bands that cannot be evaluated. 
run gel: 
use 1X MOPS as running buffer, load all of sample and run at medium voltage (~100V); 
do not add ethidium bromide (it is already in the RNA loading buffer) 
inspect probe: 
Successful probe synthesis should yield a single fragment at the expected size for intact 
probes and a smear at ~300 nt for fragmented probes. If this is not observed, DO NOT 
PROCEED with in situ hybridization! 
f. Store probes at –80 °C after adding a small amount (~1 μl) of Ambion SUPERaseIn 
RNase inhibitor 
 
Embryo Fixation and Hybridization 
-Fix embryos in 4% Paraformaldehyde/PBS (PFA), 5 h. at room temp. or overnight at 
4oC 
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(Paraformaldehyde should be made fresh weekly as an 8% stock in sterile water and 
diluted 1:1 with 2x PBS before use. 8% PFA should be stored at 4°C) 
optional: for long term storage, wash 1 x in 100% MeOH, 10 min., then store at  -20oC in 
100% MeOH. If embryos are stored in MeOH, before proceeding to next step, rehydrate 
embryos through 75% methanol/25% PBST, 50%methanol/50% PBST, and 
25%methanol/75% PBST washes.  
-Wash 5 x 5 min. at room temp in PBST (PBS/0.1% Tween-20). All PBST washes should 
be in 
approximately 0.5 mls. 
-For embryos older than ~10 hpf: 
-permeabilize by treating with 10 ug/ml Prot. K in PBST, 5-20 min at room temp 
accordingto age: eg: 1 min for 2-4 somite embryos, 3min for 9-13 somite mbryos, 
5 min for 18-24 hour embryos, etc. Do not over-digest or embryos will fall apart 
during subsequent steps. 
-refix in 4% PFA in PBS for 20 min. at room temp. 
-rinse 5 x 5 min. in PBST (not necessary if embryos were not proK’d) 
-Prehyb for at least 1 hour at 65oC in hyb. mix (recipe below) 
-Dilute 100ng labeled RNA probe in hyb. mix (probe dilution is arrived at empirically, 
however asa first approximation, dilute probe 1/200 in hyb mix.) 
-Remove prehyb and add pre-warmed hyb mix plus probe to embryos. 
-Hybridize overnight at 65ºC 
Day 2: post-hybridization washes 
Notes: 
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a) Prewarm washing solutions before adding to embryos. 
b) hyb mix containing probe can be removed, stored at –20°C and re-used many times 
without anyloss of signal. 
c) For the following washes, you can use hyb mix that does not contain tRNA or heparin 
if youwish to conserve these reagents. 
-Wash 5 min in 66% hyb mix, 33% 2 x SSC at 65oC. 
-Wash 5 min in 33% hyb mix, 66% 2 x SSC at 65oC 
-Wash 5 min in 2 x SSC at 65oC 
-*Wash 1 x 20 min in 0.2 x SSC +0.1% Tween-20 at 65oC 
-*Wash 2 x 20 min in 0.1 x SSC+0.1% Tween-20 at 65oC (high stringency) 
-Wash 5 min in 66% 0.2 x SSC, 33% PBST at room temp. 
-Wash 5 min in 33% 0.2 x SSC, 66% PBST at room temp. 
-Wash 5 min in PBST at room temp 
* Timing is critical 
Anti-digoxigenin-Alkaline Phosphatase Binding (first antibody) 
-incubate in blocking solution (PBST plus 2% sheep serum, 2 mg/ml BSA) 1 hour at 
room temp. 
-prepare first antibody (eg, alkaline-phosphatase conjugated anti-digoxigenin) by diluting 
it in blocking solution; 1:5000. 
-incubate in antibody for 2 hours shaking at room temp, or overnight at 4oC. 
-wash 5 x 15 min in PBST (may leave in the last PBST wash at 4oC overnight, or 
proceed directly to the next step) 
Day 3: First Colouration Step 
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-wash 4 x 5 min in Coloration Buffer2 
-mix 45 ul nitro-blue tetrazolium (NBT) stock with 10 ml Coloration Buffer, then add 35 
ul 5-bromo-4-chloro-3-indolyl phosphate (BCIP) stock. 
- add 500 ul of this mix to embryos and incubate in the dark at room temperature until a 
blue reaction product is visible. (colour should become visible within 3-4 hours at most. 
Coloration reaction can be sped up by incubating at 30oC, or slow by incubating at 4oC). 
-stop reaction by washing embryos 2-4 x in sterile water. 
-store in PBST unless doing a two color in situ. For single-colour in situs proceed to 
mounting. 
 
 
2. Colouration Buffer 
(make fresh each use) 
100 mM Tris-Hcl, pH9.5 5 ml of 1M 
50 mM MgCl2 2.5 ml of 1M 
100 mM NaCl 1 ml of 5M 
0.1% Tween-20 250 μl of 20% 
sterile water to 50 ml 
 
“Fake” hybridization solution: 
Same as hybridization solution, but without expensive components. 
formamide 250 ml 
20X SSC 125 ml 
10% Tween-20 10 ml 
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1 M citric acid 4.6 ml 
nano H2O to 500 ml total 
Store at room temperature. 
 
Hybridization solution (T-hyb): 
formamide 250 ml 
20X SSC12 125 ml 
50 mg/ml yeast tRNA 5 ml 
10% Tween-20 10 ml 
1 M citric acid 4.60 ml 
50 mg/ml heparin 500 μl 
nano H2O to 500 ml total 
 
Antibody blocking solution: 
5% heat inactivated goat serum, 2 mg / ml BSA in PBST2. Sterile filter and store at 4 °C. 
Goat serum is heat inactivated by incubating 45 min at 50 °C, aliquot and freeze at –20 
°C. 
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